BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12:1203-1207. [PMID: 16964257 DOI: 10.1038/nm1477] [Cited by in Crossref: 1394] [Cited by in F6Publishing: 1448] [Article Influence: 82.0] [Reference Citation Analysis]
Number Citing Articles
1 Yunis J, Short KR, Yu D. Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation. Trends Microbiol 2023:S0966-842X(22)00342-0. [PMID: 36635162 DOI: 10.1016/j.tim.2022.12.008] [Reference Citation Analysis]
2 Debnath A, Saha A, Singh MK, Saha RP, Das A. Avian influenza virus: Prevalence infection and therapy. Viral, Parasitic, Bacterial, and Fungal Infections 2023. [DOI: 10.1016/b978-0-323-85730-7.00035-7] [Reference Citation Analysis]
3 Lianou A, Panagou EZ, Nychas GE. Meat safety—I Foodborne pathogens and other biological issues. Lawrie's Meat Science 2023. [DOI: 10.1016/b978-0-323-85408-5.00015-7] [Reference Citation Analysis]
4 Nymo IH, Siebert U, Baechlein C, Postel A, Breines EM, Lydersen C, Kovacs KM, Tryland M. Pathogen Exposure in White Whales (Delphinapterus leucas) in Svalbard, Norway. Pathogens 2022;12. [PMID: 36678406 DOI: 10.3390/pathogens12010058] [Reference Citation Analysis]
5 Vakili K, Fathi M, Yaghoobpoor S, Sayehmiri F, Nazerian Y, Nazerian A, Mohamadkhani A, Khodabakhsh P, Réus GZ, Hajibeygi R, Rezaei-Tavirani M. The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature. Front Cell Infect Microbiol 2022;12:983089. [PMID: 36619768 DOI: 10.3389/fcimb.2022.983089] [Reference Citation Analysis]
6 Chen Y, Wang F, Yin L, Jiang H, Lu X, Bi Y, Zhang W, Shi Y, Burioni R, Tong Z, Song H, Qi J, Gao GF. Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes. Nat Commun 2022;13:7603. [PMID: 36494358 DOI: 10.1038/s41467-022-35236-y] [Reference Citation Analysis]
7 Shi X, Wu B, Chen J, Luo J, Li M, Jiang Z, Shi Y. Enhanced activity of NLRP3 inflammasome and its proinflammatory effect in influenza A viral pneumonia. Future Virology 2022. [DOI: 10.2217/fvl-2021-0025] [Reference Citation Analysis]
8 Chen Z, Ye SY. Research progress on antiviral constituents in traditional Chinese medicines and their mechanisms of action. Pharm Biol 2022;60:1063-76. [PMID: 35634712 DOI: 10.1080/13880209.2022.2074053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Torres A, Shahi A, Quelal K, Malhotra S. Worse In-Hospital Outcomes Among Patients With Heart Failure (HF) and Concomitant Influenza Infection. Cureus 2022;14:e32925. [PMID: 36699806 DOI: 10.7759/cureus.32925] [Reference Citation Analysis]
10 Yao D, Bao L, Li F, Liu B, Wu X, Hu Z, Xu J, Wang W, Zhang X. H1N1 influenza virus dose dependent induction of dysregulated innate immune responses and STAT1/3 activation are associated with pulmonary immunopathological damage. Virulence 2022;13:1558-72. [PMID: 36082929 DOI: 10.1080/21505594.2022.2120951] [Reference Citation Analysis]
11 Zhang J, Wang X, Ding S, Ma K, Jiang Y, Guo Y, Zhang T, Liu Y, Li H, Liao M, Qi W. Key amino acid position 272 in neuraminidase determines the replication and virulence of H5N6 avian influenza virus in mammals. iScience 2022;25:105693. [PMID: 36567717 DOI: 10.1016/j.isci.2022.105693] [Reference Citation Analysis]
12 Xu P, Yang Z, Du S, Hong Z, Zhong S. Intestinal microbiota analysis and network pharmacology reveal the mechanism by which Lianhua Qingwen capsule improves the immune function of mice infected with influenza A virus. Front Microbiol 2022;13:1035941. [PMID: 36504796 DOI: 10.3389/fmicb.2022.1035941] [Reference Citation Analysis]
13 Mumtaz A, Rehman E, Rahaman MA, Rehman S. Inflammatory biomarkers and cardiac injury in COVID-19 patients. Front Public Health 2022;10:1024535. [PMID: 36505005 DOI: 10.3389/fpubh.2022.1024535] [Reference Citation Analysis]
14 Meng H, Wang S, Tang X, Guo J, Xu X, Wang D, Jin F, Zheng M, Yin S, He C, Han Y, Chen J, Han J, Ren C, Gao Y, Liu H, Wang Y, Jin R. Respiratory immune status and microbiome in recovered COVID-19 patients revealed by metatranscriptomic analyses. Front Cell Infect Microbiol 2022;12:1011672. [PMID: 36483456 DOI: 10.3389/fcimb.2022.1011672] [Reference Citation Analysis]
15 Gandhi L, Maisnam D, Rathore D, Chauhan P, Bonagiri A, Venkataramana M. Respiratory illness virus infections with special emphasis on COVID-19. Eur J Med Res 2022;27:236. [DOI: 10.1186/s40001-022-00874-x] [Reference Citation Analysis]
16 Wang M, Huang P, Liu W, Tan W, Chen T, Zeng T, Zhu C, Shao J, Xue H, Li J, Yue M. Risk factors of severe fever with thrombocytopenia syndrome combined with central neurological complications: A five-year retrospective case–control study. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1033946] [Reference Citation Analysis]
17 Raghavan G, Shivanna Y, Gunti P, Bapna A, Pravin C, Vyas T. Immunostimulatory Activity of a Novel Ayurvedic Propriety Formulation Based on Extracts of Herbs used in Chyavanprash. Phytomedicine Plus 2022. [DOI: 10.1016/j.phyplu.2022.100383] [Reference Citation Analysis]
18 Seth P, Sarkar N. A comprehensive mini-review on amyloidogenesis of different SARS-CoV-2 proteins and its effect on amyloid formation in various host proteins. 3 Biotech 2022;12. [DOI: 10.1007/s13205-022-03390-1] [Reference Citation Analysis]
19 Penn R, Tregoning JS, Flight KE, Baillon L, Frise R, Goldhill DH, Johansson C, Barclay WS. Levels of Influenza A Virus Defective Viral Genomes Determine Pathogenesis in the BALB/c Mouse Model. J Virol 2022;:e0117822. [PMID: 36226985 DOI: 10.1128/jvi.01178-22] [Reference Citation Analysis]
20 Rada M. Grubovic Rastvorceva, Sedula Useini, Milena Stevanovic, Ilir Demiri, Elena Petkovic, Massimo Franchini, Daniele Focosi. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients—An Open-Label Phase II Clinical Trial. Life (Basel) 2022;12:1565. [PMID: 36295001 DOI: 10.3390/life12101565] [Reference Citation Analysis]
21 Kelly JN, Laloli L, V’kovski P, Holwerda M, Portmann J, Thiel V, Dijkman R. Comprehensive single cell analysis of pandemic influenza A virus infection in the human airways uncovers cell-type specific host transcriptional signatures relevant for disease progression and pathogenesis. Front Immunol 2022;13:978824. [DOI: 10.3389/fimmu.2022.978824] [Reference Citation Analysis]
22 Mia MM, Hasan M, Ahmed S, Rahman MN. Insight into the first multi-epitope-based peptide subunit vaccine against avian influenza A virus (H5N6): An immunoinformatics approach. Infection, Genetics and Evolution 2022;104:105355. [DOI: 10.1016/j.meegid.2022.105355] [Reference Citation Analysis]
23 Tao P, Ning Z, Zhou P, Xiao W, Wang G, Li S, Zhang G. H3N2 canine influenza virus NS1 protein inhibits canine NLRP3 inflammasome activation. Vet Immunol Immunopathol 2022;252:110483. [PMID: 36088788 DOI: 10.1016/j.vetimm.2022.110483] [Reference Citation Analysis]
24 Yang S, Wang L, Pan X, Liang Y, Zhang Y, Li J, Zhou B. 5-Methoxyflavone-induced AMPKα activation inhibits NF-κB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo. Cell Mol Biol Lett 2022;27:82. [PMID: 36180831 DOI: 10.1186/s11658-022-00381-1] [Reference Citation Analysis]
25 Sabikunnahar B, Lahue KG, Asarian L, Fang Q, Mcgill MM, Haynes L, Teuscher C, Krementsov DN. Sex differences in susceptibility to influenza A virus infection depend on host genotype. PLoS ONE 2022;17:e0273050. [DOI: 10.1371/journal.pone.0273050] [Reference Citation Analysis]
26 Lee M, Yu C, Chen X, Liu M, Yang J, Chen A, Huang C. Influenza A virus NS1 protein represses antiviral immune response by hijacking NF-κB to mediate transcription of type III IFN. Front Cell Infect Microbiol 2022;12:998584. [DOI: 10.3389/fcimb.2022.998584] [Reference Citation Analysis]
27 Sun J, Ma X, Zhang M, Xie M, Zhang X, Han X, Li X, Zhou E, Wang J, She D, Wang J. Comparisons of lymphocytes profiles and inflammatory cytokines levels in blood of patients with differed severity of infection by human adenovirus type 7 Running title: HAdV-7 infection and immune dysfunction.. [DOI: 10.21203/rs.3.rs-2017183/v1] [Reference Citation Analysis]
28 French H, Pitré E, Oade MS, Elshina E, Bisht K, King A, Bauer DLV, Te Velthuis AJW. Transient RNA structures cause aberrant influenza virus replication and innate immune activation. Sci Adv 2022;8:eabp8655. [PMID: 36083899 DOI: 10.1126/sciadv.abp8655] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
29 Zhang Z, Wang P, Ma C, Wang J, Li W, Quan C, Cao H, Guo H, Wang L, Yan C, Carr MJ, Meng L, Shi W. Host inflammatory response is the major factor in the progression of Chlamydia psittaci pneumonia. Front Immunol 2022;13:929213. [DOI: 10.3389/fimmu.2022.929213] [Reference Citation Analysis]
30 Kazempour Dizaji M, Jamaati H, Bahrami N, Farzanegan B, Rekabi M, Mokhber Dezfuli M, Heshmat Nia J, Madani M, Daustani M, Shirian S, Masoumi L, Ghaemi A, Narimani A, Khakbaz M, Mohamadnia A, Varahram M, Velayati AA, Biostatistics Department, Mycobacteriology Research Center, National Research Institute of Tuberculosis and lung Diseases, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran, Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran, Critical Care Quality Improvement Research Center at Shahid Modarres Hospital, Department of Anesthesiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Lung transplantation Research Center, National Research Institute of Tuberculosis, and lung Diseases, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran, Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran, Department of Biotechnology, Faculty of Sciences, Islamic Azad University, Tehran, Iran, Department of Pathology, School of Veterinary Medicine, Shahrekord University, Shahrekord, Iran, Shefa Khatam Neuroscience Research Center, Tehran, Iran, Department of Virology, Pasture Institute, Tehran, Iran, Department of Cell and Molecular Biology, School of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran, Department of Cell and Molecular Biology, School of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran, Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran, Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. Effect of Cytokines Gene Expression and Serum Level of Vitamin D on the Severity of COVID-19. Iran J Med Microbiol 2022;16:412-419. [DOI: 10.30699/ijmm.16.5.412] [Reference Citation Analysis]
31 Bauer L, Rijsbergen LC, Leijten L, Benavides FFW, Noack D, Lamers MM, Haagmans BL, de Vries RD, de Swart RL, van Riel D. The pro-inflammatory response to influenza A virus infection is fueled by endothelial cells.. [DOI: 10.1101/2022.08.19.504520] [Reference Citation Analysis]
32 Bisht K, Te Velthuis AJW. Decoding the Role of Temperature in RNA Virus Infections. mBio 2022;:e0202122. [PMID: 35980031 DOI: 10.1128/mbio.02021-22] [Reference Citation Analysis]
33 Li K, Mccaw JM, Cao P. Enhanced viral infectivity and reduced interferon production are associated with high pathogenicity for influenza viruses.. [DOI: 10.1101/2022.07.29.501947] [Reference Citation Analysis]
34 Almanza G, Clark AE, Kouznetsova V, Olmedillas E, Castro A, Tsigelny IF, Wu Y, Gao GF, Leibel SL, Bray W, Ollmann Saphire E, Carlin AF, Zanetti M. Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern. PLoS Pathog 2022;18:e1010686. [DOI: 10.1371/journal.ppat.1010686] [Reference Citation Analysis]
35 Faist A, Janowski J, Kumar S, Hinse S, Çalışkan DM, Lange J, Ludwig S, Brunotte L. Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond. Cells 2022;11:2198. [DOI: 10.3390/cells11142198] [Reference Citation Analysis]
36 Pliasas VC, Menne Z, Aida V, Yin J, Naskou MC, Neasham PJ, North JF, Wilson D, Horzmann KA, Jacob J, Skountzou I, Kyriakis CS. A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model. Front Immunol 2022;13:915364. [DOI: 10.3389/fimmu.2022.915364] [Reference Citation Analysis]
37 Kostikova V, Zarubaev V, Esaulkova I, Sinegubova E, Kadyrova R, Shaldaeva T, Veklich T, Kuznetsov A. The antiviral, antiradical, and phytochemical potential of dry extracts from Spiraea hypericifolia, S. media, and S. salicifolia (Rosaceae). South African Journal of Botany 2022;147:215-22. [DOI: 10.1016/j.sajb.2022.01.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Spira B. The Impact of the Highly Virulent SARS-CoV-2 Gamma Variant on Young Adults in the State of São Paulo: Was It Inevitable? Cureus 2022. [DOI: 10.7759/cureus.26486] [Reference Citation Analysis]
39 Xing J, Shi C, Sun M, Gu W, Zhang R, Chen H, Li Y, Wang D, Li J, Niu T, Huang Q, Qian J, Huang HB, Jiang Y, Wang J, Cao X, Wang N, Zeng Y, Yang G, Yang WT, Wang C. Lactiplantibacillus plantarum 0111 Protects Against Influenza Virus by Modulating Intestinal Microbial-Mediated Immune Responses. Front Microbiol 2022;13:820484. [DOI: 10.3389/fmicb.2022.820484] [Reference Citation Analysis]
40 Briceno Noriega D, Savelkoul HFJ. Vitamin D: A Potential Mitigation Tool for the Endemic Stage of the COVID-19 Pandemic? Front Public Health 2022;10:888168. [PMID: 35757617 DOI: 10.3389/fpubh.2022.888168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Wang Y, Lee Y, Matsuura K, Liu X, Cheng C. Editorial: Detection Nanodevices for Infectious Diseases. Front Bioeng Biotechnol 2022;10:962746. [DOI: 10.3389/fbioe.2022.962746] [Reference Citation Analysis]
42 Wang M, Bohórquez JA, Muñoz-González S, Gerber M, Alberch M, Pérez-Simó M, Abad X, Liniger M, Ruggli N, Ganges L. Removal of the Erns RNase Activity and of the 3' Untranslated Region Polyuridine Insertion in a Low-Virulence Classical Swine Fever Virus Triggers a Cytokine Storm and Lethal Disease. J Virol 2022;:e0043822. [PMID: 35758667 DOI: 10.1128/jvi.00438-22] [Reference Citation Analysis]
43 Chatterjee B, Singh Sandhu H, Dixit NM. Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms. PLoS Pathog 2022;18:e1010630. [DOI: 10.1371/journal.ppat.1010630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 de Sá KS, Amaral LA, Caetano CC, Becerra A, Batah SS, de Oliveira IM, Lopes LS, Almeida L, Oliveira S, Wada DT, Koenigkam-santos M, Martins RB, Rosales RRC, Arruda E, Fabro AT, Zamboni DS. Inflammasome activation and pulmonary viral loads define two distinct clinical outcomes in COVID-19.. [DOI: 10.1101/2022.06.24.22276878] [Reference Citation Analysis]
45 Rybkina K, Davis-Porada J, Farber DL. Tissue immunity to SARS-CoV-2: Role in protection and immunopathology. Immunol Rev 2022. [PMID: 35752871 DOI: 10.1111/imr.13112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
46 Li P, Xu Y, Cao Y, Ding Z. Polypeptides Isolated from Lactococcus lactis Alleviates Lipopolysaccharide (LPS)-Induced Inflammation in Ctenopharyngodon idella. Int J Mol Sci 2022;23:6733. [PMID: 35743169 DOI: 10.3390/ijms23126733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Ashtiwi NM, Sarr D, Nagy T, Reneer ZB, Tripp RA, Rada B. The Hypothiocyanite and Amantadine Combination Treatment Prevents Lethal Influenza A Virus Infection in Mice. Front Immunol 2022;13:859033. [PMID: 35663985 DOI: 10.3389/fimmu.2022.859033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Wallis RS, O’garra A, Sher A, Wack A. Host-directed immunotherapy of viral and bacterial infections: past, present and future. Nat Rev Immunol. [DOI: 10.1038/s41577-022-00734-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Pacheco-Hernández LM, Ramírez-Noyola JA, Gómez-García IA, Ignacio-Cortés S, Zúñiga J, Choreño-Parra JA. Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza. J Interferon Cytokine Res 2022. [PMID: 35674675 DOI: 10.1089/jir.2022.0029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
50 Karwaciak I, Karaś K, Sałkowska A, Pastwińska J, Ratajewski M. Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes. Molecules 2022;27:3651. [PMID: 35744777 DOI: 10.3390/molecules27123651] [Reference Citation Analysis]
51 Stumpff JP, Kim SY, Forero A, Nishida A, Steuerman Y, Gat-viks I, Nair MG, Morrison J. Pleural macrophages promote recovery from influenza virus infection.. [DOI: 10.1101/2022.05.25.493482] [Reference Citation Analysis]
52 Lampart M, Zellweger N, Bassetti S, Tschudin-Sutter S, Rentsch KM, Siegemund M, Bingisser R, Osswald S, Kuster GM, Twerenbold R. Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections-A prospective cohort study. PLoS One 2022;17:e0269005. [PMID: 35622838 DOI: 10.1371/journal.pone.0269005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Shokouhi Targhi H, Mehrbod P, Fotouhi F, Amininasab M. In vitro anti-influenza assessment of anionic compounds ascorbate, acetate and citrate. Virol J 2022;19. [DOI: 10.1186/s12985-022-01823-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Lee YJ, Shirkey JD, Park J, Bisht K, Cowan AJ. An Overview of Antiviral Peptides and Rational Biodesign Considerations. BioDesign Research 2022;2022:1-19. [DOI: 10.34133/2022/9898241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Lezhnina A, Lem V, Blatt N. Application of Extracorporeal Apheresis in Treatment of COVID-19: a Rapid Review. BioNanoSci . [DOI: 10.1007/s12668-022-00987-x] [Reference Citation Analysis]
56 Kolter J, Henneke P, Groß O, Kierdorf K, Prinz M, Graf L, Schwemmle M. Paradoxical immunodeficiencies-When failures of innate immunity cause immunopathology. Eur J Immunol 2022. [PMID: 35551651 DOI: 10.1002/eji.202149531] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Ilinykh PA, Huang K. What Do Antibody Studies Tell Us about Viral Infections? Pathogens 2022;11:560. [DOI: 10.3390/pathogens11050560] [Reference Citation Analysis]
58 Chen X, Pacis AS, Aracena KA, Gona S, Kwan T, Groza C, Lin YL, Sindeaux RHM, Yotova V, Pramatarova A, Simon M, Pastinen TM, Barreiro L, Bourque G. Transposable elements are associated with the variable response to influenza infection.. [DOI: 10.1101/2022.05.10.491101] [Reference Citation Analysis]
59 Kashem MA, Li L, Yuan X, Plummer FA, Luo M. Toll-like Interleukin -1 Receptor Regulator (TILRR) Protein, a Major Modulator of Inflammation, is Expressed in Normal Human and Macaque Tissues and PBMCs. JIR 2022;Volume 15:2925-37. [DOI: 10.2147/jir.s357866] [Reference Citation Analysis]
60 Baqerkhani M, Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran, Soleimanzadeh A, Ghaleh HE, Farzanehpour M, Department of Theriogenology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran, Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran, Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. Futurology and monitoring in the field of virology to deal with emerging diseases. RJMM 2022;125:253-263. [DOI: 10.55453/rjmm.2022.125.2.12] [Reference Citation Analysis]
61 Koszalka P, Subbarao K, Baz M. Preclinical and clinical developments for combination treatment of influenza. PLoS Pathog 2022;18:e1010481. [PMID: 35551301 DOI: 10.1371/journal.ppat.1010481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Zhang L, Xu J, Qi X, Tao Z, Yang Z, Chen W, Wang X, Pan T, Dai Y, Tian R, Chen Y, Tang B, Liu Z, Tan R, Qu H, Yu Y, Liu J. Development and Validation of a Nomogram for Predicting the Risk of Coronavirus-Associated Acute Respiratory Distress Syndrome: A Retrospective Cohort Study. IDR 2022;Volume 15:2371-81. [DOI: 10.2147/idr.s348278] [Reference Citation Analysis]
63 González-ruiz FJ. Pharmacological and non-pharmacological strategies in coronavirus disease 2019: A literature review. Annals of Medicine and Surgery 2022;77:103709. [DOI: 10.1016/j.amsu.2022.103709] [Reference Citation Analysis]
64 Chauhan RP, Gordon ML. An overview of influenza A virus genes, protein functions, and replication cycle highlighting important updates. Virus Genes 2022. [PMID: 35471490 DOI: 10.1007/s11262-022-01904-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
65 Ferreira AC, Sacramento CQ, Pereira-dutra FS, Fintelman-rodrigues N, Silva PP, Mattos M, de Freitas CS, Marttorelli A, de Melo GR, Macedo MC, Azevedo-quintanilha IG, Carlos AS, Emídio JV, Garcia CC, Bozza PT, Bozza FA, Souza TML. Macrophages undergo necroptosis during severe influenza A infection and contribute to virus-associated cytokine storm.. [DOI: 10.1101/2022.04.20.488871] [Reference Citation Analysis]
66 Brownlie D, Rødahl I, Varnaite R, Asgeirsson H, Glans H, Falck-Jones S, Vangeti S, Buggert M, Ljunggren HG, Michaëlsson J, Gredmark-Russ S, Smed-Sörensen A, Marquardt N. Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza. Front Immunol 2022;13:834862. [PMID: 35371005 DOI: 10.3389/fimmu.2022.834862] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
67 Corry J, Kettenburg G, Upadhyay AA, Wallace M, Marti MM, Wonderlich ER, Bissel SJ, Goss K, Sturgeon TJ, Watkins SC, Reed DS, Bosinger SE, Barratt-Boyes SM. Infiltration of inflammatory macrophages and neutrophils and widespread pyroptosis in lung drive influenza lethality in nonhuman primates. PLoS Pathog 2022;18:e1010395. [PMID: 35271686 DOI: 10.1371/journal.ppat.1010395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
68 Geyer RE, Kotnik JH, Lyon V, Brandstetter E, Zigman Suchsland M, Han PD, Graham C, Ilcisin M, Kim AE, Chu HY, Nickerson DA, Starita LM, Bedford T, Lutz B, Thompson MJ. Diagnostic Accuracy of an At-Home, Rapid Self-test for Influenza: Prospective Comparative Accuracy Study. JMIR Public Health Surveill 2022;8:e28268. [PMID: 35191852 DOI: 10.2196/28268] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
69 Pandey P, Al Rumaih Z, Kels MJT, Ng E, Kc R, Chaudhri G, Karupiah G. Targeting ectromelia virus and TNF/NF-κB or STAT3 signaling for effective treatment of viral pneumonia. Proc Natl Acad Sci U S A 2022;119:e2112725119. [PMID: 35177474 DOI: 10.1073/pnas.2112725119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Pandey P, Al Rumaih Z, Kels MJT, Ng E, Rajendra K, Malley R, Chaudhri G, Karupiah G. Simultaneous therapeutic targeting of inflammation and virus ameliorates influenza pneumonia and protects from morbidity and mortality.. [DOI: 10.1101/2022.02.09.479486] [Reference Citation Analysis]
71 Planz O. Antiviral Drugs Against Influenza Virus. New Drug Development for Known and Emerging Viruses 2022. [DOI: 10.1002/9783527810697.ch3] [Reference Citation Analysis]
72 Lin S, Peng Y, Xu Y, Zhang W, Wu J, Zhang W, Shao L, Gao Y. Establishment of a Risk Score Model for Early Prediction of Severe H1N1 Influenza. Front Cell Infect Microbiol 2021;11:776840. [PMID: 35059324 DOI: 10.3389/fcimb.2021.776840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 French H, Pitré E, Oade MS, Elshina E, Bisht K, King A, Bauer DL, te Velthuis AJ. Transient RNA structures cause aberrant influenza virus replication and innate immune activation.. [DOI: 10.1101/2022.01.25.476955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Reed SG, Ager A. Immune Responses to IAV Infection and the Roles of L-Selectin and ADAM17 in Lymphocyte Homing. Pathogens 2022;11:150. [DOI: 10.3390/pathogens11020150] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Gui R, Chen Q. Molecular Events Involved in Influenza A Virus-Induced Cell Death. Front Microbiol 2021;12:797789. [PMID: 35069499 DOI: 10.3389/fmicb.2021.797789] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Guan M, Blackmon S, Olivier AK, Zhang X, Liu L, Woolums A, Crenshaw MA, Liao SF, Webby R, Epperson W, Wan X. Time-Dependent Proinflammatory Responses Shape Virus Interference during Coinfections of Influenza A Virus and Influenza D Virus. Viruses 2022;14:224. [DOI: 10.3390/v14020224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
77 Wang X, Xiong J, Zhou D, Zhang S, Wang L, Tian Q, Li C, Liu J, Wu Y, Li J, Wang J. TRIM34 modulates influenza virus-activated programmed cell death by targeting Z-DNA-binding protein 1 for K63-linked polyubiquitination. J Biol Chem 2022;298:101611. [PMID: 35065966 DOI: 10.1016/j.jbc.2022.101611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
78 Taniguchi K, Ando Y, Kobayashi M, Toba S, Nobori H, Sanaki T, Noshi T, Kawai M, Yoshida R, Sato A, Shishido T, Naito A, Matsuno K, Okamatsu M, Sakoda Y, Kida H. Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection. Viruses 2022;14:111. [PMID: 35062315 DOI: 10.3390/v14010111] [Reference Citation Analysis]
79 Sego TJ, Mochan ED, Ermentrout GB, Glazier JA. A multiscale multicellular spatiotemporal model of local influenza infection and immune response. J Theor Biol 2022;532:110918. [PMID: 34592264 DOI: 10.1016/j.jtbi.2021.110918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Huang X, Lu F, Tian H, Hu H, Ning F, Shang Q, Hao D, Zhu W, Kong G, Ma X, Feng J, Wang T, Wang X. Association between plasma glycocalyx component levels and poor prognosis in severe influenza type A (H1N1). Sci Rep 2022;12:163. [PMID: 34997090 DOI: 10.1038/s41598-021-04146-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Miranda D, Sanchez DJ. Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy. Stem Cells and COVID-19 2022. [DOI: 10.1016/b978-0-323-89972-7.00006-4] [Reference Citation Analysis]
82 Zvimba JN, Nhamo L, Mpandeli S, Mabhaudhi T. SARS-CoV-2 and the wastewater environment. COVID-19 in the Environment 2022. [DOI: 10.1016/b978-0-323-90272-4.00016-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Shu Z, Wu P, Qian Q, Zhou L, Du D, Ding M, Peng T, Fang K. Effectiveness and Controversy of Convalescent Plasma Therapy for Coronavirus Disease 2019 Patients. Infectious Diseases & Immunity 2022;2:49-54. [DOI: 10.1097/id9.0000000000000033] [Reference Citation Analysis]
84 Terrier O, Si-Tahar M, Ducatez M, Chevalier C, Pizzorno A, Le Goffic R, Crépin T, Simon G, Naffakh N. Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges. PLoS Pathog 2021;17:e1010106. [PMID: 34969061 DOI: 10.1371/journal.ppat.1010106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
85 Chen Y, Zhuang Z, Yang J, Bai L. Screening of Microbial Natural Products and Biological Evaluation of Trichomicin as Potential Anti-Cytokine Storm Agents. Front Pharmacol 2021;12:770910. [PMID: 34955842 DOI: 10.3389/fphar.2021.770910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Almutairi F, Sarr D, Tucker SL, Fantone K, Lee JK, Rada B. RGS10 Reduces Lethal Influenza Infection and Associated Lung Inflammation in Mice. Front Immunol 2021;12:772288. [PMID: 34912341 DOI: 10.3389/fimmu.2021.772288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Rozario C, Martínez-Sobrido L, McSorley HJ, Chauché C. Could Interleukin-33 (IL-33) Govern the Outcome of an Equine Influenza Virus Infection? Learning from Other Species. Viruses 2021;13:2519. [PMID: 34960788 DOI: 10.3390/v13122519] [Reference Citation Analysis]
88 Patel MM, York IA, Monto AS, Thompson MG, Fry AM. Immune-mediated attenuation of influenza illness after infection: opportunities and challenges. The Lancet Microbe 2021;2:e715-25. [DOI: 10.1016/s2666-5247(21)00180-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
89 Bird G, Braithwaite I, Harper J, Koorevaar I, van den Berg M, Maijers I, Kearns N, Dilcher M, Jennings L, Fingleton J, Shortt N, Weatherall M, Beasley R. Rhinothermy delivered by nasal high flow therapy in the treatment of the common cold: a randomised controlled trial. BMJ Open 2021;11:e047760. [PMID: 34848508 DOI: 10.1136/bmjopen-2020-047760] [Reference Citation Analysis]
90 Brunet-Ratnasingham E, Anand SP, Gantner P, Dyachenko A, Moquin-Beaudry G, Brassard N, Beaudoin-Bussières G, Pagliuzza A, Gasser R, Benlarbi M, Point F, Prévost J, Laumaea A, Niessl J, Nayrac M, Sannier G, Orban C, Messier-Peet M, Butler-Laporte G, Morrison DR, Zhou S, Nakanishi T, Boutin M, Descôteaux-Dinelle J, Gendron-Lepage G, Goyette G, Bourassa C, Medjahed H, Laurent L, Rébillard RM, Richard J, Dubé M, Fromentin R, Arbour N, Prat A, Larochelle C, Durand M, Richards JB, Chassé M, Tétreault M, Chomont N, Finzi A, Kaufmann DE. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality. Sci Adv 2021;7:eabj5629. [PMID: 34826237 DOI: 10.1126/sciadv.abj5629] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
91 Wang Y, Sun W, Wang Z, Zhao M, Zhang X, Kong Y, Wang X, Feng N, Wang T, Yan F, Zhao Y, Xia X, Yang S, Gao Y. Amino acid sites related to the PB2 subunits of IDV affect polymerase activity. Virol J 2021;18:230. [PMID: 34809668 DOI: 10.1186/s12985-021-01703-z] [Reference Citation Analysis]
92 Chan L, Karimi N, Morovati S, Alizadeh K, Kakish JE, Vanderkamp S, Fazel F, Napoleoni C, Alizadeh K, Mehrani Y, Minott JA, Bridle BW, Karimi K. The Roles of Neutrophils in Cytokine Storms. Viruses 2021;13:2318. [PMID: 34835125 DOI: 10.3390/v13112318] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
93 Hulme KD, Noye EC, Short KR, Labzin LI. Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections. Front Immunol 2021;12:770066. [PMID: 34777390 DOI: 10.3389/fimmu.2021.770066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
94 Murdaca G, Paladin F, Tonacci A, Isola S, Allegra A, Gangemi S. The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic. Biomedicines 2021;9:1688. [PMID: 34829918 DOI: 10.3390/biomedicines9111688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
95 Piontkivska H, Wales-McGrath B, Miyamoto M, Wayne ML. ADAR Editing in Viruses: An Evolutionary Force to Reckon with. Genome Biol Evol 2021;13:evab240. [PMID: 34694399 DOI: 10.1093/gbe/evab240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
96 Rappe JCF, Finsterbusch K, Crotta S, Mack M, Priestnall SL, Wack A. A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza. J Exp Med 2021;218:e20201631. [PMID: 34473195 DOI: 10.1084/jem.20201631] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
97 Motallebi S, Cheung RC, Mohit B, Shahabi S, Alishahi Tabriz A, Moattari S. Modeling COVID-19 Mortality Across 44 Countries: Face Covering May Reduce Deaths. American Journal of Preventive Medicine 2021. [DOI: 10.1016/j.amepre.2021.09.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
98 Latha K, Jamison KF, Watford WT. Tpl2 Ablation Leads to Hypercytokinemia and Excessive Cellular Infiltration to the Lungs During Late Stages of Influenza Infection. Front Immunol 2021;12:738490. [PMID: 34691044 DOI: 10.3389/fimmu.2021.738490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
99 Lin SW, Shen CF, Liu CC, Cheng CM. A Paper-Based IL-6 Test Strip Coupled With a Spectrum-Based Optical Reader for Differentiating Influenza Severity in Children. Front Bioeng Biotechnol 2021;9:752681. [PMID: 34692664 DOI: 10.3389/fbioe.2021.752681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
100 Elshina E, Te Velthuis AJW. The influenza virus RNA polymerase as an innate immune agonist and antagonist. Cell Mol Life Sci 2021. [PMID: 34677644 DOI: 10.1007/s00018-021-03957-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
101 Mifsud EJ, Kuba M, Barr IG. Innate Immune Responses to Influenza Virus Infections in the Upper Respiratory Tract. Viruses 2021;13:2090. [PMID: 34696520 DOI: 10.3390/v13102090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
102 Kombiah S, Kumar M, Murugkar HV, Nagarajan S, Tosh C, Senthilkumar D, Rajukumar K, Kalaiyarasu S, Gautam S, Singh R, Karikalan M, Sharma AK, Singh VP. Role of expression of host cytokines in the pathogenesis of H9N2-PB2 reassortant and non-reassortant H5N1 avian influenza viruses isolated from crows in BALB/c mice. Microb Pathog 2021;161:105239. [PMID: 34648926 DOI: 10.1016/j.micpath.2021.105239] [Reference Citation Analysis]
103 Aoyagi T, Sato Y, Baba H, Shiga T, Seike I, Niitsuma Sugaya I, Takei K, Iwasaki Y, Oshima K, Kanamori H, Yoshida M, Saito K, Tokuda K, Kaku M. Case Report: Successful Treatment of Five Critically Ill Coronavirus Disease 2019 Patients Using Combination Therapy With Etoposide and Corticosteroids. Front Med (Lausanne) 2021;8:718641. [PMID: 34631741 DOI: 10.3389/fmed.2021.718641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
104 Bonifacio JP, Williams N, Garnier L, Hugues S, Schmolke M, Mazel-sanchez B. Optimizing the live attenuated influenza A vaccine backbone for high-risk patient groups.. [DOI: 10.1101/2021.10.06.462766] [Reference Citation Analysis]
105 Mansouri V, Yazdanpanah N, Rezaei N. The immunologic aspects of cytokine release syndrome and graft versus host disease following CAR T cell therapy. Int Rev Immunol 2021;:1-20. [PMID: 34607523 DOI: 10.1080/08830185.2021.1984449] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
106 Almanza G, Kouznetsova V, Clark AE, Olmedillas E, Castro A, Tsigelny IF, Wu Y, Gao GF, Saphire EO, Carlin AF, Zanetti M. Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern.. [DOI: 10.1101/2021.10.01.462840] [Reference Citation Analysis]
107 Fu B, Wu Z, Huang L, Chai Z, Zheng P, Sun Q, Gu S, Xu Q, Feng H, Tang L. A comparison of demographic, epidemiological and clinical characteristics of hospital influenza-related viral pneumonia patients. BMC Infect Dis 2021;21:1002. [PMID: 34563110 DOI: 10.1186/s12879-021-06485-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 He XL, Zhou YY, Fu W, Xue YE, Liang MY, Yang BH, Ma WL, Zhou Q, Chen L, Zhang JC, Wang XR. Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study. Curr Med Sci 2021. [PMID: 34515914 DOI: 10.1007/s11596-021-2434-y] [Reference Citation Analysis]
109 Musiu C, Caligola S, Fiore A, Lamolinara A, Frusteri C, Del Pizzo FD, De Sanctis F, Canè S, Adamo A, Hofer F, Barouni RM, Grilli A, Zilio S, Serafini P, Tacconelli E, Donadello K, Gottin L, Polati E, Girelli D, Polidoro I, Iezzi PA, Angelucci D, Capece A, Chen Y, Shi ZL, Murray PJ, Chilosi M, Amit I, Bicciato S, Iezzi M, Bronte V, Ugel S. Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis. Cell Death Differ 2021. [PMID: 34518653 DOI: 10.1038/s41418-021-00866-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
110 Zhao F, Wang Y, Chen L, Zhang X, Ducatez M, He J, Wan Z, Ye J, Bai Z, Xia Y, Dong Z, Gu W, Huang Z, Liang T, Lin Z, Song W, Chen Z, Yang Z, Wong S, Hao C, Zanin M. Critical Influenza-Like Illness in a Nine-Year-Old Associated With a Poultry-Origin H9N2 Avian Influenza Virus: Risk Assessment and Zoonotic Potential. Front Virol 2021;1. [DOI: 10.3389/fviro.2021.727163] [Reference Citation Analysis]
111 Nogales A, Villamayor L, Utrilla-Trigo S, Ortego J, Martinez-Sobrido L, DeDiego ML. Natural Selection of H5N1 Avian Influenza A Viruses with Increased PA-X and NS1 Shutoff Activity. Viruses 2021;13:1760. [PMID: 34578340 DOI: 10.3390/v13091760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
112 Wandzik JM, Kouba T, Cusack S. Structure and Function of Influenza Polymerase. Cold Spring Harb Perspect Med 2021;11:a038372. [PMID: 32341065 DOI: 10.1101/cshperspect.a038372] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
113 Wei F, Gao C, Wang Y. The role of influenza A virus-induced hypercytokinemia. Crit Rev Microbiol 2021;:1-17. [PMID: 34353210 DOI: 10.1080/1040841X.2021.1960482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
114 Madonna G, Sale S, Capone M, De Falco C, Santocchio V, Di Matola T, Fiorentino G, Pirozzi C, D'Antonio A, Sabatino R, Atripaldi L, Atripaldi U, Raffone M, Curvietto M, Grimaldi AM, Vanella V, Festino L, Scarpato L, Palla M, Spatarella M, Perna F, Cerino P, Botti G, Parrella R, Montesarchio V, Ascierto PA, Atripaldi L. Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-α Expression. Biology (Basel) 2021;10:735. [PMID: 34439967 DOI: 10.3390/biology10080735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Callon D, Berri F, Lebreil AL, Fornès P, Andreoletti L. Coinfection of Parvovirus B19 with Influenza A/H1N1 Causes Fulminant Myocarditis and Pneumonia. An Autopsy Case Report. Pathogens 2021;10:958. [PMID: 34451422 DOI: 10.3390/pathogens10080958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 Sahanic S, Löffler-Ragg J, Tymoszuk P, Hilbe R, Demetz E, Masanetz RK, Theurl M, Holfeld J, Gollmann-Tepeköylü C, Tzankov A, Weiss G, Giera M, Tancevski I. The Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza. Front Physiol 2021;12:688946. [PMID: 34366882 DOI: 10.3389/fphys.2021.688946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
117 Myers MA, Smith AP, Lane LC, Moquin DJ, Aogo R, Woolard S, Thomas P, Vogel P, Smith AM. Dynamically linking influenza virus infection kinetics, lung injury, inflammation, and disease severity. Elife 2021;10:e68864. [PMID: 34282728 DOI: 10.7554/eLife.68864] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
118 Yang B, Yang KD. Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention. Front Immunol 2021;12:690976. [PMID: 34335596 DOI: 10.3389/fimmu.2021.690976] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Chen TH, Yang YL, Jan JT, Chen CC, Wu SC. Site-Specific Glycan-Masking/Unmasking Hemagglutinin Antigen Design to Elicit Broadly Neutralizing and Stem-Binding Antibodies Against Highly Pathogenic Avian Influenza H5N1 Virus Infections. Front Immunol 2021;12:692700. [PMID: 34335603 DOI: 10.3389/fimmu.2021.692700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
120 Mousavi-Roknabadi RS, Haddad F, Fazlzadeh A, Kheirabadi D, Dehghan H, Rezaeisadrabadi M. Investigation of plasma exchange and hemoperfusion effects and complications for the treatment of patients with severe COVID-19 (SARS-CoV-2) disease: A systematic scoping review. J Med Virol 2021;93:5742-55. [PMID: 34228355 DOI: 10.1002/jmv.27182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
121 Ji ZX, Wang XQ, Liu XF. NS1: A Key Protein in the "Game" Between Influenza A Virus and Host in Innate Immunity. Front Cell Infect Microbiol 2021;11:670177. [PMID: 34327148 DOI: 10.3389/fcimb.2021.670177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
122 Santamaria S. Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2? Int J Biol Sci 2021;17:2770-1. [PMID: 34345206 DOI: 10.7150/ijbs.63969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Montano L, Donato F, Bianco PM, Lettieri G, Guglielmino A, Motta O, Bonapace IM, Piscopo M. Air Pollution and COVID-19: A Possible Dangerous Synergy for Male Fertility. Int J Environ Res Public Health 2021;18:6846. [PMID: 34202243 DOI: 10.3390/ijerph18136846] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
124 Chatterjee B, Sandhu HS, Dixit NM. The relative strength and timing of innate immune and CD8 T-cell responses underlie the heterogeneous outcomes of SARS-CoV-2 infection.. [DOI: 10.1101/2021.06.15.21258935] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
125 Blumberg EA, Tebas P, Frank I, Marshall A, Chew A, Veloso EA, Carulli A, Rogal W, Gaymon AL, Schmidt AH, Barnette T, Jurek R, Noorchashm H, Hwang W, Noll JH, Fraietta JA, June CH, Hexner EO. Phase 1 Trial of Cyclosporine for Hospitalized Patients with COVID-19.. [DOI: 10.1101/2021.06.10.21258714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Priyadarshi H, Das R. Complexities in viral replication strategies as a potential explanation for prevalence of asymptomatic carriers in Covid-19 infections: analytical observation on SARS-Cov2 genome characteristics. Theory Biosci 2021. [PMID: 34114198 DOI: 10.1007/s12064-021-00349-3] [Reference Citation Analysis]
127 Li J, Wei J, Xu Z, Jiang C, Li M, Chen J, Li Y, Yang M, Gu Y, Wang F, Shu Y, Yang Y, Sun L, Liu Y. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression. Front Immunol 2021;12:691879. [PMID: 34163488 DOI: 10.3389/fimmu.2021.691879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
128 Darzianiazizi M, Allison KE, Kulkarni RR, Sharif S, Karimi K, Bridle BW. Disruption of type I interferon signaling causes sexually dimorphic dysregulation of anti-viral cytokines. Cytokine X 2021;3:100053. [PMID: 34189454 DOI: 10.1016/j.cytox.2021.100053] [Reference Citation Analysis]
129 George ST, Lai J, Ma J, Stacey HD, Miller MS, Mullarkey CE. Neutrophils and Influenza: A Thin Line between Helpful and Harmful. Vaccines (Basel) 2021;9:597. [PMID: 34199803 DOI: 10.3390/vaccines9060597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
130 Bahadoran A, Bezavada L, Smallwood HS. Fueling influenza and the immune response: Implications for metabolic reprogramming during influenza infection and immunometabolism. Immunol Rev 2020;295:140-66. [PMID: 32320072 DOI: 10.1111/imr.12851] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
131 Mochan E, Sego TJ, Gaona L, Rial E, Ermentrout GB. Compartmental Model Suggests Importance of Innate Immune Response to COVID-19 Infection in Rhesus Macaques. Bull Math Biol 2021;83:79. [PMID: 34037874 DOI: 10.1007/s11538-021-00909-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
132 Morris G, Bortolasci CC, Puri BK, Marx W, O'Neil A, Athan E, Walder K, Berk M, Olive L, Carvalho AF, Maes M. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Cytokine 2021;144:155593. [PMID: 34074585 DOI: 10.1016/j.cyto.2021.155593] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 12.5] [Reference Citation Analysis]
133 Thiele S, Stanelle-Bertram S, Beck S, Kouassi NM, Zickler M, Müller M, Tuku B, Resa-Infante P, van Riel D, Alawi M, Günther T, Rother F, Hügel S, Reimering S, McHardy A, Grundhoff A, Brune W, Osterhaus A, Bader M, Hartmann E, Gabriel G. Cellular Importin-α3 Expression Dynamics in the Lung Regulate Antiviral Response Pathways against Influenza A Virus Infection. Cell Rep 2020;31:107549. [PMID: 32320654 DOI: 10.1016/j.celrep.2020.107549] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
134 Nguyen THO, Koutsakos M, van de Sandt CE, Crawford JC, Loh L, Sant S, Grzelak L, Allen EK, Brahm T, Clemens EB, Auladell M, Hensen L, Wang Z, Nüssing S, Jia X, Günther P, Wheatley AK, Kent SJ, Aban M, Deng YM, Laurie KL, Hurt AC, Gras S, Rossjohn J, Crowe J, Xu J, Jackson D, Brown LE, La Gruta N, Chen W, Doherty PC, Turner SJ, Kotsimbos TC, Thomas PG, Cheng AC, Kedzierska K. Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients. Nat Commun 2021;12:2691. [PMID: 33976217 DOI: 10.1038/s41467-021-23018-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
135 Johnson AM, Barigye R, Saminathan H. Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases. Hum Vaccin Immunother 2021;17:2824-40. [PMID: 33974497 DOI: 10.1080/21645515.2021.1908060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
136 Fan L, Zhu X, Zheng Y, Zhang W, Seidner DL, Ness R, Murff HJ, Yu C, Huang X, Shrubsole MJ, Hou L, Dai Q. Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2). Nutrition 2021;89:111340. [PMID: 34116393 DOI: 10.1016/j.nut.2021.111340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
137 Li K, Cao P, McCaw JM. Modelling the Effect of MUC1 on Influenza Virus Infection Kinetics and Macrophage Dynamics. Viruses 2021;13:850. [PMID: 34066999 DOI: 10.3390/v13050850] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
138 Chua KH, Mohamed IN, Mohd Yunus MH, Shafinaz Md Nor N, Kamil K, Ugusman A, Kumar J. The Anti-Viral and Anti-Inflammatory Properties of Edible Bird's Nest in Influenza and Coronavirus Infections: From Pre-Clinical to Potential Clinical Application. Front Pharmacol 2021;12:633292. [PMID: 34025406 DOI: 10.3389/fphar.2021.633292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
139 Musiu C, Caligola S, Fiore A, Lamolinara A, Frusteri C, Del Pizzo FD, De Sanctis F, Canè S, Adamo A, Hofer F, Barouni RM, Grilli A, Zilio S, Serafini P, Tacconelli E, Donadello K, Gottin L, Polati E, Girelli D, Polidoro I, Iezzi PA, Angelucci D, Capece A, Chen Y, Shi Z, Murray PJ, Chilosi M, Amit I, Bicciato S, Iezzi M, Bronte V, Ugel S. Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis.. [DOI: 10.1101/2021.05.04.21256298] [Reference Citation Analysis]
140 Okda F, Sakr A, Webster R, Webby R. Tropism, susceptibility, infectivity, and cytokine releases of differentiated human tonsillar epithelial cells by different Influenza viruses.. [DOI: 10.1101/2021.05.03.442542] [Reference Citation Analysis]
141 Teyssou E, Soulie C, Visseaux B, Lambert-Niclot S, Ferre V, Marot S, Jary A, Sayon S, Zafilaza K, Leducq V, Schnuriger A, Abdi B, Wirden M, Houhou-Fidouh N, Charpentier C, Morand-Joubert L, Burrel S, Descamps D, Calvez V, Marcelin AG. The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. J Infect 2021;83:119-45. [PMID: 33932451 DOI: 10.1016/j.jinf.2021.04.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
142 Stegelmeier AA, Darzianiazizi M, Hanada K, Sharif S, Wootton SK, Bridle BW, Karimi K. Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils. Int J Mol Sci 2021;22:4726. [PMID: 33946935 DOI: 10.3390/ijms22094726] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
143 Weis S, Te Velthuis AJW. Influenza Virus RNA Synthesis and the Innate Immune Response. Viruses 2021;13:780. [PMID: 33924859 DOI: 10.3390/v13050780] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
144 Chen R, Lan Z, Ye J, Pang L, Liu Y, Wu W, Qin X, Guo Y, Zhang P. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration. Front Immunol 2021;12:589095. [PMID: 33995341 DOI: 10.3389/fimmu.2021.589095] [Cited by in Crossref: 41] [Cited by in F6Publishing: 49] [Article Influence: 20.5] [Reference Citation Analysis]
145 Ge Y, Tian T, Huang S, Wan F, Li J, Li S, Wang X, Yang H, Hong L, Wu N, Yuan E, Luo Y, Cheng L, Hu C, Lei Y, Shu H, Feng X, Jiang Z, Wu Y, Chi Y, Guo X, Cui L, Xiao L, Li Z, Yang C, Miao Z, Chen L, Li H, Zeng H, Zhao D, Zhu F, Shen X, Zeng J. An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. Signal Transduct Target Ther 2021;6:165. [PMID: 33895786 DOI: 10.1038/s41392-021-00568-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 41] [Article Influence: 11.5] [Reference Citation Analysis]
146 Morozova SV, Selezneva LV. Possibilities of using multidirectional immunomodulators for acute and recurrent infectious and inflammatory diseases of the upper respiratory tract. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-4-89-95] [Reference Citation Analysis]
147 Lu W, Yang L, Li X, Sun M, Zhang A, Qi S, Chen Z, Zhang L, Li J, Xiong H. Early immune responses and prognostic factors in children with COVID-19: a single-center retrospective analysis. BMC Pediatr 2021;21:181. [PMID: 33865340 DOI: 10.1186/s12887-021-02561-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
148 Chen Q, Yu B, Yang Y, Huang J, Liang Y, Zhou J, Li L, Peng X, Cheng B, Lin Y. Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients. Int Immunopharmacol 2021;97:107685. [PMID: 33951560 DOI: 10.1016/j.intimp.2021.107685] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
149 Gangwar M, Rastogi S, Singh D, Shukla A, Dhameja N, Kumar D, Kumar R, Nath G. Study on the Effect of Oral Administration of Bacteriophages in Charles Foster Rats With Special Reference to Immunological and Adverse Effects. Front Pharmacol 2021;12:615445. [PMID: 33912038 DOI: 10.3389/fphar.2021.615445] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
150 Flerlage T, Boyd DF, Meliopoulos V, Thomas PG, Schultz-Cherry S. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev Microbiol 2021;19:425-41. [PMID: 33824495 DOI: 10.1038/s41579-021-00542-7] [Cited by in Crossref: 73] [Cited by in F6Publishing: 80] [Article Influence: 36.5] [Reference Citation Analysis]
151 Wang D, Zhu W, Yang L, Shu Y. The Epidemiology, Virology, and Pathogenicity of Human Infections with Avian Influenza Viruses. Cold Spring Harb Perspect Med 2021;11:a038620. [PMID: 31964651 DOI: 10.1101/cshperspect.a038620] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
152 Teyssou E, Soulie C, Visseaux B, Lambert-niclot S, Ferre V, Marot S, Jary A, Sayon S, Zafilaza K, Leducq V, Schnuriger A, Abdi B, Wirden M, Houhou-fidouh N, Charpentier C, Morand-joubert L, Burrel S, Descamps D, Calvez V, Geneviève Marcelin A. The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.. [DOI: 10.1101/2021.03.21.21253498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
153 Li K, Cao P, Mccaw JM. Modelling The Effect of MUC1 on Influenza Virus Infection Kinetics and Macrophage Dynamics.. [DOI: 10.1101/2021.03.25.436891] [Reference Citation Analysis]
154 Zhao J, Wang Y, Huang X, Ma Q, Song J, Wu X, Zhou H, Weng Y, Yang Z, Wang X. Liu Shen Wan inhibits influenza virus-induced secondary Staphylococcus aureus infection in vivo and in vitro. J Ethnopharmacol 2021;277:114066. [PMID: 33766755 DOI: 10.1016/j.jep.2021.114066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
155 Sender V, Hentrich K, Henriques-Normark B. Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae. Front Cell Infect Microbiol 2021;11:643326. [PMID: 33828999 DOI: 10.3389/fcimb.2021.643326] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
156 Brunet-ratnasingham E, Anand SP, Gantner P, Moquin-beaudry G, Dyachenko A, Brassard N, Beaudoin-bussières G, Pagliuzza A, Gasser R, Benlarbi M, Point F, Prévost J, Laumaea A, Niessl J, Nayrac M, Sannier G, Boutin M, Descôteux-dinelle J, Gendron-lepage G, Goyette G, Bourassa C, Medjahed H, Orban C, Butler-laporte G, Morrison D, Zhou S, Nakanishi T, Laurent L, Richard J, Dubé M, Fromentin R, Rébillard R, Arbour N, Prat A, Larochelle C, Durand M, Brent Richards J, Chassé M, Tétreault M, Chomont N, Finzi A, Kaufmann DE. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality.. [DOI: 10.1101/2021.03.18.21253907] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
157 Li J, Zhang S, Li B, Hu Y, Kang XP, Wu XY, Huang MT, Li YC, Zhao ZP, Qin CF, Jiang T. Machine Learning Methods for Predicting Human-Adaptive Influenza A Viruses Based on Viral Nucleotide Compositions. Mol Biol Evol 2020;37:1224-36. [PMID: 31750915 DOI: 10.1093/molbev/msz276] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
158 Taraskin AS, Semenov KK, Protasov AV, Lozhkov AA, Tyulin AA, Shaldzhyan AA, Ramsay ES, Mirgorodskaya OA, Klotchenko SA, Zabrodskaya YA. Quench me if you can: Alpha-2-macroglobulin trypsin complexes enable serum biomarker analysis by MALDI mass spectrometry. Biochimie 2021;185:87-95. [PMID: 33744341 DOI: 10.1016/j.biochi.2021.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
159 Guan M, Blackmon S, Olivier AK, Zhang X, Liu L, Woolums A, Crenshaw MA, Liao SF, Webby R, Epperson W, Wan X. Time dependent proinflammatory responses shape virus interference during coinfections of influenza A virus and influenza D virus.. [DOI: 10.1101/2021.03.14.435363] [Reference Citation Analysis]
160 Luellen E. A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study. JMIRx Med 2020;1:e23582. [PMID: 33711083 DOI: 10.2196/23582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
161 Fan L, Zhu X, Zheng Y, Zhang W, Seidner DL, Ness R, Murff HJ, Yu C, Huang X, Shrubsole MJ, Hou L, Dai Q. Magnesium Treatment on Methylation Changes of Transmembrane Serine Protease 2 (TMPRSS2).. [DOI: 10.1101/2021.03.11.21253287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
162 Liou TG, Adler FR, Cahill BC, Cox DR, Cox JE, Grant GJ, Hanson KE, Hartsell SC, Hatton ND, Helms MN, Jensen JL, Kartsonaki C, Li Y, Leung DT, Marvin JE, Middleton EA, Osburn-Staker SM, Packer KA, Shakir SM, Sturrock AB, Tardif KD, Warren KJ, Waddoups LJ, Weaver LJ, Zimmerman E, Paine R 3rd. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection. Physiol Rep 2021;9:e14761. [PMID: 33625796 DOI: 10.14814/phy2.14761] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
163 Zhang N, Zhu L, Zhang Y, Zhou C, Song R, Yang X, Huang L, Xiong S, Huang X, Xu F, Wang Y, Wan G, Chen Z, Li A, Zhan Q, Zeng H. Circulating Rather Than Alveolar Extracellular Deoxyribonucleic Acid Levels Predict Outcomes in Influenza. J Infect Dis 2020;222:1145-54. [PMID: 32436580 DOI: 10.1093/infdis/jiaa241] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
164 Topham DJ, DeDiego ML, Nogales A, Sangster MY, Sant A. Immunity to Influenza Infection in Humans. Cold Spring Harb Perspect Med 2021;11:a038729. [PMID: 31871226 DOI: 10.1101/cshperspect.a038729] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
165 Pronier C, Gacouin A, Lagathu G, Le Tulzo Y, Tadié J, Thibault V. Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms. Journal of Clinical Virology 2021;136:104761. [DOI: 10.1016/j.jcv.2021.104761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
166 Olbei M, Hautefort I, Modos D, Treveil A, Poletti M, Gul L, Shannon-Lowe CD, Korcsmaros T. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients. Front Immunol 2021;12:629193. [PMID: 33732251 DOI: 10.3389/fimmu.2021.629193] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 29.5] [Reference Citation Analysis]
167 Pandey P, Karupiah G. Targeting tumour necrosis factor to ameliorate viral pneumonia. FEBS J 2021. [PMID: 33624419 DOI: 10.1111/febs.15782] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
168 Pérez-Rubio G, Ponce-Gallegos MA, Domínguez-Mazzocco BA, Ponce-Gallegos J, García-Ramírez RA, Falfán-Valencia R. Role of the Host Genetic Susceptibility to 2009 Pandemic Influenza A H1N1. Viruses 2021;13:344. [PMID: 33671828 DOI: 10.3390/v13020344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
169 Mooij P, Stammes MA, Mortier D, Fagrouch Z, van Driel N, Verschoor EJ, Kondova I, Bogers WMJM, Koopman G. Aerosolized Exposure to H5N1 Influenza Virus Causes Less Severe Disease Than Infection via Combined Intrabronchial, Oral, and Nasal Inoculation in Cynomolgus Macaques. Viruses 2021;13:345. [PMID: 33671829 DOI: 10.3390/v13020345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
170 Sego T, Mochan ED, Ermentrout GB, Glazier JA. A Multiscale Multicellular Spatiotemporal Model of Local Influenza Infection and Immune Response.. [DOI: 10.1101/2021.02.20.432089] [Reference Citation Analysis]
171 Wang B, Su Q, Luo J, Li M, Wu Q, Chang H, Du J, Huang C, Ma J, Han S, Yuan G, He Y, Guo M, Zhang Q, He H. Differences in Highly Pathogenic H5N6 Avian Influenza Viral Pathogenicity and Inflammatory Response in Chickens and Ducks. Front Microbiol 2021;12:593202. [PMID: 33584608 DOI: 10.3389/fmicb.2021.593202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
172 Alam S, Bhuiyan FR, Emon TH, Hasan M. Prospects of nutritional interventions in the care of COVID-19 patients. Heliyon 2021;7:e06285. [PMID: 33615017 DOI: 10.1016/j.heliyon.2021.e06285] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
173 Dulek DE, Fuhlbrigge RC, Tribble AC, Connelly JA, Loi MM, El Chebib H, Chandrakasan S, Otto WR, Diorio C, Keim G, Walkovich K, Jaggi P, Girotto JE, Yarbrough A, Behrens EM, Cron RQ, Bassiri H. Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients. J Pediatric Infect Dis Soc 2020;9:716-37. [PMID: 32808988 DOI: 10.1093/jpids/piaa098] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
174 Oh TK, Song IA, Jeon YT. Statin Therapy and the Risk of COVID-19: A Cohort Study of the National Health Insurance Service in South Korea. J Pers Med 2021;11:116. [PMID: 33578937 DOI: 10.3390/jpm11020116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
175 Gao C, Wang Y, Gu X, Shen X, Zhou D, Zhou S, Huang JA, Cao B, Guo Q; Community-Acquired Pneumonia–China Network. Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus. Crit Care Med 2020;48:451-8. [PMID: 32205590 DOI: 10.1097/CCM.0000000000004207] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 29.5] [Reference Citation Analysis]
176 Kuchipudi SV, Nelli RK, Gontu A, Satyakumar R, Surendran Nair M, Subbiah M. Sialic Acid Receptors: The Key to Solving the Enigma of Zoonotic Virus Spillover. Viruses 2021;13:262. [PMID: 33567791 DOI: 10.3390/v13020262] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
177 Muhammad R, Ogunti R, Ahmed B, Munawar M, Donaldson S, Sumon M, Kibreab A, Thomas AN, Mehari A. Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection. J Racial Ethn Health Disparities 2021. [PMID: 33538998 DOI: 10.1007/s40615-020-00961-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
178 Othumpangat S, Lindsley WG, Beezhold DH, Kashon ML, Burrell CN, Mubareka S, Noti JD. Differential Expression of Serum Exosome microRNAs and Cytokines in Influenza A and B Patients Collected in the 2016 and 2017 Influenza Seasons. Pathogens 2021;10:149. [PMID: 33540650 DOI: 10.3390/pathogens10020149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
179 Latino I, Gonzalez SF. Spatio-temporal profile of innate inflammatory cells and mediators during influenza virus infection. Current Opinion in Physiology 2021;19:175-86. [DOI: 10.1016/j.cophys.2020.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
180 Choudhary J, Dheeman S, Sharma V, Katiyar P, Karn SK, Sarangi MK, Chauhan AK, Verma G, Baliyan N. Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review. Biol Proced Online 2021;23:5. [PMID: 33526007 DOI: 10.1186/s12575-020-00141-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
181 Thepmankorn P, Bach J, Lasfar A, Zhao X, Souayah S, Chong ZZ, Souayah N. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations. Cytokine 2021;138:155404. [PMID: 33360025 DOI: 10.1016/j.cyto.2020.155404] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 15.0] [Reference Citation Analysis]
182 Okuno D, Kido T, Muramatsu K, Tokutsu K, Moriyama S, Miyamura T, Hara A, Ishimoto H, Yamaguchi H, Miyazaki T, Sakamoto N, Obase Y, Ishimatsu Y, Fujino Y, Yatera K, Matsuda S, Mukae H. Impact of Corticosteroid Administration within 7 Days of the Hospitalization for Influenza Pneumonia with Respiratory Failure: A Propensity Score Analysis Using a Nationwide Administrative Database. J Clin Med 2021;10:494. [PMID: 33572558 DOI: 10.3390/jcm10030494] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
183 Bergamaschi L, D'Angelo EC, Paolisso P, Toniolo S, Fabrizio M, Angeli F, Donati F, Magnani I, Rinaldi A, Bartoli L, Chiti C, Biffi M, Pizzi C, Viale P, Galié N. The value of ECG changes in risk stratification of COVID-19 patients. Ann Noninvasive Electrocardiol 2021;26:e12815. [PMID: 33512742 DOI: 10.1111/anec.12815] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 10.5] [Reference Citation Analysis]
184 Latreille E, Lee WL. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy. Viruses. 2021;13. [PMID: 33499234 DOI: 10.3390/v13020161] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
185 Li RF, Zhou XB, Zhou HX, Yang ZF, Jiang HM, Wu X, Li WJ, Qiu JJ, Mi JN, Chen M, Zhong NS, Zhu GY, Jiang ZH. Novel Fatty Acid in Cordyceps Suppresses Influenza A (H1N1) Virus-Induced Proinflammatory Response Through Regulating Innate Signaling Pathways. ACS Omega 2021;6:1505-15. [PMID: 33490810 DOI: 10.1021/acsomega.0c05264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
186 Ashar HK, Pulavendran S, Rudd JM, Maram P, Achanta M, Chow VTK, Malayer JR, Snider TA, Teluguakula N. Administration of a CXC Chemokine Receptor 2 (CXCR2) Antagonist, SCH527123, Together with Oseltamivir Suppresses NETosis and Protects Mice from Lethal Influenza and Piglets from Swine-Influenza Infection. Am J Pathol 2021;191:669-85. [PMID: 33453177 DOI: 10.1016/j.ajpath.2020.12.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
187 Richard SA. Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids. Mediators Inflamm 2021;2021:6699560. [PMID: 33505216 DOI: 10.1155/2021/6699560] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
188 Pawestri HA, Eggink D, Isfandari S, Thanh TT, Rogier van Doorn H, Setiawaty V, de Jong MD. Viral Factors Associated With the High Mortality Related to Human Infections With Clade 2.1 Influenza A/H5N1 Virus in Indonesia. Clin Infect Dis 2020;70:1139-46. [PMID: 31321436 DOI: 10.1093/cid/ciz328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
189 Zhao Y, Zeng H, Zhu X, Lu W, Li D. Metal–organic frameworks as photoluminescent biosensing platforms: mechanisms and applications. Chem Soc Rev 2021;50:4484-513. [DOI: 10.1039/d0cs00955e] [Cited by in Crossref: 114] [Cited by in F6Publishing: 131] [Article Influence: 57.0] [Reference Citation Analysis]
190 Efremov DO, Beloborodov VB, Meshkov AV. Use of corticosteroid hormones in patients with moderate COVID-19: what goals can be achieved. Epidemiology and Infectious Diseases 2021;26:23-36. [DOI: 10.17816/eid90533] [Reference Citation Analysis]
191 Forbester JL, Humphreys IR. Genetic influences on viral-induced cytokine responses in the lung. Mucosal Immunol 2021;14:14-25. [PMID: 33184476 DOI: 10.1038/s41385-020-00355-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
192 Zhang Y, Yu L, Tang L, Zhu M, Jin Y, Wang Z, Li L. A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System. Engineering (Beijing) 2021;7:11-3. [PMID: 32292628 DOI: 10.1016/j.eng.2020.03.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 51] [Article Influence: 21.0] [Reference Citation Analysis]
193 Ti H, Mai Z, Wang Z, Zhang W, Xiao M, Yang Z, Shaw P. Bisabolane-type sesquiterpenoids from Curcuma longa L. exert anti-influenza and anti-inflammatory activities through NF-κB/MAPK and RIG-1/STAT1/2 signaling pathways. Food Funct 2021;12:6697-711. [PMID: 34179914 DOI: 10.1039/d1fo01212f] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
194 Alrahmany D, Ghazi IM. Cytokine storm is the cryptic killer behind coronavirus disease-2019 infections, review of the current evidence to identify therapeutic options. Reviews in Medical Microbiology 2021;32:57-65. [DOI: 10.1097/mrm.0000000000000242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
195 Ural BB, Yeung ST, Damani-Yokota P, Devlin JC, de Vries M, Vera-Licona P, Samji T, Sawai CM, Jang G, Perez OA, Pham Q, Maher L, Loke P, Dittmann M, Reizis B, Khanna KM. Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties. Sci Immunol 2020;5:eaax8756. [PMID: 32220976 DOI: 10.1126/sciimmunol.aax8756] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 31.3] [Reference Citation Analysis]
196 Jayakumar I, Uppuluri R, Lakshmanan C, Kumar Gowdhaman A, Vellaichamy Swaminathan V, Raj R. Risk-adapted therapy for the management of cytokine release syndrome in children undergoing unmanipulated haploidentical stem cell transplantation. Pediatr Transplant 2021;25:e13964. [PMID: 33370509 DOI: 10.1111/petr.13964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
197 Guo J, Xia H, Wang S, Yu L, Zhang H, Chen J, Shi D, Chen Y, Zhang Y, Xu K, Xu X, Sheng J, Qiu Y, Li L. The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19. Front Immunol 2020;11:586073. [PMID: 33424838 DOI: 10.3389/fimmu.2020.586073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
198 Thakur V. Framework for PESTEL dimensions of sustainable healthcare waste management: Learnings from COVID-19 outbreak. J Clean Prod 2021;287:125562. [PMID: 33349739 DOI: 10.1016/j.jclepro.2020.125562] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
199 Bermejo-Martin JF, González-Rivera M, Almansa R, Micheloud D, Tedim AP, Domínguez-Gil M, Resino S, Martín-Fernández M, Ryan Murua P, Pérez-García F, Tamayo L, Lopez-Izquierdo R, Bustamante E, Aldecoa C, Gómez JM, Rico-Feijoo J, Orduña A, Méndez R, Fernández Natal I, Megías G, González-Estecha M, Carriedo D, Doncel C, Jorge N, Ortega A, de la Fuente A, Del Campo F, Fernández-Ratero JA, Trapiello W, González-Jiménez P, Ruiz G, Kelvin AA, Ostadgavahi AT, Oneizat R, Ruiz LM, Miguéns I, Gargallo E, Muñoz I, Pelegrin S, Martín S, García Olivares P, Cedeño JA, Ruiz Albi T, Puertas C, Berezo JÁ, Renedo G, Herrán R, Bustamante-Munguira J, Enríquez P, Cicuendez R, Blanco J, Abadia J, Gómez Barquero J, Mamolar N, Blanca-López N, Valdivia LJ, Fernández Caso B, Mantecón MÁ, Motos A, Fernandez-Barat L, Ferrer R, Barbé F, Torres A, Menéndez R, Eiros JM, Kelvin DJ. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Crit Care 2020;24:691. [PMID: 33317616 DOI: 10.1186/s13054-020-03398-0] [Cited by in Crossref: 137] [Cited by in F6Publishing: 141] [Article Influence: 45.7] [Reference Citation Analysis]
200 Bermejo-Martin JF, González-Rivera M, Almansa R, Micheloud D, Tedim AP, Domínguez-Gil M, Resino S, Martín-Fernández M, Ryan Murua P, Pérez-García F, Tamayo L, Lopez-Izquierdo R, Bustamante E, Aldecoa C, Gómez JM, Rico-Feijoo J, Orduña A, Méndez R, Fernández Natal I, Megías G, González-Estecha M, Carriedo D, Doncel C, Jorge N, Ortega A, de la Fuente A, Del Campo F, Fernández-Ratero JA, Trapiello W, González-Jiménez P, Ruiz G, Kelvin AA, Ostadgavahi AT, Oneizat R, Ruiz LM, Miguéns I, Gargallo E, Muñoz I, Pelegrin S, Martín S, García Olivares P, Cedeño JA, Ruiz Albi T, Puertas C, Berezo JÁ, Renedo G, Herrán R, Bustamante-Munguira J, Enríquez P, Cicuendez R, Blanco J, Abadia J, Gómez Barquero J, Mamolar N, Blanca-López N, Valdivia LJ, Fernández Caso B, Mantecón MÁ, Motos A, Fernandez-Barat L, Ferrer R, Barbé F, Torres A, Menéndez R, Eiros JM, Kelvin DJ. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Crit Care 2020;24:691. [PMID: 33317616 DOI: 10.1186/s13054-020-03398-0] [Cited by in Crossref: 127] [Cited by in F6Publishing: 1] [Article Influence: 42.3] [Reference Citation Analysis]
201 Sudhakar P, Verstockt B, Cremer J, Verstockt S, Sabino J, Ferrante M, Vermeire S. Understanding the Molecular Drivers of Disease Heterogeneity in Crohn's Disease Using Multi-omic Data Integration and Network Analysis. Inflamm Bowel Dis 2021;27:870-86. [PMID: 33313682 DOI: 10.1093/ibd/izaa281] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
202 Kircheis R, Haasbach E, Lueftenegger D, Heyken WT, Ocker M, Planz O. NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients. Front Immunol 2020;11:598444. [PMID: 33362782 DOI: 10.3389/fimmu.2020.598444] [Cited by in Crossref: 90] [Cited by in F6Publishing: 92] [Article Influence: 30.0] [Reference Citation Analysis]
203 McBride DA, Kerr MD, Dorn NC, Ogbonna DA, Santos EC, Shah NJ. Triggers, Timescales, and Treatments for Cytokine-Mediated Tissue Damage. Euro Med J Innov 2021;5:52-62. [PMID: 34013158 DOI: 10.33590/emjinnov/20-00203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
204 Chen S, Wang X, Su X, Miao X, Qin T, Peng D, Liu X. Deep sequencing of the transcriptome from murine lung infected with H5N8 subtype avian influenza virus with combined substitutions I283M and K526R in PB2 gene. Infect Genet Evol 2021;87:104672. [PMID: 33309772 DOI: 10.1016/j.meegid.2020.104672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
205 Wang Y, Huo P, Dai R, Lv X, Yuan S, Zhang Y, Guo Y, Li R, Yu Q, Zhu K. Convalescent plasma may be a possible treatment for COVID-19: A systematic review. Int Immunopharmacol 2021;91:107262. [PMID: 33338863 DOI: 10.1016/j.intimp.2020.107262] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
206 Wu XX, Zhao LZ, Tang SJ, Weng TH, Wu WG, Yao SH, Wu HB, Cheng LF, Wang J, Hu FY, Wu NP, Yao HP, Zhang FC, Li LJ. Novel pathogenic characteristics of highly pathogenic avian influenza virus H7N9: viraemia and extrapulmonary infection. Emerg Microbes Infect 2020;9:962-75. [PMID: 32267217 DOI: 10.1080/22221751.2020.1754135] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
207 Yang Y, Zhao Y, Zhang F, Zhang L, Li L. COVID-19 in Elderly Adults: Clinical Features, Molecular Mechanisms, and Proposed Strategies. Aging Dis 2020;11:1481-95. [PMID: 33269102 DOI: 10.14336/AD.2020.0903] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
208 Tang N, Lu CY, Sue SC, Chen TH, Jan JT, Huang MH, Huang CH, Chen CC, Chiang BL, Huang LM, Wu SC. Type IIb Heat Labile Enterotoxin B Subunit as a Mucosal Adjuvant to Enhance Protective Immunity against H5N1 Avian Influenza Viruses. Vaccines (Basel) 2020;8:E710. [PMID: 33266210 DOI: 10.3390/vaccines8040710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
209 Taraskin AS, Semenov KK, Protasov AV, Lozhkov AA, Tyulin AA, Shaldzhyan AA, Ramsay ES, Mirgorodskaya OA, Klotchenko SA, Zabrodskaya YA. Quench me if you can: Alpha-2-macroglobulin trypsin complexes enable serum biomarker analysis by MALDI mass spectrometry.. [DOI: 10.1101/2020.11.23.394759] [Reference Citation Analysis]
210 Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, Zheng M, Sundaram B, Banoth B, Malireddi RKS, Schreiner P, Neale G, Vogel P, Webby R, Jonsson CB, Kanneganti TD. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes. Cell 2021;184:149-168.e17. [PMID: 33278357 DOI: 10.1016/j.cell.2020.11.025] [Cited by in Crossref: 444] [Cited by in F6Publishing: 481] [Article Influence: 148.0] [Reference Citation Analysis]
211 Olbei M, Hautefort I, Modos D, Treveil A, Poletti M, Gul L, Shannon-lowe CD, Korcsmaros T. SARS-CoV-2 causes a different cytokine response compared to other cytokine storm-causing respiratory viruses in severely ill patients.. [DOI: 10.1101/2020.11.14.20231878] [Reference Citation Analysis]
212 Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, Zheng M, Sundaram B, Banoth B, Malireddi RKS, Schreiner P, Neale G, Vogel P, Webby R, Jonsson CB, Kanneganti TD. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. bioRxiv 2020:2020. [PMID: 33140051 DOI: 10.1101/2020.10.29.361048] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
213 Boal-Carvalho I, Mazel-Sanchez B, Silva F, Garnier L, Yildiz S, Bonifacio JP, Niu C, Williams N, Francois P, Schwerk N, Schöning J, Carlens J, Viemann D, Hugues S, Schmolke M. Influenza A viruses limit NLRP3-NEK7-complex formation and pyroptosis in human macrophages. EMBO Rep 2020;21:e50421. [PMID: 33180976 DOI: 10.15252/embr.202050421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
214 Liou TG, Adler FR, Cahill BC, Cox DR, Cox JE, Grant GJ, Hanson KE, Hartsell SC, Hatton ND, Helms MN, Jensen JL, Kartsonaki C, Li Y, Leung DT, Marvin JE, Middleton EA, Osburn-staker SM, Packer KA, Shakir SM, Sturrock AB, Tardif KD, Warren KJ, Waddoups LJ, Weaver LJ, Zimmerman E, Paine R. SARS-CoV-2 Innate Effector Associations and Viral Load in Early Nasopharyngeal Infection.. [DOI: 10.1101/2020.10.30.20223545] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
215 Grunwell JR, Stephenson ST, Mohammad AF, Jones K, Mason C, Opolka C, Fitzpatrick AM. Differential type I interferon response and primary airway neutrophil extracellular trap release in children with acute respiratory distress syndrome. Sci Rep 2020;10:19049. [PMID: 33149247 DOI: 10.1038/s41598-020-76122-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
216 Brazee PL, Morales-Nebreda L, Magnani ND, Garcia JG, Misharin AV, Ridge KM, Budinger GRS, Iwai K, Dada LA, Sznajder JI. Linear ubiquitin assembly complex regulates lung epithelial-driven responses during influenza infection. J Clin Invest 2020;130:1301-14. [PMID: 31714898 DOI: 10.1172/JCI128368] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
217 Khorramdelazad H, Kazemi MH, Najafi A, Keykhaee M, Zolfaghari Emameh R, Falak R. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection. Microb Pathog 2021;152:104554. [PMID: 33157216 DOI: 10.1016/j.micpath.2020.104554] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 12.7] [Reference Citation Analysis]
218 Engen RC. CAF health protection during pandemic disease events: 1918 and 2020. Journal of Military, Veteran and Family Health 2020;6:9-16. [DOI: 10.3138/jmvfh-co19-0009] [Reference Citation Analysis]
219 Engen RC. CAF health protection during pandemic disease events: 1918 and 2020. Journal of Military, Veteran and Family Health 2020;6:9-16. [DOI: 10.3138/jmvfh-6.s2-co19-0009] [Reference Citation Analysis]
220 Romero J, Alviz I, Parides M, Diaz JC, Briceno D, Gabr M, Gamero M, Patel K, Braunstein ED, Purkayastha S, Polanco D, Valencia CR, Della Rocca D, Velasco A, Yang R, Tarantino N, Zhang XD, Mohanty S, Bello J, Natale A, Jorde UP, Garcia M, Di Biase L. T-wave inversion as a manifestation of COVID-19 infection: a case series. J Interv Card Electrophysiol 2020;59:485-93. [PMID: 33128658 DOI: 10.1007/s10840-020-00896-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
221 Chivukula RR, Maley JH, Dudzinski DM, Hibbert K, Hardin CC. Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection. J Intensive Care Med 2021;36:18-41. [PMID: 33111601 DOI: 10.1177/0885066620969132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
222 Milanez-almeida P, Martins AJ, Torabi-parizi P, Franco LM, Tsang JS, Germain RN. Blood gene expression-based prediction of lethality after respiratory infection by influenza A virus in mice.. [DOI: 10.1101/2020.10.27.357053] [Reference Citation Analysis]
223 Gao YL, Du Y, Zhang C, Cheng C, Yang HY, Jin YF, Duan GC, Chen SY. Role of Renin-Angiotensin System in Acute Lung Injury Caused by Viral Infection. Infect Drug Resist 2020;13:3715-25. [PMID: 33116692 DOI: 10.2147/IDR.S265718] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
224 Pecora F, Persico F, Argentiero A, Neglia C, Esposito S. The Role of Micronutrients in Support of the Immune Response against Viral Infections. Nutrients 2020;12:E3198. [PMID: 33092041 DOI: 10.3390/nu12103198] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 22.7] [Reference Citation Analysis]
225 Yang F, Yue R, Luo X, Liu R, Huang X. Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients. Front Pharmacol 2020;11:543718. [PMID: 33178011 DOI: 10.3389/fphar.2020.543718] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
226 Azar MM, Shin JJ, Kang I, Landry M. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome. Expert Rev Mol Diagn 2020;20:1087-97. [PMID: 32990479 DOI: 10.1080/14737159.2020.1830760] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
227 Zhan S, Wang Y, Chen X. RNA virus-encoded microRNAs: biogenesis, functions and perspectives on application. ExRNA 2020;2:15. [PMID: 33209991 DOI: 10.1186/s41544-020-00056-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
228 Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-810. [PMID: 32211816 DOI: 10.1001/jamacardio.2020.0950] [Cited by in Crossref: 2428] [Cited by in F6Publishing: 2765] [Article Influence: 809.3] [Reference Citation Analysis]
229 Cornish EF, Filipovic I, Åsenius F, Williams DJ, McDonnell T. Innate Immune Responses to Acute Viral Infection During Pregnancy. Front Immunol 2020;11:572567. [PMID: 33101294 DOI: 10.3389/fimmu.2020.572567] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
230 Galván-Román JM, Rodríguez-García SC, Roy-Vallejo E, Marcos-Jiménez A, Sánchez-Alonso S, Fernández-Díaz C, Alcaraz-Serna A, Mateu-Albero T, Rodríguez-Cortes P, Sánchez-Cerrillo I, Esparcia L, Martínez-Fleta P, López-Sanz C, Gabrie L, Del Campo Guerola L, Suárez-Fernández C, Ancochea J, Canabal A, Albert P, Rodríguez-Serrano DA, Aguilar JM, Del Arco C, de Los Santos I, García-Fraile L, de la Cámara R, Serra JM, Ramírez E, Alonso T, Landete P, Soriano JB, Martín-Gayo E, Fraile Torres A, Zurita Cruz ND, García-Vicuña R, Cardeñoso L, Sánchez-Madrid F, Alfranca A, Muñoz-Calleja C, González-Álvaro I; REINMUN-COVID Group. IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study. J Allergy Clin Immunol 2021;147:72-80.e8. [PMID: 33010257 DOI: 10.1016/j.jaci.2020.09.018] [Cited by in Crossref: 98] [Cited by in F6Publishing: 105] [Article Influence: 32.7] [Reference Citation Analysis]
231 McGowan EM, Haddadi N, Nassif NT, Lin Y. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19. Int J Mol Sci 2020;21:E7189. [PMID: 33003377 DOI: 10.3390/ijms21197189] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
232 Aziz M, Haghbin H, Abu Sitta E, Nawras Y, Fatima R, Sharma S, Lee-Smith W, Duggan J, Kammeyer JA, Hanrahan J, Assaly R. Efficacy of tocilizumab in COVID-19: A systematic review and meta-analysis. J Med Virol 2021;93:1620-30. [PMID: 32918755 DOI: 10.1002/jmv.26509] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 19.3] [Reference Citation Analysis]
233 Goncalves Mendes Neto A, Lo KB, Wattoo A, Salacup G, Pelayo J, DeJoy R 3rd, Bhargav R, Gul F, Peterson E, Albano J, Patarroyo-Aponte G, Rangaswami J, Azmaiparashvili Z. Bacterial infections and patterns of antibiotic use in patients with COVID-19. J Med Virol 2021;93:1489-95. [PMID: 32808695 DOI: 10.1002/jmv.26441] [Cited by in Crossref: 52] [Cited by in F6Publishing: 60] [Article Influence: 17.3] [Reference Citation Analysis]
234 Horman WSJ, Nguyen THO, Kedzierska K, Butler J, Shan S, Layton R, Bingham J, Payne J, Bean AGD, Layton DS. The Dynamics of the Ferret Immune Response During H7N9 Influenza Virus Infection. Front Immunol 2020;11:559113. [PMID: 33072098 DOI: 10.3389/fimmu.2020.559113] [Reference Citation Analysis]
235 Yang C, Liu F, Liu W, Cao G, Liu J, Huang S, Zhu M, Tu C, Wang J, Xiong B. Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia. Int J Cardiol. 2020;. [PMID: 32979425 DOI: 10.1016/j.ijcard.2020.09.048] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
236 Li K, McCaw JM, Cao P. Modelling within-host macrophage dynamics in influenza virus infection. J Theor Biol 2021;508:110492. [PMID: 32966828 DOI: 10.1016/j.jtbi.2020.110492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
237 Hwang HS, Chang M, Kim YA. Influenza-Host Interplay and Strategies for Universal Vaccine Development. Vaccines (Basel) 2020;8:E548. [PMID: 32962304 DOI: 10.3390/vaccines8030548] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
238 Eberhardt KA, Meyer-Schwickerath C, Heger E, Knops E, Lehmann C, Rybniker J, Schommers P, Eichenauer DA, Kurth F, Ramharter M, Kaiser R, Holtick U, Klein F, Jung N, Di Cristanziano V. RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients. Viruses 2020;12:E1045. [PMID: 32962125 DOI: 10.3390/v12091045] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 12.7] [Reference Citation Analysis]
239 Kongsomros S, Thanunchai M, Manopwisedjaroen S, Na-Ek P, Wang SF, Taechalertpaisarn T, Thitithanyanont A. Trogocytosis with monocytes associated with increased α2,3 sialic acid expression on B cells during H5N1 influenza virus infection. PLoS One 2020;15:e0239488. [PMID: 32946496 DOI: 10.1371/journal.pone.0239488] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
240 Copaescu A, Smibert O, Gibson A, Phillips EJ, Trubiano JA. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J Allergy Clin Immunol. 2020;146:518-534.e1. [PMID: 32896310 DOI: 10.1016/j.jaci.2020.07.001] [Cited by in Crossref: 111] [Cited by in F6Publishing: 121] [Article Influence: 37.0] [Reference Citation Analysis]
241 Brazee PL, Sznajder JI. Targeting the Linear Ubiquitin Assembly Complex to Modulate the Host Response and Improve Influenza A Virus Induced Lung Injury. Arch Bronconeumol (Engl Ed) 2020;56:586-91. [PMID: 33994643 DOI: 10.1016/j.arbr.2020.04.008] [Reference Citation Analysis]
242 Hutchinson NT, Steelman A, Woods JA. Behavioral strategies to prevent and mitigate COVID-19 infection. Sports Med Health Sci 2020. [PMID: 34189481 DOI: 10.1016/j.smhs.2020.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
243 Cazzolla AP, Lovero R, Lo Muzio L, Testa NF, Schirinzi A, Palmieri G, Pozzessere P, Procacci V, Di Comite M, Ciavarella D, Pepe M, De Ruvo C, Crincoli V, Di Serio F, Santacroce L. Taste and Smell Disorders in COVID-19 Patients: Role of Interleukin-6. ACS Chem Neurosci 2020;11:2774-81. [PMID: 32786309 DOI: 10.1021/acschemneuro.0c00447] [Cited by in Crossref: 80] [Cited by in F6Publishing: 88] [Article Influence: 26.7] [Reference Citation Analysis]
244 Kasal DA, De Lorenzo A, Tibiriçá E. COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System. Heart Lung Circ 2020;29:1596-602. [PMID: 32972810 DOI: 10.1016/j.hlc.2020.08.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
245 Fodor E, Te Velthuis AJW. Structure and Function of the Influenza Virus Transcription and Replication Machinery. Cold Spring Harb Perspect Med 2020;10:a038398. [PMID: 31871230 DOI: 10.1101/cshperspect.a038398] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 14.0] [Reference Citation Analysis]
246 Zhou BX, Li J, Liang XL, Pan XP, Hao YB, Xie PF, Jiang HM, Yang ZF, Zhong NS. β-sitosterol ameliorates influenza A virus-induced proinflammatory response and acute lung injury in mice by disrupting the cross-talk between RIG-I and IFN/STAT signaling. Acta Pharmacol Sin 2020;41:1178-96. [PMID: 32504068 DOI: 10.1038/s41401-020-0403-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
247 Luellen E. A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study (Preprint).. [DOI: 10.2196/preprints.23582] [Reference Citation Analysis]
248 Chen Q, Liu J, Liang W, Chen Y, Dou M, Liu Z, Chen Y, Zheng Z, Zhu B, Lin Y. Clinical Features, Replication Competence, and Innate Immune Responses of Human Adenovirus Type 7 Infection. J Infect Dis 2021;223:1390-9. [PMID: 32840612 DOI: 10.1093/infdis/jiaa524] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
249 Crimi E, Benincasa G, Figueroa-Marrero N, Galdiero M, Napoli C. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review. Br J Anaesth 2020;125:1002-17. [PMID: 32828489 DOI: 10.1016/j.bja.2020.06.060] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
250 Kaur S, Bansal R, Kollimuttathuillam S, Gowda AM, Singh B, Mehta D, Maroules M. The looming storm: Blood and cytokines in COVID-19. Blood Rev 2021;46:100743. [PMID: 32829962 DOI: 10.1016/j.blre.2020.100743] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 13.3] [Reference Citation Analysis]
251 Sabatino J, De Rosa S, Di Salvo G, Indolfi C. Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis. PLoS One 2020;15:e0237131. [PMID: 32797054 DOI: 10.1371/journal.pone.0237131] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
252 Yim HCH, Leon TYY, Li JCB. MXD1 regulates the H9N2 and H1N1 influenza A virus-induced chemokine expression and their replications in human macrophage. J Leukoc Biol 2020;108:1631-40. [PMID: 32794336 DOI: 10.1002/JLB.4MA0620-703RR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
253 Zhao Y, Zhou J, Pan L, Zhang Y, Wang H, Wu W, He J, Chen J, Huang H. Detection and analysis of clinical features of patients with different types of coronavirus disease 2019. J Med Virol. 2021;93:401-408. [PMID: 32589755 DOI: 10.1002/jmv.26225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
254 Xu K, Chen Y, Yuan J, Yi P, Ding C, Wu W, Li Y, Ni Q, Zou R, Li X, Xu M, Zhang Y, Zhao H, Zhang X, Yu L, Su J, Lang G, Liu J, Wu X, Guo Y, Tao J, Shi D, Yu L, Cao Q, Ruan B, Liu L, Wang Z, Xu Y, Liu Y, Sheng J, Li L. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Clin Infect Dis. 2020;. [PMID: 32271376 DOI: 10.1093/cid/ciaa351] [Cited by in Crossref: 265] [Cited by in F6Publishing: 311] [Article Influence: 88.3] [Reference Citation Analysis]
255 Johnson KEE, Ghedin E. Quantifying between-Host Transmission in Influenza Virus Infections. Cold Spring Harb Perspect Med 2020;10:a038422. [PMID: 31871239 DOI: 10.1101/cshperspect.a038422] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
256 Luellen E. A machine learning explanation of the pathogen-immune relationship of SARS-CoV-2 (COVID-19), model to predict immunity, and therapeutic opportunity.. [DOI: 10.1101/2020.07.27.20162867] [Reference Citation Analysis]
257 Taubenberger JK, Kash JC, Morens DM. The 1918 influenza pandemic: 100 years of questions answered and unanswered. Sci Transl Med 2019;11:eaau5485. [PMID: 31341062 DOI: 10.1126/scitranslmed.aau5485] [Cited by in Crossref: 90] [Cited by in F6Publishing: 88] [Article Influence: 30.0] [Reference Citation Analysis]
258 Gao YM, Xu G, Wang B, Liu BC. Cytokine storm syndrome in coronavirus disease 2019: A narrative review. J Intern Med 2021;289:147-61. [PMID: 32696489 DOI: 10.1111/joim.13144] [Cited by in Crossref: 104] [Cited by in F6Publishing: 113] [Article Influence: 34.7] [Reference Citation Analysis]
259 Camacho-Zarco AR, Kalayil S, Maurin D, Salvi N, Delaforge E, Milles S, Jensen MR, Hart DJ, Cusack S, Blackledge M. Molecular basis of host-adaptation interactions between influenza virus polymerase PB2 subunit and ANP32A. Nat Commun 2020;11:3656. [PMID: 32694517 DOI: 10.1038/s41467-020-17407-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
260 Cai W, Wen H, Zhou Q, Wu L, Chen Y, Zhou H, Jin M. 14-Deoxy-11,12-didehydroandrographolide inhibits apoptosis in influenza A(H5N1) virus-infected human lung epithelial cells via the caspase-9-dependent intrinsic apoptotic pathway which contributes to its antiviral activity. Antiviral Res 2020;181:104885. [PMID: 32702348 DOI: 10.1016/j.antiviral.2020.104885] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
261 Kang K, Kim HH, Choi Y. Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis. Viruses 2020;12:E776. [PMID: 32698440 DOI: 10.3390/v12070776] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
262 Chen KK, Minakuchi M, Wuputra K, Ku CC, Pan JB, Kuo KK, Lin YC, Saito S, Lin CS, Yokoyama KK. Redox control in the pathophysiology of influenza virus infection. BMC Microbiol 2020;20:214. [PMID: 32689931 DOI: 10.1186/s12866-020-01890-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
263 Guillon A, Hiemstra PS, Si-Tahar M. Pulmonary immune responses against SARS-CoV-2 infection: harmful or not? Intensive Care Med 2020;46:1897-900. [PMID: 32681297 DOI: 10.1007/s00134-020-06170-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
264 Liu L, Song S, Shen Y, Ma C, Wang T, Tong Q, Sun H, Pu J, Iqbal M, Liu J, Sun Y. Truncation of PA-X Contributes to Virulence and Transmission of H3N8 and H3N2 Canine Influenza Viruses in Dogs. J Virol 2020;94:e00949-20. [PMID: 32461313 DOI: 10.1128/JVI.00949-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
265 Guihot A, Litvinova E, Autran B, Debré P, Vieillard V. Cell-Mediated Immune Responses to COVID-19 Infection. Front Immunol 2020;11:1662. [PMID: 32719687 DOI: 10.3389/fimmu.2020.01662] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
266 Mastroianni A, Greco S, Apuzzo G, De Santis S, Oriolo C, Zanolini A, Chidichimo L, Vangeli V. Subcutaneous tocilizumab treatment in patients with severe COVID-19-related cytokine release syndrome: An observational cohort study. EClinicalMedicine 2020;24:100410. [PMID: 32766535 DOI: 10.1016/j.eclinm.2020.100410] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
267 Lu Y, Li Y, Deng W, Liu M, He Y, Huang L, Lv M, Li J, Du H. Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus Disease 2019: A Retrospective Study of 110 Children in Wuhan. Pediatr Infect Dis J 2020;39:e95-9. [PMID: 32379191 DOI: 10.1097/INF.0000000000002729] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 21.3] [Reference Citation Analysis]
268 Aoyagi T, Sato Y, Toyama M, Oshima K, Kawakami K, Kaku M. Etoposide and Corticosteroid Combination Therapy Improves Acute Respiratory Distress Syndrome in Mice. Shock 2019;52:83-91. [PMID: 30028782 DOI: 10.1097/SHK.0000000000001231] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
269 Yang JW, Yang L, Luo RG, Xu JF. Corticosteroid administration for viral pneumonia: COVID-19 and beyond. Clin Microbiol Infect 2020;26:1171-7. [PMID: 32603802 DOI: 10.1016/j.cmi.2020.06.020] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 14.3] [Reference Citation Analysis]
270 Quraishi MN, Cooney R, Brookes MJ, Sharma N. An urgent need to institute COVID-19 testing in patients with IBD experiencing flares. Frontline Gastroenterol 2020;11:330-1. [PMID: 32582424 DOI: 10.1136/flgastro-2020-101477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
271 Boyd DF, Wilson TL, Thomas PG. One hundred years of (influenza) immunopathology. Adv Virus Res 2020;107:247-84. [PMID: 32711731 DOI: 10.1016/bs.aivir.2020.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
272 Nguyen CT, Suzuki S, Itoh Y, Ishigaki H, Nakayama M, Hayashi K, Matsuno K, Okamatsu M, Sakoda Y, Kida H, Ogasawara K. Efficacy of Neuraminidase Inhibitors against H5N6 Highly Pathogenic Avian Influenza Virus in a Nonhuman Primate Model. Antimicrob Agents Chemother 2020;64:e02561-19. [PMID: 32284377 DOI: 10.1128/AAC.02561-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
273 Putri K, Widyarini S, Sugiyono, Asmara W. The Thrift of Avian Influenza in Indonesia. Viruses and Viral Infections in Developing Countries 2020. [DOI: 10.5772/intechopen.85105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
274 Takemoto Y. Adequate Monitor of Avian Influenza Viral Infections and Foresight About Possibilities of Its Human Epidemic and Pandemic Infections. Viruses and Viral Infections in Developing Countries 2020. [DOI: 10.5772/intechopen.86551] [Reference Citation Analysis]
275 . Translation: Expert Consensus on the Application of Artificial Liver Blood Purification System in the Treatment of Severe and Critical COVID-19. Infectious Microbes and Diseases 2020;2:64-6. [DOI: 10.1097/im9.0000000000000021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
276 Pawestri HA, Nugraha AA, Han AX, Pratiwi E, Parker E, Richard M, van der Vliet S, Fouchier RAM, Muljono DH, de Jong MD, Setiawaty V, Eggink D. Genetic and antigenic characterization of influenza A/H5N1 viruses isolated from patients in Indonesia, 2008-2015. Virus Genes 2020;56:417-29. [PMID: 32483655 DOI: 10.1007/s11262-020-01765-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
277 Al-Lami RA, Urban RJ, Volpi E, Algburi AMA, Baillargeon J. Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19). Mayo Clin Proc 2020;95:1710-4. [PMID: 32753145 DOI: 10.1016/j.mayocp.2020.05.013] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 25.0] [Reference Citation Analysis]
278 Sun Y, Hu Z, Zhang X, Chen M, Wang Z, Xu G, Bi Y, Tong Q, Wang M, Sun H, Pu J, Iqbal M, Liu J. An R195K Mutation in the PA-X Protein Increases the Virulence and Transmission of Influenza A Virus in Mammalian Hosts. J Virol 2020;94:e01817-19. [PMID: 32161172 DOI: 10.1128/JVI.01817-19] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
279 Vigeveno RM, Poen MJ, Parker E, Holwerda M, de Haan K, van Montfort T, Lewis NS, Russell CA, Fouchier RAM, de Jong MD, Eggink D. Outbreak Severity of Highly Pathogenic Avian Influenza A(H5N8) Viruses Is Inversely Correlated to Polymerase Complex Activity and Interferon Induction. J Virol 2020;94:e00375-20. [PMID: 32238581 DOI: 10.1128/JVI.00375-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
280 Levi M. Tocilizumab for severe COVID-19: A promising intervention affecting inflammation and coagulation. Eur J Intern Med 2020;76:21-2. [PMID: 32425364 DOI: 10.1016/j.ejim.2020.05.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
281 Chen S, Xie Y, Su X, Xue J, Wang X, Du Y, Qin T, Peng D, Liu X. Substitutions in the PB2 methionine 283 residue affect H5 subtype avian influenza virus virulence. Transbound Emerg Dis 2020;67:2554-63. [PMID: 32351035 DOI: 10.1111/tbed.13601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
282 Brazee PL, Sznajder JI. Targeting the Linear Ubiquitin Assembly Complex to Modulate the Host Response and Improve Influenza A Virus Induced Lung Injury. Arch Bronconeumol (Engl Ed) 2020;56:586-91. [PMID: 32405132 DOI: 10.1016/j.arbres.2020.04.019] [Reference Citation Analysis]
283 Xia X, Wen M, Zhan S, He J, Chen W. [An increased neutrophil/lymphocyte ratio is an early warning signal of severe COVID-19]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:333-6. [PMID: 32376581 DOI: 10.12122/j.issn.1673-4254.2020.03.06] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
284 Li K, Mccaw JM, Cao P. Modelling within-host macrophage dynamics in influenza virus infection.. [DOI: 10.1101/2020.05.07.083360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
285 Picchianti Diamanti A, Rosado MM, Pioli C, Sesti G, Laganà B. Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity. Int J Mol Sci 2020;21:E3330. [PMID: 32397174 DOI: 10.3390/ijms21093330] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 25.3] [Reference Citation Analysis]
286 Li J, Jie X, Liang X, Chen Z, Xie P, Pan X, Zhou B, Li J. Sinensetin suppresses influenza a virus-triggered inflammation through inhibition of NF-κB and MAPKs signalings. BMC Complement Med Ther 2020;20:135. [PMID: 32370749 DOI: 10.1186/s12906-020-02918-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
287 Zhou Z, Ren L, Zhang L, Zhong J, Xiao Y, Jia Z, Guo L, Yang J, Wang C, Jiang S, Yang D, Zhang G, Li H, Chen F, Xu Y, Chen M, Gao Z, Dong J, Liu B, Zhang X, Wang W, He K, Jin Q, Li M, Wang J. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients. Cell Host Microbe. 2020;27:883-890.e2. [PMID: 32407669 DOI: 10.1016/j.chom.2020.04.017] [Cited by in Crossref: 613] [Cited by in F6Publishing: 633] [Article Influence: 204.3] [Reference Citation Analysis]
288 Yang Y, Shen C, Li J, Yuan J, Wei J, Huang F, Wang F, Li G, Li Y, Xing L, Peng L, Yang M, Cao M, Zheng H, Wu W, Zou R, Li D, Xu Z, Wang H, Zhang M, Zhang Z, Gao GF, Jiang C, Liu L, Liu Y. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol 2020;146:119-127.e4. [PMID: 32360286 DOI: 10.1016/j.jaci.2020.04.027] [Cited by in Crossref: 399] [Cited by in F6Publishing: 322] [Article Influence: 133.0] [Reference Citation Analysis]
289 Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA 2020;323:1582-9. [PMID: 32219428 DOI: 10.1001/jama.2020.4783] [Cited by in Crossref: 1517] [Cited by in F6Publishing: 1612] [Article Influence: 505.7] [Reference Citation Analysis]
290 Lee CC, Liu Y, Lu KT, Wei C, Su K, Hsu WT, Chen SC. Comparison of influenza hospitalization outcomes among adults, older adults, and octogenarians: a US national population-based study. Clin Microbiol Infect 2021;27:435-42. [PMID: 32325126 DOI: 10.1016/j.cmi.2020.04.013] [Reference Citation Analysis]
291 Dunning J, Thwaites RS, Openshaw PJM. Seasonal and pandemic influenza: 100 years of progress, still much to learn. Mucosal Immunol 2020;13:566-73. [PMID: 32317736 DOI: 10.1038/s41385-020-0287-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
292 Forbester JL, Clement M, Wellington D, Yeung A, Dimonte S, Marsden M, Chapman L, Coomber EL, Tolley C, Lees E, Hale C, Clare S, Udalova I, Dong T, Dougan G, Humphreys IR. IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models. J Virol 2020;94:e00121-20. [PMID: 32075938 DOI: 10.1128/JVI.00121-20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
293 Kandasamy M, Furlong K, Perez JT, Manicassamy S, Manicassamy B. Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection. J Virol 2020;94:e00057-20. [PMID: 32075925 DOI: 10.1128/JVI.00057-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
294 Quirouette C, Younis NP, Reddy MB, Beauchemin CAA. A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract. PLoS Comput Biol 2020;16:e1007705. [PMID: 32282797 DOI: 10.1371/journal.pcbi.1007705] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
295 Hao S, Jin D, Zhang S, Qing R. QTY Code-designed Water-soluble Fc-fusion Cytokine Receptors Bind to their Respective Ligands. QRB Discov 2020;1:e4. [PMID: 34192260 DOI: 10.1017/qrd.2020.4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
296 Cheng Q, Sun Z, Zhao G, Xie L. Nomogram for the Individualized Prediction of Survival Among Patients with H7N9 Infection. Risk Manag Healthc Policy 2020;13:255-69. [PMID: 32256136 DOI: 10.2147/RMHP.S242168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
297 Zarco AC, Kalayil S, Maurin D, Salvi N, Delaforge E, Milles S, Jensen MR, Hart DJ, Cusack S, Blackledge M. Molecular Basis of Host-Adaptation Interactions between Influenza Virus Polymerase PB2 Subunit and ANP32A.. [DOI: 10.1101/2020.03.18.996579] [Reference Citation Analysis]
298 Venkatesh D, Bianco C, Núñez A, Collins R, Thorpe D, Reid SM, Brookes SM, Essen S, McGinn N, Seekings J, Cooper J, Brown IH, Lewis NS. Detection of H3N8 influenza A virus with multiple mammalian-adaptive mutations in a rescued Grey seal (Halichoerus grypus) pup. Virus Evol 2020;6:veaa016. [PMID: 32211197 DOI: 10.1093/ve/veaa016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
299 Yang S, Adaway M, Du J, Huang S, Sun J, Bidwell JP, Zhou B. NMP4 regulates the innate immune response to influenza A virus infection. Mucosal Immunol 2021;14:209-18. [PMID: 32152414 DOI: 10.1038/s41385-020-0280-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
300 Liu Y, Zhang C, Huang F, Yang Y, Wang F, Yuan J, Zhang Z, Qin Y, Li X, Zhao D, Li S, Tan S, Wang Z, Li J, Shen C, Li J, Peng L, Wu W, Cao M, Xing L, Xu Z, Chen L, Zhou C, Liu WJ, Liu L, Jiang C. Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury. National Science Review 2020;7:1003-11. [DOI: 10.1093/nsr/nwaa037] [Cited by in Crossref: 148] [Cited by in F6Publishing: 152] [Article Influence: 49.3] [Reference Citation Analysis]
301 Peretz A, Azrad M, Blum A. Influenza virus and atherosclerosis. QJM 2019;112:749-55. [PMID: 30605546 DOI: 10.1093/qjmed/hcy305] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
302 Tsai MJ, Yang KY, Chan MC, Kao KC, Wang HC, Perng WC, Wu CL, Liang SJ, Fang WF, Tsai JR, Chang WA, Chien YC, Chen WC, Hu HC, Lin CY, Chao WC, Sheu CC; for Taiwan Severe Influenza Research Consortium (TSIRC) Investigators. Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study. Ann Intensive Care 2020;10:26. [PMID: 32107651 DOI: 10.1186/s13613-020-0642-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
303 Zhang J, Liu J, Yuan Y, Huang F, Ma R, Luo B, Xi Z, Pan T, Liu B, Zhang Y, Zhang X, Luo Y, Wang J, Zhao M, Lu G, Deng K, Zhang H. Two waves of pro-inflammatory factors are released during the influenza A virus (IAV)-driven pulmonary immunopathogenesis. PLoS Pathog 2020;16:e1008334. [PMID: 32101596 DOI: 10.1371/journal.ppat.1008334] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
304 Rodriguez-Frandsen A, Martin-Sancho L, Gounder AP, Chang MW, Liu WC, De Jesus PD, von Recum-Knepper J, Dutra MS, Huffmaster NJ, Chavarria M, Mena I, Riva L, Nguyen CB, Dobariya S, Herbert KM, Benner C, Albrecht RA, García-Sastre A, Chanda SK. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells. J Virol 2020;94:e01410-19. [PMID: 31776276 DOI: 10.1128/JVI.01410-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
305 Huo C, Xiao J, Xiao K, Zou S, Wang M, Qi P, Liu T, Hu Y. Pre-Treatment with Zirconia Nanoparticles Reduces Inflammation Induced by the Pathogenic H5N1 Influenza Virus. Int J Nanomedicine 2020;15:661-74. [PMID: 32099358 DOI: 10.2147/IJN.S221667] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
306 Cui H, Zhang C, Zhao Z, Zhang C, Fu Y, Li J, Chen G, Lai M, Li Z, Dong S, Chen L, Li Z, Wang C, Liu J, Gao Y, Guo Z. Identification of cellular microRNA miR-188-3p with broad-spectrum anti-influenza A virus activity. Virol J 2020;17:12. [PMID: 32000791 DOI: 10.1186/s12985-020-1283-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
307 Spencer JV, Religa P, Lehmann MH. Editorial: Cytokine-Mediated Organ Dysfunction and Tissue Damage Induced by Viruses. Front Immunol 2020;11:2. [PMID: 32038654 DOI: 10.3389/fimmu.2020.00002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
308 Ma Q, Huang W, Zhao J, Yang Z. Liu Shen Wan inhibits influenza a virus and excessive virus-induced inflammatory response via suppression of TLR4/NF-κB signaling pathway in vitro and in vivo. J Ethnopharmacol 2020;252:112584. [PMID: 31972325 DOI: 10.1016/j.jep.2020.112584] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
309 Kandasamy M, Furlong K, Perez JT, Manicassamy S, Manicassamy B. Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue Resident Memory T cell During H5N1 infection.. [DOI: 10.1101/2020.01.09.901132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
310 Daidoji T, Kajikawa J, Arai Y, Watanabe Y, Hirose R, Nakaya T. Infection of Human Tracheal Epithelial Cells by H5 Avian Influenza Virus Is Regulated by the Acid Stability of Hemagglutinin and the pH of Target Cell Endosomes. Viruses 2020;12:E82. [PMID: 31936692 DOI: 10.3390/v12010082] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
311 Nagarajan S, Kumar M, Murugkar HV, Tosh C, Singh VP. Avian Influenza Virus. Livestock Diseases and Management 2020. [DOI: 10.1007/978-981-15-2651-0_5] [Reference Citation Analysis]
312 Zhang S, Li L, Shen A, Chen Y, Qi Z. Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia. Clin Drug Investig 2020;40:511-8. [PMID: 32337664 DOI: 10.1007/s40261-020-00917-3] [Cited by in Crossref: 116] [Cited by in F6Publishing: 125] [Article Influence: 38.7] [Reference Citation Analysis]
313 Zhang C, Zhang Y, Qin Y, Zhang Q, Liu Q, Shang D, Lu H, Li X, Zhou C, Huang F, Jin N, Jiang C. Ifenprodil and Flavopiridol Identified by Genomewide RNA Interference Screening as Effective Drugs To Ameliorate Murine Acute Lung Injury after Influenza A H5N1 Virus Infection. mSystems 2019;4:e00431-19. [PMID: 31822599 DOI: 10.1128/mSystems.00431-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
314 Liu Q, Yang J, Huang X, Liu Y, Han K, Zhao D, Zhang L, Li Y. Transcriptomic profile of chicken bone marrow-derive dendritic cells in response to H9N2 avian influenza A virus. Vet Immunol Immunopathol 2020;220:109992. [PMID: 31846798 DOI: 10.1016/j.vetimm.2019.109992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
315 Mehrbod P, Ebrahimi SN, Fotouhi F, Eskandari F, Eloff JN, McGaw LJ, Fasina FO. Experimental validation and computational modeling of anti-influenza effects of quercetin-3-O-α-L-rhamnopyranoside from indigenous south African medicinal plant Rapanea melanophloeos. BMC Complement Altern Med 2019;19:346. [PMID: 31791311 DOI: 10.1186/s12906-019-2774-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
316 Uyeki TM, Peiris M. Novel Avian Influenza A Virus Infections of Humans. Infectious Disease Clinics of North America 2019;33:907-32. [DOI: 10.1016/j.idc.2019.07.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
317 Li J, Yang C, Ma X, Gao Y, Fu C, Yang H. Suppressing epidemic spreading by optimizing the allocation of resources between prevention and treatment. Chaos 2019;29:113108. [PMID: 31779370 DOI: 10.1063/1.5114873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
318 Bhattacharya S, Kawamura A. Using evasins to target the chemokine network in inflammation. Adv Protein Chem Struct Biol 2020;119:1-38. [PMID: 31997766 DOI: 10.1016/bs.apcsb.2019.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
319 Misra RS, Nayak JL. The Importance of Vaccinating Children and Pregnant Women against Influenza Virus Infection. Pathogens 2019;8:E265. [PMID: 31779153 DOI: 10.3390/pathogens8040265] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
320 Tang N, Lin SW, Chen TH, Jan JT, Wu HY, Wu SC. Highly Pathogenic Avian Influenza H5 Hemagglutinin Fused with the A Subunit of Type IIb Escherichia coli Heat Labile Enterotoxin Elicited Protective Immunity and Neutralization by Intranasal Immunization in Mouse and Chicken Models. Vaccines (Basel) 2019;7:E193. [PMID: 31766677 DOI: 10.3390/vaccines7040193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
321 Liu B, Bao L, Wang L, Li F, Wen M, Li H, Deng W, Zhang X, Cao B. Anti-IFN-γ therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice. J Microbiol Immunol Infect 2021;54:396-403. [PMID: 31780358 DOI: 10.1016/j.jmii.2019.07.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
322 Song Y, Li W, Wu W, Liu Z, He Z, Chen Z, Zhao B, Wu S, Yang C, Qu X, Liao M, Jiao P. Phylogeny, Pathogenicity, Transmission, and Host Immune Responses of Four H5N6 Avian Influenza Viruses in Chickens and Mice. Viruses 2019;11:E1048. [PMID: 31717638 DOI: 10.3390/v11111048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
323 Alosaimi B, Hamed ME, Naeem A, Alsharef AA, AlQahtani SY, AlDosari KM, Alamri AA, Al-Eisa K, Khojah T, Assiri AM, Enani MA. MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract. Cytokine 2020;126:154895. [PMID: 31706200 DOI: 10.1016/j.cyto.2019.154895] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 19.3] [Reference Citation Analysis]
324 Musharrafieh R, Ma C, Wang J. Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N/L26I and M2-S31N/V27A from the influenza A viruses. Eur J Pharm Sci 2020;141:105124. [PMID: 31669761 DOI: 10.1016/j.ejps.2019.105124] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
325 Puggioni F, Alves-Correia M, Mohamed MF, Stomeo N, Mager R, Marinoni M, Racca F, Paoletti G, Varricchi G, Giorgis V, Melioli G, Canonica GW, Heffler E. Immunostimulants in respiratory diseases: focus on Pidotimod. Multidiscip Respir Med 2019;14:31. [PMID: 31700623 DOI: 10.1186/s40248-019-0195-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
326 Xie Y, Liu K, Luo J, Liu S, Zheng H, Cao L, Li X. Identification of DDX58 and CXCL10 as Potential Biomarkers in Acute Respiratory Distress Syndrome. DNA Cell Biol 2019;38:1444-51. [PMID: 31651197 DOI: 10.1089/dna.2019.4968] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
327 Le Gars M, Seiler C, Kay AW, Bayless NL, Starosvetsky E, Moore L, Shen-Orr SS, Aziz N, Khatri P, Dekker CL, Swan GE, Davis MM, Holmes S, Blish CA. Pregnancy-Induced Alterations in NK Cell Phenotype and Function. Front Immunol 2019;10:2469. [PMID: 31708922 DOI: 10.3389/fimmu.2019.02469] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
328 Yang G, Huang H, Tang M, Cai Z, Huang C, Qi B, Chen JL. Role of neuromedin B and its receptor in the innate immune responses against influenza A virus infection in vitro and in vivo. Vet Res 2019;50:80. [PMID: 31601264 DOI: 10.1186/s13567-019-0695-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
329 Liang X, Huang Y, Pan X, Hao Y, Chen X, Jiang H, Li J, Zhou B, Yang Z. Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway. J Pharm Anal 2020;10:130-46. [PMID: 32373385 DOI: 10.1016/j.jpha.2019.09.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
330 Cantan B, Luyt CE, Martin-Loeches I. Influenza Infections and Emergent Viral Infections in Intensive Care Unit. Semin Respir Crit Care Med 2019;40:488-97. [PMID: 31585475 DOI: 10.1055/s-0039-1693497] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
331 Butler J, Middleton D, Haining J, Layton R, Rockman S, Brown LE, Sapats S. Insights into the Acquisition of Virulence of Avian Influenza Viruses during a Single Passage in Ferrets. Viruses 2019;11:E915. [PMID: 31590265 DOI: 10.3390/v11100915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
332 Schloer S, Hübel N, Masemann D, Pajonczyk D, Brunotte L, Ehrhardt C, Brandenburg LO, Ludwig S, Gerke V, Rescher U. The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model. FASEB J 2019;33:12188-99. [PMID: 31398292 DOI: 10.1096/fj.201901265R] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
333 Yan L, Wang H, Sun L, Liu Y, Sun J, Zhao X, Li Y, Xie X, Hu J. An epitope on the stem region of hemagglutinin of H1N1 influenza A virus recognized by neutralizing monoclonal antibody. Biochemical and Biophysical Research Communications 2019;518:319-24. [DOI: 10.1016/j.bbrc.2019.08.055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
334 Zhou B, Liang X, Feng Q, Li J, Pan X, Xie P, Jiang Z, Yang Z. Ergosterol peroxide suppresses influenza A virus-induced pro-inflammatory response and apoptosis by blocking RIG-I signaling. European Journal of Pharmacology 2019;860:172543. [DOI: 10.1016/j.ejphar.2019.172543] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
335 Mak GCK, Kwan MY, Mok CKP, Lo JYC, Peiris M, Leung CW. Influenza A(H5N1) Virus Infection in a Child With Encephalitis Complicated by Obstructive Hydrocephalus. Clin Infect Dis 2018;66:136-9. [PMID: 29020163 DOI: 10.1093/cid/cix707] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
336 Lamichhane PP, Samarasinghe AE. The Role of Innate Leukocytes during Influenza Virus Infection. J Immunol Res 2019;2019:8028725. [PMID: 31612153 DOI: 10.1155/2019/8028725] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 9.5] [Reference Citation Analysis]
337 Sengupta S, Tang SY, Devine JC, Anderson ST, Nayak S, Zhang SL, Valenzuela A, Fisher DG, Grant GR, López CB, FitzGerald GA. Circadian control of lung inflammation in influenza infection. Nat Commun 2019;10:4107. [PMID: 31511530 DOI: 10.1038/s41467-019-11400-9] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 17.5] [Reference Citation Analysis]
338 Wang Y, Guo Q, Yan Z, Zhou D, Zhang W, Zhou S, Li YP, Yuan J, Uyeki TM, Shen X, Wu W, Zhao H, Wu YF, Shang J, He Z, Yang Y, Zhao H, Hong Y, Zhang Z, Wu M, Wei T, Deng X, Deng Y, Cai LH, Lu W, Shu H, Zhang L, Luo H, Ing Zhou Y, Weng H, Song K, Yao L, Jiang M, Zhao B, Chi R, Guo B, Fu L, Yu L, Min H, Chen P, Chen S, Hong L, Mao W, Huang X, Gu L, Li H, Wang C, Cao B; CAP-China Network. Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection. J Infect Dis 2018;217:1708-17. [PMID: 29648602 DOI: 10.1093/infdis/jiy115] [Cited by in Crossref: 62] [Cited by in F6Publishing: 157] [Article Influence: 15.5] [Reference Citation Analysis]
339 Venkatesh D, Bianco C, Núñez A, Collins R, Thorpe D, Reid SM, Brookes SM, Essen S, Mcginn N, Seekings J, Cooper J, Brown IH, Lewis NS. Detection of H3N8 influenza A virus with multiple mammalian-adaptive mutations in a rescued Grey seal (Halichoerus grypus) pup.. [DOI: 10.1101/741173] [Reference Citation Analysis]
340 Li P, Ye J, Zeng S, Yang C. Florfenicol alleviated lipopolysaccharide (LPS)-induced inflammatory responses in Ctenopharyngodon idella through inhibiting toll / NF-κB signaling pathways. Fish Shellfish Immunol 2019;94:479-84. [PMID: 31472264 DOI: 10.1016/j.fsi.2019.08.073] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
341 DeDiego ML, Nogales A, Martinez-Sobrido L, Topham DJ. Interferon-Induced Protein 44 Interacts with Cellular FK506-Binding Protein 5, Negatively Regulates Host Antiviral Responses, and Supports Virus Replication. mBio 2019;10:e01839-19. [PMID: 31455651 DOI: 10.1128/mBio.01839-19] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
342 Ye Y, Wang H, Liu J, Zhao F, Xu P. Polygalasaponin F treats mice with pneumonia induced by influenza virus. Inflammopharmacology. 2020;28:299-310. [PMID: 31446589 DOI: 10.1007/s10787-019-00633-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
343 Baral S, Antia R, Dixit NM. A dynamical motif comprising the interactions between antigens and CD8 T cells may underlie the outcomes of viral infections. Proc Natl Acad Sci U S A 2019;116:17393-8. [PMID: 31413198 DOI: 10.1073/pnas.1902178116] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
344 Tang BM, Shojaei M, Teoh S, Meyers A, Ho J, Ball TB, Keynan Y, Pisipati A, Kumar A, Eisen DP, Lai K, Gillett M, Santram R, Geffers R, Schreiber J, Mozhui K, Huang S, Parnell GP, Nalos M, Holubova M, Chew T, Booth D, Kumar A, McLean A, Schughart K. Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection. Nat Commun 2019;10:3422. [PMID: 31366921 DOI: 10.1038/s41467-019-11249-y] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 19.0] [Reference Citation Analysis]
345 Cheng QL, Zhao G, Xie L, Sun Z. Predicting overall death risk in patients with H7N9 infection using a nomogram (Preprint).. [DOI: 10.2196/preprints.15567] [Reference Citation Analysis]
346 Liu G, Chen S, Hu A, Zhang L, Sun W, Chen J, Tang W, Zhang H, Liu C, Ke C, Chen X. The Establishment and Validation of the Human U937 Cell Line as a Cellular Model to Screen Immunomodulatory Agents Regulating Cytokine Release Induced by Influenza Virus Infection. Virol Sin 2019;34:648-61. [PMID: 31286365 DOI: 10.1007/s12250-019-00145-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
347 de Wit E, Siegers JY, Cronin JM, Weatherman S, van den Brand JM, Leijten LM, van Run P, Begeman L, van den Ham HJ, Andeweg AC, Bushmaker T, Scott DP, Saturday G, Munster VJ, Feldmann H, van Riel D. 1918 H1N1 Influenza Virus Replicates and Induces Proinflammatory Cytokine Responses in Extrarespiratory Tissues of Ferrets. J Infect Dis 2018;217:1237-46. [PMID: 29329410 DOI: 10.1093/infdis/jiy003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
348 Rosli S, Tate MD. TANKing Influenza A Virus in the Lung. Am J Respir Cell Mol Biol 2019;60:255-6. [PMID: 30365353 DOI: 10.1165/rcmb.2018-0337ED] [Reference Citation Analysis]
349 Huang S, Liao C, Chen S, Shi L, Lin L, Chen Y, Cheng C, Sytwu H, Shang S, Lin G. Melatonin possesses an anti-influenza potential through its immune modulatory effect. Journal of Functional Foods 2019;58:189-98. [DOI: 10.1016/j.jff.2019.04.062] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
350 Gautam S, Sharma L, Dela Cruz CS. Personalizing the Management of Pneumonia. Clin Chest Med 2018;39:871-900. [PMID: 30390755 DOI: 10.1016/j.ccm.2018.08.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
351 Yuan B, Yang C, Xia X, Zanin M, Wong SS, Yang F, Chang J, Mai Z, Zhao J, Zhang Y, Li R, Zhong N, Yang Z. The tree shrew is a promising model for the study of influenza B virus infection. Virol J 2019;16:77. [PMID: 31174549 DOI: 10.1186/s12985-019-1171-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
352 Wang WH, Erazo EM, Ishcol MRC, Lin CY, Assavalapsakul W, Thitithanyanont A, Wang SF. Virus-induced pathogenesis, vaccine development, and diagnosis of novel H7N9 avian influenza A virus in humans: a systemic literature review. J Int Med Res 2020;48:300060519845488. [PMID: 31068040 DOI: 10.1177/0300060519845488] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
353 Zeng H, Goldsmith CS, Kumar A, Belser JA, Sun X, Pappas C, Brock N, Bai Y, Levine M, Tumpey TM, Maines TR. Tropism and Infectivity of a Seasonal A(H1N1) and a Highly Pathogenic Avian A(H5N1) Influenza Virus in Primary Differentiated Ferret Nasal Epithelial Cell Cultures. J Virol 2019;93:e00080-19. [PMID: 30814288 DOI: 10.1128/JVI.00080-19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
354 Roberts G, Chen S, Yates P, Madan A, Walker J, Washburn ML, Peat AJ, Soucie G, Kerwin E, Roy-Ghanta S. Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Clinical Effect of Danirixin in Adults With Acute, Uncomplicated Influenza. Open Forum Infect Dis 2019;6:ofz072. [PMID: 31024969 DOI: 10.1093/ofid/ofz072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
355 Warren CJ, Sawyer SL. How host genetics dictates successful viral zoonosis. PLoS Biol 2019;17:e3000217. [PMID: 31002666 DOI: 10.1371/journal.pbio.3000217] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
356 Huang S, Zhu B, Cheon IS, Goplen NP, Jiang L, Zhang R, Peebles RS, Mack M, Kaplan MH, Limper AH, Sun J. PPAR-γ in Macrophages Limits Pulmonary Inflammation and Promotes Host Recovery following Respiratory Viral Infection. J Virol 2019;93:e00030-19. [PMID: 30787149 DOI: 10.1128/JVI.00030-19] [Cited by in Crossref: 47] [Cited by in F6Publishing: 54] [Article Influence: 11.8] [Reference Citation Analysis]
357 Rudd JM, Pulavendran S, Ashar HK, Ritchey JW, Snider TA, Malayer JR, Marie M, Chow VTK, Narasaraju T. Neutrophils Induce a Novel Chemokine Receptors Repertoire During Influenza Pneumonia. Front Cell Infect Microbiol 2019;9:108. [PMID: 31041196 DOI: 10.3389/fcimb.2019.00108] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
358 Alfardan R, Guo C, Toth LA, Nie D. Impaired Recovery from Influenza A/X-31(H3N2) Infection in Mice with 8-Lipoxygenase Deficiency. Med Sci (Basel) 2019;7:E60. [PMID: 31013822 DOI: 10.3390/medsci7040060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
359 Fisher CE, Boeckh M, Jerome KR, Englund J, Kuypers J. Evaluating addition of self-collected throat swabs to nasal swabs for respiratory virus detection. J Clin Virol 2019;115:43-6. [PMID: 30978619 DOI: 10.1016/j.jcv.2019.04.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
360 Garcia Borrega J, Gödel P, Rüger MA, Onur ÖA, Shimabukuro-Vornhagen A, Kochanek M, Böll B. In the Eye of the Storm: Immune-mediated Toxicities Associated With CAR-T Cell Therapy. Hemasphere 2019;3:e191. [PMID: 31723828 DOI: 10.1097/HS9.0000000000000191] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 15.0] [Reference Citation Analysis]
361 Biondo C, Lentini G, Beninati C, Teti G. The dual role of innate immunity during influenza. Biomed J 2019;42:8-18. [PMID: 30987709 DOI: 10.1016/j.bj.2018.12.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
362 Sekiya T, Mifsud EJ, Ohno M, Nomura N, Sasada M, Fujikura D, Daito T, Shingai M, Ohara Y, Nishimura T, Endo M, Mitsumata R, Ikeda T, Hatanaka H, Kitayama H, Motokawa K, Sobue T, Suzuki S, Itoh Y, Brown LE, Ogasawara K, Kino Y, Kida H. Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza. Vaccine 2019;37:2158-66. [PMID: 30857932 DOI: 10.1016/j.vaccine.2019.02.057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
363 Washburn ML, Crosby R, Remlinger K, Wang F, Creech D. Therapeutically Attenuating Neutrophil Recruitment With a CXCR2 Antagonist in Combination With Oseltamivir Ameliorates Influenza-Induced Lung Injury and Disease. Open Forum Infect Dis 2019;6:ofz106. [PMID: 31041337 DOI: 10.1093/ofid/ofz106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
364 Taniguchi K, Ando Y, Nobori H, Toba S, Noshi T, Kobayashi M, Kawai M, Yoshida R, Sato A, Shishido T, Naito A, Matsuno K, Okamatsu M, Sakoda Y, Kida H. Inhibition of avian-origin influenza A(H7N9) virus by the novel cap-dependent endonuclease inhibitor baloxavir marboxil. Sci Rep 2019;9:3466. [PMID: 30837531 DOI: 10.1038/s41598-019-39683-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
365 Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev 2019;2:CD010406. [PMID: 30798570 DOI: 10.1002/14651858.CD010406.pub3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 86] [Article Influence: 10.5] [Reference Citation Analysis]
366 Lu Y, Landreth S, Gaba A, Hlasny M, Liu G, Huang Y, Zhou Y. In Vivo Characterization of Avian Influenza A (H5N1) and (H7N9) Viruses Isolated from Canadian Travelers. Viruses 2019;11:E193. [PMID: 30813415 DOI: 10.3390/v11020193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
367 Nuñez IA, Ross TM. A review of H5Nx avian influenza viruses. Ther Adv Vaccines Immunother 2019;7:2515135518821625. [PMID: 30834359 DOI: 10.1177/2515135518821625] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
368 Stegelmeier AA, van Vloten JP, Mould RC, Klafuric EM, Minott JA, Wootton SK, Bridle BW, Karimi K. Myeloid Cells during Viral Infections and Inflammation. Viruses 2019;11:E168. [PMID: 30791481 DOI: 10.3390/v11020168] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 13.0] [Reference Citation Analysis]
369 Li N, Zhang Y, Wu S, Xu R, Li Z, Zhu J, Wang H, Li X, Tian M, Lu H, Jin N, Jiang C. Tauroursodeoxycholic acid (TUDCA) inhibits influenza A viral infection by disrupting viral proton channel M2. Sci Bull (Beijing) 2019;64:180-8. [PMID: 32288967 DOI: 10.1016/j.scib.2018.08.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
370 Wang L, Zhou Y, Chen Z, Sun L, Wu J, Li H, Liu F, Wang F, Yang C, Yang J, Leng Q, Zhang Q, Xu A, Shen L, Sun J, Wu D, Fang C, Lu H, Yan D, Ge B. PLCβ2 negatively regulates the inflammatory response to virus infection by inhibiting phosphoinositide-mediated activation of TAK1. Nat Commun 2019;10:746. [PMID: 30765691 DOI: 10.1038/s41467-019-08524-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
371 Cao Y, Zhang K, Liu L, Li W, Zhu B, Zhang S, Xu P, Liu W, Li J. Global transcriptome analysis of H5N1 influenza virus-infected human cells. Hereditas 2019;156:10. [PMID: 30774581 DOI: 10.1186/s41065-019-0085-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
372 Schuster JE, Williams JV. Emerging Respiratory Viruses in Children. Infect Dis Clin North Am 2018;32:65-74. [PMID: 29406977 DOI: 10.1016/j.idc.2017.10.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
373 James J, Smith N, Ross C, Iqbal M, Goodbourn S, Digard P, Barclay WS, Shelton H. The cellular localization of avian influenza virus PB1-F2 protein alters the magnitude of IFN2 promoter and NFκB-dependent promoter antagonism in chicken cells. J Gen Virol 2019;100:414-30. [PMID: 30672726 DOI: 10.1099/jgv.0.001220] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
374 Koutsakos M, Kedzierska K, Subbarao K. Immune Responses to Avian Influenza Viruses. J I 2019;202:382-91. [DOI: 10.4049/jimmunol.1801070] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
375 Zhang J, Su R, Jian X, An H, Jiang R, Mok CKP. The D253N Mutation in the Polymerase Basic 2 Gene in Avian Influenza (H9N2) Virus Contributes to the Pathogenesis of the Virus in Mammalian Hosts. Virol Sin 2018;33:531-7. [PMID: 30569291 DOI: 10.1007/s12250-018-0072-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
376 Kaur US, Shet A, Rajnala N, Gopalan BP, Moar P, D H, Singh BP, Chaturvedi R, Tandon R. High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy. Sci Rep 2018;8:17679. [PMID: 30518941 DOI: 10.1038/s41598-018-35877-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
377 Yeo SJ, Kang H, Dao TD, Cuc BT, Nguyen ATV, Tien TTT, Hang NLK, Phuong HVM, Thanh LT, Mai LQ, Rah Y, Yu K, Shin HJ, Chong CK, Choi HS, Park H. Development of a smartphone-based rapid dual fluorescent diagnostic system for the simultaneous detection of influenza A and H5 subtype in avian influenza A-infected patients. Theranostics 2018;8:6132-48. [PMID: 30613288 DOI: 10.7150/thno.28027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
378 van Wilgenburg B, Loh L, Chen Z, Pediongco TJ, Wang H, Shi M, Zhao Z, Koutsakos M, Nüssing S, Sant S, Wang Z, D'Souza C, Jia X, Almeida CF, Kostenko L, Eckle SBG, Meehan BS, Kallies A, Godfrey DI, Reading PC, Corbett AJ, McCluskey J, Klenerman P, Kedzierska K, Hinks TSC. MAIT cells contribute to protection against lethal influenza infection in vivo. Nat Commun 2018;9:4706. [PMID: 30413689 DOI: 10.1038/s41467-018-07207-9] [Cited by in Crossref: 105] [Cited by in F6Publishing: 114] [Article Influence: 21.0] [Reference Citation Analysis]
379 Huo C, Xiao K, Zhang S, Tang Y, Wang M, Qi P, Xiao J, Tian H, Hu Y. H5N1 Influenza a Virus Replicates Productively in Pancreatic Cells and Induces Apoptosis and Pro-Inflammatory Cytokine Response. Front Cell Infect Microbiol 2018;8:386. [PMID: 30460207 DOI: 10.3389/fcimb.2018.00386] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
380 Ye S, Cowled CJ, Yap CH, Stambas J. Deep sequencing of primary human lung epithelial cells challenged with H5N1 influenza virus reveals a proviral role for CEACAM1. Sci Rep 2018;8:15468. [PMID: 30341336 DOI: 10.1038/s41598-018-33605-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
381 Hancock AS, Stairiker CJ, Boesteanu AC, Monzón-Casanova E, Lukasiak S, Mueller YM, Stubbs AP, García-Sastre A, Turner M, Katsikis PD. Transcriptome Analysis of Infected and Bystander Type 2 Alveolar Epithelial Cells during Influenza A Virus Infection Reveals In Vivo Wnt Pathway Downregulation. J Virol 2018;92:e01325-18. [PMID: 30111569 DOI: 10.1128/JVI.01325-18] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
382 Wang L, Jiang H, Shen SM, Wen CX, Xing Z, Shi Y. Inhibition of autophagy and chemokine induction by sphingosine 1-phosphate receptor 1 through NF-κB signaling in human pulmonary endothelial cells infected with influenza A viruses. PLoS One 2018;13:e0205344. [PMID: 30304001 DOI: 10.1371/journal.pone.0205344] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
383 Short KR, Kedzierska K, van de Sandt CE. Back to the Future: Lessons Learned From the 1918 Influenza Pandemic. Front Cell Infect Microbiol 2018;8:343. [PMID: 30349811 DOI: 10.3389/fcimb.2018.00343] [Cited by in Crossref: 149] [Cited by in F6Publishing: 158] [Article Influence: 29.8] [Reference Citation Analysis]
384 Vasileva D, Badawi A. C-reactive protein as a biomarker of severe H1N1 influenza. Inflamm Res. 2019;68:39-46. [PMID: 30288556 DOI: 10.1007/s00011-018-1188-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 8.4] [Reference Citation Analysis]
385 Chase M, Cocchi MN, Liu X, Andersen LW, Holmberg MJ, Donnino MW. Coenzyme Q10 in acute influenza. Influenza Other Respir Viruses 2019;13:64-70. [PMID: 30156030 DOI: 10.1111/irv.12608] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
386 Krischuns T, Günl F, Henschel L, Binder M, Willemsen J, Schloer S, Rescher U, Gerlt V, Zimmer G, Nordhoff C, Ludwig S, Brunotte L. Phosphorylation of TRIM28 Enhances the Expression of IFN-β and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial Cells. Front Immunol 2018;9:2229. [PMID: 30323812 DOI: 10.3389/fimmu.2018.02229] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 9.4] [Reference Citation Analysis]
387 Te Velthuis AJW, Long JC, Bauer DLV, Fan RLY, Yen HL, Sharps J, Siegers JY, Killip MJ, French H, Oliva-Martín MJ, Randall RE, de Wit E, van Riel D, Poon LLM, Fodor E. Mini viral RNAs act as innate immune agonists during influenza virus infection. Nat Microbiol 2018;3:1234-42. [PMID: 30224800 DOI: 10.1038/s41564-018-0240-5] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 15.4] [Reference Citation Analysis]
388 Nogales A, Martinez-Sobrido L, Chiem K, Topham DJ, DeDiego ML. Functional Evolution of the 2009 Pandemic H1N1 Influenza Virus NS1 and PA in Humans. J Virol 2018;92:e01206-18. [PMID: 30021892 DOI: 10.1128/JVI.01206-18] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
389 McMichael AJ. Legacy of the influenza pandemic 1918: The host T cell response. Biomed J 2018;41:242-8. [PMID: 30348267 DOI: 10.1016/j.bj.2018.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
390 Davidson S. Treating Influenza Infection, From Now and Into the Future. Front Immunol 2018;9:1946. [PMID: 30250466 DOI: 10.3389/fimmu.2018.01946] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 9.8] [Reference Citation Analysis]
391 Huo C, Jin Y, Zou S, Qi P, Xiao J, Tian H, Wang M, Hu Y. Lethal influenza A virus preferentially activates TLR3 and triggers a severe inflammatory response. Virus Research 2018;257:102-12. [DOI: 10.1016/j.virusres.2018.09.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
392 Kronstad LM, Seiler C, Vergara R, Holmes SP, Blish CA. Differential Induction of IFN-α and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-γ Response to Influenza A Viruses. J Immunol 2018;201:2117-31. [PMID: 30143589 DOI: 10.4049/jimmunol.1800161] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
393 Rajput C, Han M, Bentley JK, Lei J, Ishikawa T, Wu Q, Hinde JL, Callear AP, Stillwell TL, Jackson WT, Martin ET, Hershenson MB. Enterovirus D68 infection induces IL-17-dependent neutrophilic airway inflammation and hyperresponsiveness. JCI Insight 2018;3:121882. [PMID: 30135310 DOI: 10.1172/jci.insight.121882] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
394 Mochan E, Ackerman E, Shoemaker J. A Systems and Treatment Perspective of Models of Influenza Virus-Induced Host Responses. Processes 2018;6:138. [DOI: 10.3390/pr6090138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
395 Sengupta S, Tang SY, Devine J, Nayak S, Zhang S, Valenzuela A, Lopez CB, Grant G, Fitzgerald GA. Circadian control of lung inflammation in influenza infection.. [DOI: 10.1101/396556] [Reference Citation Analysis]
396 Velthuis AJT, Long JC, Bauer DL, Fan RL, Yen H, Sharps J, Siegers JY, Killip MJ, French H, José Oliva-martín M, Randall RE, Wit ED, Riel DV, Poon LL, Fodor E. Mini viral RNAs act as innate immune agonists during influenza virus infection.. [DOI: 10.1101/385716] [Reference Citation Analysis]
397 Mason S, Devincenzo JP, Toovey S, Wu JZ, Whitley RJ. Comparison of antiviral resistance across acute and chronic viral infections. Antiviral Res 2018;158:103-12. [PMID: 30086337 DOI: 10.1016/j.antiviral.2018.07.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
398 Farooq SA, Weisenthal SJ, Trayhan M, White RJ, Bush K, Mariuz PR, Zand MS. Revealing HIV viral load patterns using unsupervised machine learning and cluster summarization. F1000Res 2018;7:1144. [DOI: 10.12688/f1000research.15591.1] [Reference Citation Analysis]
399 Westenius V, Mäkelä SM, Julkunen I, Österlund P. Highly Pathogenic H5N1 Influenza A Virus Spreads Efficiently in Human Primary Monocyte-Derived Macrophages and Dendritic Cells. Front Immunol 2018;9:1664. [PMID: 30065728 DOI: 10.3389/fimmu.2018.01664] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
400 Mochan E, Ackerman E, Shoemaker JE. A systems and treatment perspective of models of influenza virus-induced host responses.. [DOI: 10.1101/368241] [Reference Citation Analysis]
401 Schräder T, Dudek SE, Schreiber A, Ehrhardt C, Planz O, Ludwig S. The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression. Antiviral Res 2018;157:80-92. [PMID: 29990517 DOI: 10.1016/j.antiviral.2018.07.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
402 Xia C, Anderson P, Hahm B. Viral dedication to vigorous destruction of interferon receptors. Virology 2018;522:19-26. [PMID: 30014854 DOI: 10.1016/j.virol.2018.06.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
403 Li Z, Li L, Zhao S, Li J, Zhou H, Zhang Y, Yang Z, Yuan B. Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies. J Thorac Dis 2018;10:S2248-59. [PMID: 30116604 DOI: 10.21037/jtd.2018.03.169] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
404 Ueki H, Wang IH, Fukuyama S, Katsura H, da Silva Lopes TJ, Neumann G, Kawaoka Y. In vivo imaging of the pathophysiological changes and neutrophil dynamics in influenza virus-infected mouse lungs. Proc Natl Acad Sci U S A 2018;115:E6622-9. [PMID: 29941581 DOI: 10.1073/pnas.1806265115] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
405 Oxford JS, Gill D. Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itself. Lancet Infect Dis 2018;18:e348-54. [PMID: 29935779 DOI: 10.1016/S1473-3099(18)30359-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
406 Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, Schlößer HA, Schlaak M, Kochanek M, Böll B, von Bergwelt-Baildon MS. Cytokine release syndrome. J Immunother Cancer 2018;6:56. [PMID: 29907163 DOI: 10.1186/s40425-018-0343-9] [Cited by in Crossref: 727] [Cited by in F6Publishing: 763] [Article Influence: 145.4] [Reference Citation Analysis]
407 Pan W, Xie H, Li X, Guan W, Chen P, Zhang B, Zhang M, Dong J, Wang Q, Li Z, Li S, Yang Z, Li C, Zhong N, Huang J, Chen L. Patient-derived avian influenza A (H5N6) virus is highly pathogenic in mice but can be effectively treated by anti-influenza polyclonal antibodies. Emerg Microbes Infect 2018;7:107. [PMID: 29899428 DOI: 10.1038/s41426-018-0113-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
408 Song N, Li P, Jiang Y, Sun H, Cui J, Zhao G, Li D, Guo Y, Chen Y, Gao J, Sun S, Zhou Y. C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury. International Immunopharmacology 2018;59:12-20. [DOI: 10.1016/j.intimp.2018.03.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
409 Dunning J, Blankley S, Hoang LT, Cox M, Graham CM, James PL, Bloom CI, Chaussabel D, Banchereau J, Brett SJ, Moffatt MF, O'Garra A, Openshaw PJM; MOSAIC Investigators. Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza. Nat Immunol 2018;19:625-35. [PMID: 29777224 DOI: 10.1038/s41590-018-0111-5] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 19.0] [Reference Citation Analysis]
410 Ye S, Cowled C, Yap C, Stambas J. Deep sequencing of primary human lung epithelial cells challenged with H5N1 influenza virus reveals a proviral role for CEACAM1.. [DOI: 10.1101/324723] [Reference Citation Analysis]
411 Zhou P, Cao Z, Zeng W, Hao X, Zheng Q, Lin X, He Y, Zhang X, Zheng Y, Wang L, Zhang G, Li S. PB2 E627K or D701N substitution does not change the virulence of canine influenza virus H3N2 in mice and dogs. Vet Microbiol 2018;220:67-72. [PMID: 29885803 DOI: 10.1016/j.vetmic.2018.05.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
412 Sellers SA, Hagan RS, Hayden FG, Fischer WA 2nd. The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection. Influenza Other Respir Viruses 2017;11:372-93. [PMID: 28745014 DOI: 10.1111/irv.12470] [Cited by in Crossref: 190] [Cited by in F6Publishing: 214] [Article Influence: 38.0] [Reference Citation Analysis]
413 Li Z, Zhao J, Zhou H, Li L, Ding Y, Li J, Zhou B, Jiang H, Zhong N, Hu W, Yang Z. Cappariloside A shows antiviral and better anti-inflammatory effects against influenza virus via regulating host IFN signaling, in vitro and vivo. Life Sciences 2018;200:115-25. [DOI: 10.1016/j.lfs.2018.03.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
414 de Bree LCJ, Marijnissen RJ, Kel JM, Rosendahl Huber SK, Aaby P, Benn CS, Wijnands MVW, Diavatopoulos DA, van Crevel R, Joosten LAB, Netea MG, Dulos J. Bacillus Calmette-Guérin-Induced Trained Immunity Is Not Protective for Experimental Influenza A/Anhui/1/2013 (H7N9) Infection in Mice. Front Immunol 2018;9:869. [PMID: 29760700 DOI: 10.3389/fimmu.2018.00869] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
415 Hottz ED, Bozza FA, Bozza PT. Platelets in Immune Response to Virus and Immunopathology of Viral Infections. Front Med (Lausanne) 2018;5:121. [PMID: 29761104 DOI: 10.3389/fmed.2018.00121] [Cited by in Crossref: 103] [Cited by in F6Publishing: 110] [Article Influence: 20.6] [Reference Citation Analysis]
416 Gounder AP, Yokoyama CC, Jarjour NN, Bricker TL, Edelson BT, Boon ACM. Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer. PLoS Pathog 2018;14:e1007001. [PMID: 29698474 DOI: 10.1371/journal.ppat.1007001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
417 Jiao P, Song Y, Huang J, Xiang C, Cui J, Wu S, Qu N, Wang N, Ouyang G, Liao M. H7N9 Avian Influenza Virus Is Efficiently Transmissible and Induces an Antibody Response in Chickens. Front Immunol 2018;9:789. [PMID: 29706970 DOI: 10.3389/fimmu.2018.00789] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
418 Mehrbod P, Abdalla MA, Njoya EM, Ahmed AS, Fotouhi F, Farahmand B, Gado DA, Tabatabaian M, Fasanmi OG, Eloff JN, McGaw LJ, Fasina FO. South African medicinal plant extracts active against influenza A virus. BMC Complement Altern Med 2018;18:112. [PMID: 29587734 DOI: 10.1186/s12906-018-2184-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
419 van Wilgenburg B, Loh L, Chen Z, Pediongco TJ, Wang H, Shi M, Zhao Z, Koutsakos M, Nüssing S, Sant S, Wang Z, D’souza C, Almeida CF, Kostenko L, Eckle SB, Meehan BS, Godfrey DI, Reading PC, Corbett AJ, Mccluskey J, Klenerman P, Kedzierska K, Hinks TS. MAIT cells contribute to protection against lethal influenza infectionin vivo.. [DOI: 10.1101/247205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
420 Petersen H, Mostafa A, Tantawy MA, Iqbal AA, Hoffmann D, Tallam A, Selvakumar B, Pessler F, Beer M, Rautenschlein S, Pleschka S. NS Segment of a 1918 Influenza A Virus-Descendent Enhances Replication of H1N1pdm09 and Virus-Induced Cellular Immune Response in Mammalian and Avian Systems. Front Microbiol 2018;9:526. [PMID: 29623073 DOI: 10.3389/fmicb.2018.00526] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
421 Zhang K, Xu WW, Zhang Z, Liu J, Li J, Sun L, Sun W, Jiao P, Sang X, Ren Z, Yu Z, Li Y, Feng N, Wang T, Wang H, Yang S, Zhao Y, Zhang X, Wilker PR, Liu W, Liao M, Chen H, Gao Y, Xia X. The innate immunity of guinea pigs against highly pathogenic avian influenza virus infection. Oncotarget 2017;8:30422-37. [PMID: 28418930 DOI: 10.18632/oncotarget.16503] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
422 Baral P, Umans BD, Li L, Wallrapp A, Bist M, Kirschbaum T, Wei Y, Zhou Y, Kuchroo VK, Burkett PR, Yipp BG, Liberles SD, Chiu IM. Nociceptor sensory neurons suppress neutrophil and γδ T cell responses in bacterial lung infections and lethal pneumonia. Nat Med 2018;24:417-26. [PMID: 29505031 DOI: 10.1038/nm.4501] [Cited by in Crossref: 181] [Cited by in F6Publishing: 193] [Article Influence: 36.2] [Reference Citation Analysis]
423 Ou X, Mao S, Jiang Y, Zhang S, Ke C, Ma G, Cheng A, Wang M, Zhu D, Chen S, Jia R, Liu M, Sun K, Yang Q, Wu Y, Chen X. Viral-host interaction in kidney reveals strategies to escape host immunity and persistently shed virus to the urine. Oncotarget 2017;8:7336-49. [PMID: 28038465 DOI: 10.18632/oncotarget.14227] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
424 Khalili N, Karimi A, Moradi M, Shirzad H. In vitro immunomodulatory activity of celastrol against influenza A virus infection. Immunopharmacology and Immunotoxicology 2018;40:250-5. [DOI: 10.1080/08923973.2018.1440591] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
425 Dash SK, Kumar M, Kataria JM, Nagarajan S, Tosh C, Murugkar HV, Rajukumar K, Kalaiyarasu S, Senthil Kumar D, Kulkarni DD. Induction profiles of mRNA of toll like receptors and cytokines in chickens pre-exposed to low pathogenic avian influenza H9N2 virus followed by challenge with highly pathogenic avian influenza H5N1 virus. Microb Pathog 2018;117:200-5. [PMID: 29476788 DOI: 10.1016/j.micpath.2018.02.041] [Reference Citation Analysis]
426 Zhang N, Bao YJ, Tong AH, Zuyderduyn S, Bader GD, Malik Peiris JS, Lok S, Lee SM. Whole transcriptome analysis reveals differential gene expression profile reflecting macrophage polarization in response to influenza A H5N1 virus infection. BMC Med Genomics 2018;11:20. [PMID: 29475453 DOI: 10.1186/s12920-018-0335-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
427 Chen YJ, Wang SF, Weng IC, Hong MH, Lo TH, Jan JT, Hsu LC, Chen HY, Liu FT. Galectin-3 Enhances Avian H5N1 Influenza A Virus-Induced Pulmonary Inflammation by Promoting NLRP3 Inflammasome Activation. Am J Pathol 2018;188:1031-42. [PMID: 29366678 DOI: 10.1016/j.ajpath.2017.12.014] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 10.4] [Reference Citation Analysis]
428 Khatri M, Richardson LA, Meulia T. Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model. Stem Cell Res Ther. 2018;9:17. [PMID: 29378639 DOI: 10.1186/s13287-018-0774-8] [Cited by in Crossref: 187] [Cited by in F6Publishing: 196] [Article Influence: 37.4] [Reference Citation Analysis]
429 Hurt AC, Kelly H. Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza. Emerg Infect Dis 2016;22:949-55. [PMID: 27191818 DOI: 10.3201/eid2206.151037] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
430 Li X, Fu Z, Liang H, Wang Y, Qi X, Ding M, Sun X, Zhou Z, Huang Y, Gu H, Li L, Chen X, Li D, Zhao Q, Liu F, Wang H, Wang J, Zen K, Zhang CY. H5N1 influenza virus-specific miRNA-like small RNA increases cytokine production and mouse mortality via targeting poly(rC)-binding protein 2. Cell Res 2018;28:157-71. [PMID: 29327729 DOI: 10.1038/cr.2018.3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
431 Hui DS, Lee N, Chan PK, Beigel JH. The role of adjuvant immunomodulatory agents for treatment of severe influenza. Antiviral Res 2018;150:202-16. [PMID: 29325970 DOI: 10.1016/j.antiviral.2018.01.002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 11.8] [Reference Citation Analysis]
432 Freitas ARR, Donalisio MR. Excess of Mortality in Adults and Elderly and Circulation of Subtypes of Influenza Virus in Southern Brazil. Front Immunol 2017;8:1903. [PMID: 29375560 DOI: 10.3389/fimmu.2017.01903] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
433 Chen X, Wang R, Tang M, Cai S, Stanley HE, Braunstein LA. Suppressing epidemic spreading in multiplex networks with social-support. New J Phys 2018;20:013007. [DOI: 10.1088/1367-2630/aa9cda] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 14.4] [Reference Citation Analysis]
434 Talaat KR, Halsey NA, Cox AB, Coles CL, Durbin AP, Ramakrishnan A, Bream JH. Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination. Influenza Other Respir Viruses 2018;12:202-10. [PMID: 28991404 DOI: 10.1111/irv.12509] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
435 Li H, Bradley KC, Long JS, Frise R, Ashcroft JW, Hartgroves LC, Shelton H, Makris S, Johansson C, Cao B, Barclay WS. Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice. PLoS Pathog 2018;14:e1006821. [PMID: 29300777 DOI: 10.1371/journal.ppat.1006821] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
436 Sun H, Yao W, Wang K, Qian Y, Chen H, Jung Y. Inhibition of neddylation pathway represses influenza virus replication and pro-inflammatory responses. Virology 2018;514:230-9. [DOI: 10.1016/j.virol.2017.11.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
437 Mccullough AE, Leslie KO. Lung Infections. Practical Pulmonary Pathology: A Diagnostic Approach 2018. [DOI: 10.1016/b978-0-323-44284-8.00007-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
438 Wang LC, Yao HW, Chang CF, Wang SW, Wang SM, Chen SH. Suppression of interleukin-6 increases enterovirus A71 lethality in mice. J Biomed Sci 2017;24:94. [PMID: 29233145 DOI: 10.1186/s12929-017-0401-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
439 van de Sandt CE, Bárcena M, Koster AJ, Kasper J, Kirkpatrick CJ, Scott DP, de Vries RD, Herold S, Rimmelzwaan GF, Kuiken T, Short KR. Human CD8+ T Cells Damage Noninfected Epithelial Cells during Influenza Virus Infection In Vitro. Am J Respir Cell Mol Biol 2017;57:536-46. [PMID: 28613916 DOI: 10.1165/rcmb.2016-0377OC] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
440 Hartmann BM, Albrecht RA, Zaslavsky E, Nudelman G, Pincas H, Marjanovic N, Schotsaert M, Martínez-Romero C, Fenutria R, Ingram JP, Ramos I, Fernandez-Sesma A, Balachandran S, García-Sastre A, Sealfon SC. Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death. Nat Commun 2017;8:1931. [PMID: 29203926 DOI: 10.1038/s41467-017-02035-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
441 Kuriakose T, Kanneganti TD. ZBP1: Innate Sensor Regulating Cell Death and Inflammation. Trends Immunol 2018;39:123-34. [PMID: 29236673 DOI: 10.1016/j.it.2017.11.002] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 16.2] [Reference Citation Analysis]
442 Bloes DA, Haasbach E, Hartmayer C, Hertlein T, Klingel K, Kretschmer D, Planz O, Peschel A. Phenol-Soluble Modulin Peptides Contribute to Influenza A Virus-Associated Staphylococcus aureus Pneumonia. Infect Immun 2017;85:e00620-17. [PMID: 28893917 DOI: 10.1128/IAI.00620-17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
443 Short KR, Veeris R, Leijten LM, van den Brand JM, Jong VL, Stittelaar K, Osterhaus ADME, Andeweg A, van Riel D. Proinflammatory Cytokine Responses in Extra-Respiratory Tissues During Severe Influenza. J Infect Dis 2017;216:829-33. [PMID: 28973159 DOI: 10.1093/infdis/jix281] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
444 Jie C, Luo Z, Chen H, Wang M, Yan C, Mao ZF, Xiao GK, Kurihara H, Li YF, He RR. Indirubin, a bisindole alkaloid from Isatis indigotica, reduces H1N1 susceptibility in stressed mice by regulating MAVS signaling. Oncotarget 2017;8:105615-29. [PMID: 29285277 DOI: 10.18632/oncotarget.22350] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
445 Fiore-Gartland A, Panoskaltsis-Mortari A, Agan AA, Mistry AJ, Thomas PG, Matthay MA, Hertz T, Randolph AG; PALISI PICFlu Investigators. Cytokine Profiles of Severe Influenza Virus-Related Complications in Children. Front Immunol 2017;8:1423. [PMID: 29163498 DOI: 10.3389/fimmu.2017.01423] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
446 Wang X, Chen S, Wang D, Zha X, Zheng S, Qin T, Ma W, Peng D, Liu X. Synergistic effect of PB2 283M and 526R contributes to enhanced virulence of H5N8 influenza viruses in mice. Vet Res 2017;48:67. [PMID: 29070059 DOI: 10.1186/s13567-017-0471-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
447 Guan W, Li J, Chen Q, Jiang Z, Zhang R, Wang X, Yang Z, Pan X. Pterodontic Acid Isolated from Laggera pterodonta Inhibits Viral Replication and Inflammation Induced by Influenza A Virus. Molecules 2017;22:E1738. [PMID: 29035328 DOI: 10.3390/molecules22101738] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
448 Almansa R, Martínez-Orellana P, Rico L, Iglesias V, Ortega A, Vidaña B, Martínez J, Expósito A, Montoya M, Bermejo-Martin JF. Pulmonary transcriptomic responses indicate a dual role of inflammation in pneumonia development and viral clearance during 2009 pandemic influenza infection. PeerJ 2017;5:e3915. [PMID: 29038764 DOI: 10.7717/peerj.3915] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
449 Guillamet CV, Kollef MH. Corticosteroids for Influenza Pneumonia: Hold Off for Now! Crit Care Med 2016;44:1246-8. [PMID: 27182862 DOI: 10.1097/CCM.0000000000001692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
450 Cho J, Yi H, Jang EY, Lee MS, Lee JY, Kang C, Lee CH, Kim K. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection. Biochem Biophys Res Commun 2017;494:298-304. [PMID: 29017920 DOI: 10.1016/j.bbrc.2017.10.037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
451 Fu Y, Romay V, Liu Y, Ibarlucea B, Baraban L, Khavrus V, Oswald S, Bachmatiuk A, Ibrahim I, Rümmeli M, Gemming T, Bezugly V, Cuniberti G. Chemiresistive biosensors based on carbon nanotubes for label-free detection of DNA sequences derived from avian influenza virus H5N1. Sensors and Actuators B: Chemical 2017;249:691-9. [DOI: 10.1016/j.snb.2017.04.080] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
452 Havers FP, Campbell AP, Uyeki TM, Fry AM. Commentary: A Historical Review of Centers for Disease Control and Prevention Antiviral Treatment and Postexposure Chemoprophylaxis Guidance for Human Infections With Novel Influenza A Viruses Associated With Severe Human Disease. J Infect Dis 2017;216:S575-80. [PMID: 28934460 DOI: 10.1093/infdis/jix065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
453 Wei P, Zhang T, Dong H, Chen Q, Mu X, Hu G. Anti-inflammatory and antiviral activities of cynanversicoside A and cynanversicoside C isolated from Cynanchun paniculatum in influenza A virus-infected mice pulmonary microvascular endothelial cells. Phytomedicine 2017;36:18-25. [PMID: 29157813 DOI: 10.1016/j.phymed.2017.09.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
454 Metcalf CJE, Tate AT, Graham AL. Demographically framing trade-offs between sensitivity and specificity illuminates selection on immunity. Nat Ecol Evol 2017;1:1766-72. [PMID: 28963489 DOI: 10.1038/s41559-017-0315-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
455 Liu M, Chen F, Liu T, Chen F, Liu S, Yang J. The role of oxidative stress in influenza virus infection. Microbes Infect 2017;19:580-6. [PMID: 28918004 DOI: 10.1016/j.micinf.2017.08.008] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 11.8] [Reference Citation Analysis]
456 Huang DT, Lu CY, Chi YH, Li WL, Chang LY, Lai MJ, Chen JS, Hsu WM, Huang LM. Adaptation of influenza A (H7N9) virus in primary human airway epithelial cells. Sci Rep 2017;7:11300. [PMID: 28900138 DOI: 10.1038/s41598-017-10749-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
457 Cline TD, Beck D, Bianchini E. Influenza virus replication in macrophages: balancing protection and pathogenesis. J Gen Virol 2017;98:2401-12. [PMID: 28884667 DOI: 10.1099/jgv.0.000922] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
458 Nagaoka Y, Nosaka N, Yamada M, Yashiro M, Washio Y, Baba K, Morishima T, Tsukahara H. Local and Systemic Immune Responses to Influenza A Virus Infection in Pneumonia and Encephalitis Mouse Models. Dis Markers 2017;2017:2594231. [PMID: 28912622 DOI: 10.1155/2017/2594231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
459 Smelkinson MG, Guichard A, Teijaro JR, Malur M, Loureiro ME, Jain P, Ganesan S, Zúñiga EI, Krug RM, Oldstone MB, Bier E. Influenza NS1 directly modulates Hedgehog signaling during infection. PLoS Pathog 2017;13:e1006588. [PMID: 28837667 DOI: 10.1371/journal.ppat.1006588] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
460 Zhou J, Guo X, Fang D, Yu Y, Si L, Wang Y, Zeng G, Yan H, Wu J, Ke C, Jiang L. Avian Influenza A (H7N9) viruses isolated from patients with mild and fatal infection differ in pathogenicity and induction of cytokines. Microb Pathog 2017;111:402-9. [PMID: 28826765 DOI: 10.1016/j.micpath.2017.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
461 Clark AM, Nogales A, Martinez-Sobrido L, Topham DJ, DeDiego ML. Functional Evolution of Influenza Virus NS1 Protein in Currently Circulating Human 2009 Pandemic H1N1 Viruses. J Virol 2017;91:e00721-17. [PMID: 28637754 DOI: 10.1128/JVI.00721-17] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
462 Ren R, Wu S, Cai J, Yang Y, Ren X, Feng Y, Chen L, Qin B, Xu C, Yang H, Song Z, Tian D, Hu Y, Zhou X, Meng G. The H7N9 influenza A virus infection results in lethal inflammation in the mammalian host via the NLRP3-caspase-1 inflammasome. Sci Rep 2017;7:7625. [PMID: 28790324 DOI: 10.1038/s41598-017-07384-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
463 Yong-Feng Z, Fei-Fei D, Jia-Yu Y, Feng-Xia Z, Chang-Qing J, Jian-Li W, Shou-Yu G, Kai C, Chuan-Yi L, Xue-Hua W, Jiang SJ, Zhi-Jing X. Intraspecies and interspecies transmission of mink H9N2 influenza virus. Sci Rep 2017;7:7429. [PMID: 28785024 DOI: 10.1038/s41598-017-07879-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
464 Pascua PNQ, Mostafa HH, Marathe BM, Vogel P, Russell CJ, Webby RJ, Govorkova EA. Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection. Sci Rep 2017;7:7345. [PMID: 28779075 DOI: 10.1038/s41598-017-07433-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
465 Cao P, McCaw JM. The Mechanisms for Within-Host Influenza Virus Control Affect Model-Based Assessment and Prediction of Antiviral Treatment. Viruses 2017;9:E197. [PMID: 28933757 DOI: 10.3390/v9080197] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
466 Zhuang J, Zang N, Ye C, Xu F. Lethal avian influenza A (H5N1) virus induces ataxic breathing in mice with apoptosis of pre-Botzinger complex neurons expressing neurokinin-1 receptor. Am J Physiol Lung Cell Mol Physiol 2017;313:L772-80. [PMID: 28729347 DOI: 10.1152/ajplung.00145.2017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
467 Phung TTB, Suzuki T, Phan PH, Kawachi S, Furuya H, Do HT, Kageyama T, Ta TA, Dao NH, Nunoi H, Tran DM, Le HT, Nakajima N. Pathogen screening and prognostic factors in children with severe ARDS of pulmonary origin. Pediatr Pulmonol 2017;52:1469-77. [PMID: 28703486 DOI: 10.1002/ppul.23694] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
468 Gao R, Wang L, Bai T, Zhang Y, Bo H, Shu Y. C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases. EBioMedicine 2017;22:133-42. [PMID: 28734805 DOI: 10.1016/j.ebiom.2017.07.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
469 Na-Ek P, Thewsoongnoen J, Thanunchai M, Wiboon-Ut S, Sa-Ard-Iam N, Mahanonda R, Thitithanyanont A. The activation of B cells enhances DC-SIGN expression and promotes susceptibility of B cells to HPAI H5N1 infection. Biochem Biophys Res Commun 2017;490:1301-6. [PMID: 28688767 DOI: 10.1016/j.bbrc.2017.07.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
470 Teijaro JR. Cytokine storms in infectious diseases. Semin Immunopathol 2017;39:501-3. [PMID: 28674818 DOI: 10.1007/s00281-017-0640-2] [Cited by in Crossref: 86] [Cited by in F6Publishing: 67] [Article Influence: 14.3] [Reference Citation Analysis]
471 Cole SL, Ho LP. Contribution of innate immune cells to pathogenesis of severe influenza virus infection. Clin Sci (Lond) 2017;131:269-83. [PMID: 28108632 DOI: 10.1042/CS20160484] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
472 Huang CT, Hung CY, Chen TC, Lin CY, Lin YC, Chang CS, He YC, Huang YL, Dutta A. Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model. Sci Rep 2017;7:4136. [PMID: 28646236 DOI: 10.1038/s41598-017-04365-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
473 Morris DE, Cleary DW, Clarke SC. Secondary Bacterial Infections Associated with Influenza Pandemics. Front Microbiol 2017;8:1041. [PMID: 28690590 DOI: 10.3389/fmicb.2017.01041] [Cited by in Crossref: 249] [Cited by in F6Publishing: 263] [Article Influence: 41.5] [Reference Citation Analysis]
474 Wang C, Liu P, Luo J, Ding H, Gao Y, Sun L, Luo F, Liu X, He H. Geldanamycin Reduces Acute Respiratory Distress Syndrome and Promotes the Survival of Mice Infected with the Highly Virulent H5N1 Influenza Virus. Front Cell Infect Microbiol 2017;7:267. [PMID: 28664154 DOI: 10.3389/fcimb.2017.00267] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
475 Liu Q, Zhou S, Fan C, Huang W, Li Q, Liu S, Wu X, Li B, Wang Y. Biodistribution and residence time of adenovector serotype 5 in normal and immunodeficient mice and rats detected with bioluminescent imaging. Sci Rep 2017;7:3597. [PMID: 28620164 DOI: 10.1038/s41598-017-03852-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
476 Kronstad LM, Seiler C, Vergara R, Holmes SP, Blish CA. Strain-Specific Human Natural Killer Cell Recognition of Influenza A Virus.. [DOI: 10.1101/148528] [Reference Citation Analysis]
477 Ito T, Itakura J, Takahashi S, Sato M, Mino M, Fushimi S, Yamada M, Morishima T, Kunkel SL, Matsukawa A. Sprouty-Related Ena/Vasodilator-Stimulated Phosphoprotein Homology 1-Domain-Containing Protein-2 Critically Regulates Influenza A Virus-Induced Pneumonia. Crit Care Med 2016;44:e530-43. [PMID: 26757161 DOI: 10.1097/CCM.0000000000001562] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
478 Guo XJ, Thomas PG. New fronts emerge in the influenza cytokine storm. Semin Immunopathol 2017;39:541-50. [PMID: 28555383 DOI: 10.1007/s00281-017-0636-y] [Cited by in Crossref: 167] [Cited by in F6Publishing: 151] [Article Influence: 27.8] [Reference Citation Analysis]
479 Rondina MT, Tatsumi K, Bastarache JA, Mackman N. Microvesicle Tissue Factor Activity and Interleukin-8 Levels are Associated with Mortality in Patients with Influenza A/H1N1 Infection. Crit Care Med 2016;44:e574-8. [PMID: 26751613 DOI: 10.1097/CCM.0000000000001584] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
480 Bobone S, Hilsch M, Storm J, Dunsing V, Herrmann A, Chiantia S. Phosphatidylserine Lateral Organization Influences the Interaction of Influenza Virus Matrix Protein 1 with Lipid Membranes. J Virol 2017;91:e00267-17. [PMID: 28356535 DOI: 10.1128/JVI.00267-17] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
481 Li W, Lee HHY, Li RF, Zhu HM, Yi G, Peiris JSM, Yang ZF, Mok CKP. The PB2 mutation with lysine at 627 enhances the pathogenicity of avian influenza (H7N9) virus which belongs to a non-zoonotic lineage. Sci Rep 2017;7:2352. [PMID: 28539661 DOI: 10.1038/s41598-017-02598-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
482 Dahal U, Sharma D, Dahal K. An Unsettled Debate About the Potential Role of Infection in Pathogenesis of Atherosclerosis. J Clin Med Res 2017;9:547-54. [PMID: 28611853 DOI: 10.14740/jocmr3032w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
483 Wang BX, Fish EN. Interactions Between NS1 of Influenza A Viruses and Interferon-α/β: Determinants for Vaccine Development. J Interferon Cytokine Res 2017;37:331-41. [PMID: 28514196 DOI: 10.1089/jir.2017.0032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
484 Camp JV, Jonsson CB. A Role for Neutrophils in Viral Respiratory Disease. Front Immunol 2017;8:550. [PMID: 28553293 DOI: 10.3389/fimmu.2017.00550] [Cited by in Crossref: 142] [Cited by in F6Publishing: 151] [Article Influence: 23.7] [Reference Citation Analysis]
485 Huipao N, Borwornpinyo S, Wiboon-Ut S, Campbell CR, Lee IH, Hiranyachattada S, Sukasem C, Thitithanyanont A, Pholpramool C, Cook DI, Dinudom A. P2Y6 receptors are involved in mediating the effect of inactivated avian influenza virus H5N1 on IL-6 & CXCL8 mRNA expression in respiratory epithelium. PLoS One 2017;12:e0176974. [PMID: 28494003 DOI: 10.1371/journal.pone.0176974] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
486 Baharom F, Rankin G, Blomberg A, Smed-Sörensen A. Human Lung Mononuclear Phagocytes in Health and Disease. Front Immunol 2017;8:499. [PMID: 28507549 DOI: 10.3389/fimmu.2017.00499] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
487 Van Braeckel-Budimir N, Harty JT. Influenza-induced lung Trm: not all memories last forever. Immunol Cell Biol 2017;95:651-5. [PMID: 28405016 DOI: 10.1038/icb.2017.32] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
488 Cole SL, Dunning J, Kok WL, Benam KH, Benlahrech A, Repapi E, Martinez FO, Drumright L, Powell TJ, Bennett M, Elderfield R, Thomas C, Dong T, McCauley J, Liew FY, Taylor S, Zambon M, Barclay W, Cerundolo V, Openshaw PJ, McMichael AJ, Ho LP; MOSAIC investigators. M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza. JCI Insight 2017;2:e91868. [PMID: 28405622 DOI: 10.1172/jci.insight.91868] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
489 Kim ES, Choe PG, Park WB, Oh HS, Kim EJ, Nam EY, Na SH, Kim M, Song KH, Bang JH, Park SW, Kim HB, Kim NJ, Oh MD. Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection. J Korean Med Sci 2016;31:1717-25. [PMID: 27709848 DOI: 10.3346/jkms.2016.31.11.1717] [Cited by in Crossref: 133] [Cited by in F6Publishing: 190] [Article Influence: 22.2] [Reference Citation Analysis]
490 Li K, Wohlford-Lenane CL, Channappanavar R, Park JE, Earnest JT, Bair TB, Bates AM, Brogden KA, Flaherty HA, Gallagher T, Meyerholz DK, Perlman S, McCray PB Jr. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proc Natl Acad Sci U S A 2017;114:E3119-28. [PMID: 28348219 DOI: 10.1073/pnas.1619109114] [Cited by in Crossref: 107] [Cited by in F6Publishing: 120] [Article Influence: 17.8] [Reference Citation Analysis]
491 Peteranderl C, Herold S. The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond. Front Immunol 2017;8:313. [PMID: 28382038 DOI: 10.3389/fimmu.2017.00313] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
492 Zhao D, Liang L, Wang S, Nakao T, Li Y, Liu L, Guan Y, Fukuyama S, Bu Z, Kawaoka Y, Chen H. Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response. J Virol 2017;91:e02215-16. [PMID: 28100622 DOI: 10.1128/JVI.02215-16] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
493 Tundup S, Kandasamy M, Perez JT, Mena N, Steel J, Nagy T, Albrecht RA, Manicassamy B. Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species. PLoS Pathog 2017;13:e1006270. [PMID: 28282445 DOI: 10.1371/journal.ppat.1006270] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
494 Mishra A, Vijayakumar P, Raut AA. Emerging avian influenza infections: Current understanding of innate immune response and molecular pathogenesis. Int Rev Immunol 2017;36:89-107. [PMID: 28272907 DOI: 10.1080/08830185.2017.1291640] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
495 Boyapelly K, Bonin M, Traboulsi H, Cloutier A, Phaneuf SC, Fortin D, Cantin AM, Richter MV, Marsault E. Synthesis and Characterization of a Phosphate Prodrug of Isoliquiritigenin. J Nat Prod 2017;80:879-86. [DOI: 10.1021/acs.jnatprod.6b00600] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
496 Zhou B, Yang Z, Feng Q, Liang X, Li J, Zanin M, Jiang Z, Zhong N. Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza A virus-infected cells. Journal of Ethnopharmacology 2017;199:60-7. [DOI: 10.1016/j.jep.2017.01.038] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
497 Kobzik L. Searching for a Lifeline: Transcriptome Profiling Studies of Influenza Susceptibility and Resistance. J Innate Immun 2017;9:232-42. [PMID: 28249256 DOI: 10.1159/000457902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
498 Li H, Cao B. Pandemic and Avian Influenza A Viruses in Humans. Clinics in Chest Medicine 2017;38:59-70. [DOI: 10.1016/j.ccm.2016.11.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
499 Krementsov DN, Case LK, Dienz O, Raza A, Fang Q, Ather JL, Poynter ME, Boyson JE, Bunn JY, Teuscher C. Genetic variation in chromosome Y regulates susceptibility to influenza A virus infection. Proc Natl Acad Sci U S A 2017;114:3491-6. [PMID: 28242695 DOI: 10.1073/pnas.1620889114] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
500 Ding Y, Zeng L, Li R, Chen Q, Zhou B, Chen Q, Cheng PL, Yutao W, Zheng J, Yang Z, Zhang F. The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function. BMC Complement Altern Med 2017;17:130. [PMID: 28235408 DOI: 10.1186/s12906-017-1585-7] [Cited by in Crossref: 133] [Cited by in F6Publishing: 143] [Article Influence: 22.2] [Reference Citation Analysis]
501 Mao H, Liu Y, Sia SF, Peiris JSM, Lau YL, Tu W. Avian influenza virus directly infects human natural killer cells and inhibits cell activity. Virol Sin 2017;32:122-9. [PMID: 28255852 DOI: 10.1007/s12250-016-3918-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
502 Leber A, Bassaganya-Riera J, Tubau-Juni N, Zoccoli-Rodriguez V, Lu P, Godfrey V, Kale S, Hontecillas R. Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection. Front Immunol 2017;8:178. [PMID: 28270815 DOI: 10.3389/fimmu.2017.00178] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
503 Kedzierski L, Tate MD, Hsu AC, Kolesnik TB, Linossi EM, Dagley L, Dong Z, Freeman S, Infusini G, Starkey MR, Bird NL, Chatfield SM, Babon JJ, Huntington N, Belz G, Webb A, Wark PA, Nicola NA, Xu J, Kedzierska K, Hansbro PM, Nicholson SE. Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling. Elife 2017;6:e20444. [PMID: 28195529 DOI: 10.7554/eLife.20444] [Cited by in Crossref: 47] [Cited by in F6Publishing: 54] [Article Influence: 7.8] [Reference Citation Analysis]
504 Bertram S, Thiele S, Dreier C, Resa-Infante P, Preuß A, van Riel D, Mok CKP, Schwalm F, Peiris JSM, Klenk HD, Gabriel G. H7N9 Influenza A Virus Exhibits Importin-α7-Mediated Replication in the Mammalian Respiratory Tract. Am J Pathol 2017;187:831-40. [PMID: 28189564 DOI: 10.1016/j.ajpath.2016.12.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
505 Meunier I, Kaufmann E, Downey J, Divangahi M. Unravelling the networks dictating host resistance versus tolerance during pulmonary infections. Cell Tissue Res 2017;367:525-36. [PMID: 28168323 DOI: 10.1007/s00441-017-2572-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
506 Fowler III AA, Kim C, Lepler L, Malhotra R, Debesa O, Natarajan R, Fisher BJ, Syed A, DeWilde C, Priday A, Kasirajan V. Intravenous vitamin C as adjunctive therapy for enterovirus/rhinovirus induced acute respiratory distress syndrome. World J Crit Care Med 2017; 6(1): 85-90 [PMID: 28224112 DOI: 10.5492/wjccm.v6.i1.85] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 63] [Article Influence: 10.0] [Reference Citation Analysis]
507 Wong JP, Viswanathan S, Wang M, Sun LQ, Clark GC, D'Elia RV. Current and future developments in the treatment of virus-induced hypercytokinemia. Future Med Chem 2017;9:169-78. [PMID: 28128003 DOI: 10.4155/fmc-2016-0181] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 7.2] [Reference Citation Analysis]
508 Zanin M, Koçer ZA, Poulson RL, Gabbard JD, Howerth EW, Jones CA, Friedman K, Seiler J, Danner A, Kercher L, McBride R, Paulson JC, Wentworth DE, Krauss S, Tompkins SM, Stallknecht DE, Webster RG. Potential for Low-Pathogenic Avian H7 Influenza A Viruses To Replicate and Cause Disease in a Mammalian Model. J Virol 2017;91:e01934-16. [PMID: 27852855 DOI: 10.1128/JVI.01934-16] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
509 Li Z, Li L, Zhou H, Zeng L, Chen T, Chen Q, Zhou B, Wang Y, Chen Q, Hu P, Yang Z. Radix isatidis Polysaccharides Inhibit Influenza a Virus and Influenza A Virus-Induced Inflammation via Suppression of Host TLR3 Signaling In Vitro. Molecules 2017;22:E116. [PMID: 28085062 DOI: 10.3390/molecules22010116] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]
510 Wonderlich ER, Swan ZD, Bissel SJ, Hartman AL, Carney JP, O'Malley KJ, Obadan AO, Santos J, Walker R, Sturgeon TJ, Frye LJ Jr, Maiello P, Scanga CA, Bowling JD, Bouwer AL, Duangkhae PA, Wiley CA, Flynn JL, Wang J, Cole KS, Perez DR, Reed DS, Barratt-Boyes SM. Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques. J Immunol 2017;198:1616-26. [PMID: 28062701 DOI: 10.4049/jimmunol.1601770] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
511 Lianou A, Panagou EZ, Nychas GE. Meat Safety—I Foodborne Pathogens and Other Biological Issues. Lawrie´s Meat Science 2017. [DOI: 10.1016/b978-0-08-100694-8.00017-0] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
512 Scagnolari C, Turriziani O, Monteleone K, Pierangeli A, Antonelli G. Consolidation of molecular testing in clinical virology. Expert Rev Anti Infect Ther 2017;15:387-400. [PMID: 28002969 DOI: 10.1080/14787210.2017.1271711] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
513 Kobayashi M, Kodama M, Noshi T, Yoshida R, Kanazu T, Nomura N, Soda K, Isoda N, Okamatsu M, Sakoda Y, Yamano Y, Sato A, Kida H. Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation. Antiviral Res 2017;139:41-8. [PMID: 28012921 DOI: 10.1016/j.antiviral.2016.12.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
514 Hu Y, Xu P, Luo J, He H, Du W. Absolute Quantification of H5-Subtype Avian Influenza Viruses Using Droplet Digital Loop-Mediated Isothermal Amplification. Anal Chem 2017;89:745-50. [PMID: 28105842 DOI: 10.1021/acs.analchem.6b03328] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 8.9] [Reference Citation Analysis]
515 Teng O, Chen ST, Hsu TL, Sia SF, Cole S, Valkenburg SA, Hsu TY, Zheng JT, Tu W, Bruzzone R, Peiris JSM, Hsieh SL, Yen HL. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo. J Virol 2017;91:e01813-16. [PMID: 27795434 DOI: 10.1128/JVI.01813-16] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
516 Zhu P, Liang L, Shao X, Luo W, Jiang S, Zhao Q, Sun N, Zhao Y, Li J, Wang J, Zhou Y, Zhang J, Wang G, Jiang L, Chen H, Li C. Host Cellular Protein TRAPPC6AΔ Interacts with Influenza A Virus M2 Protein and Regulates Viral Propagation by Modulating M2 Trafficking. J Virol 2017;91:e01757-16. [PMID: 27795429 DOI: 10.1128/JVI.01757-16] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
517 Aoyagi T, Newstead MW, Zeng X, Kunkel SL, Kaku M, Standiford TJ. IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia. Mucosal Immunol 2017;10:1043-55. [PMID: 27966554 DOI: 10.1038/mi.2016.107] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
518 Yasui F, Itoh Y, Ikejiri A, Kitabatake M, Sakaguchi N, Munekata K, Shichinohe S, Hayashi Y, Ishigaki H, Nakayama M, Sakoda Y, Kida H, Ogasawara K, Kohara M. Sensitization with vaccinia virus encoding H5N1 hemagglutinin restores immune potential against H5N1 influenza virus. Sci Rep 2016;6:37915. [PMID: 27892498 DOI: 10.1038/srep37915] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
519 Lipsitch M, Barclay W, Raman R, Russell CJ, Belser JA, Cobey S, Kasson PM, Lloyd-Smith JO, Maurer-Stroh S, Riley S, Beauchemin CA, Bedford T, Friedrich TC, Handel A, Herfst S, Murcia PR, Roche B, Wilke CO, Russell CA. Viral factors in influenza pandemic risk assessment. Elife 2016;5:e18491. [PMID: 27834632 DOI: 10.7554/eLife.18491] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 10.0] [Reference Citation Analysis]
520 Liu Q, Liu Y, Yang J, Huang X, Han K, Zhao D, Bi K, Li Y. Two Genetically Similar H9N2 Influenza A Viruses Show Different Pathogenicity in Mice. Front Microbiol 2016;7:1737. [PMID: 27867373 DOI: 10.3389/fmicb.2016.01737] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
521 Vervelde L, Kapczynski DR. The innate and adaptive immune response to avian influenza virus. Animal Influenza 2016. [DOI: 10.1002/9781118924341.ch6] [Reference Citation Analysis]
522 Cox NJ, Trock SC, Uyeki TM. Public health implications of animal influenza viruses. Animal Influenza 2016. [DOI: 10.1002/9781118924341.ch5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
523 Tisoncik-Go J, Gasper DJ, Kyle JE, Eisfeld AJ, Selinger C, Hatta M, Morrison J, Korth MJ, Zink EM, Kim YM, Schepmoes AA, Nicora CD, Purvine SO, Weitz KK, Peng X, Green RR, Tilton SC, Webb-Robertson BJ, Waters KM, Metz TO, Smith RD, Kawaoka Y, Suresh M, Josset L, Katze MG. Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism. Cell Host Microbe 2016;19:254-66. [PMID: 26867183 DOI: 10.1016/j.chom.2016.01.002] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 7.7] [Reference Citation Analysis]
524 Yang P, Lou X, Zheng Y, Shi W, Li Y, Dong Y, Han Y, Pang X, Liu S, Wang Q. Cytokines and chemokines in mild/asymptomatic cases infected with avian influenza A (H7N9) virus. Journal of Medical Microbiology 2016;65:1232-5. [DOI: 10.1099/jmm.0.000333] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
525 Duan M, Hibbs ML, Chen W. The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesis. Immunol Cell Biol 2017;95:225-35. [DOI: 10.1038/icb.2016.97] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
526 Tavares LP, Teixeira MM, Garcia CC. The inflammatory response triggered by Influenza virus: a two edged sword. Inflamm Res 2017;66:283-302. [PMID: 27744631 DOI: 10.1007/s00011-016-0996-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 10.4] [Reference Citation Analysis]
527 Chen J, Duan M, Zhao Y, Ling F, Xiao K, Li Q, Li B, Lu C, Qi W, Zeng Z, Liao M, Liu Y, Chen W. Saikosaponin A inhibits influenza A virus replication and lung immunopathology. Oncotarget 2015;6:42541-56. [PMID: 26637810 DOI: 10.18632/oncotarget.6448] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
528 Wang J, Cao Z, Guo X, Zhang Y, Wang D, Xu S, Yin Y. Cytokine expression in three chicken host systems infected with H9N2 influenza viruses with different pathogenicities. Avian Pathol 2016;45:630-9. [PMID: 27215697 DOI: 10.1080/03079457.2016.1193665] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
529 Wang C, Lee HH, Yang ZF, Mok CK, Zhang Z. PB2-Q591K Mutation Determines the Pathogenicity of Avian H9N2 Influenza Viruses for Mammalian Species. PLoS One 2016;11:e0162163. [PMID: 27684944 DOI: 10.1371/journal.pone.0162163] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
530 Le Gars M, Kay AW, Bayless NL, Aziz N, Dekker CL, Swan GE, Davis MM, Blish CA. Increased Proinflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy. J Infect Dis 2016;214:1666-71. [PMID: 27655870 DOI: 10.1093/infdis/jiw448] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
531 Pascolutti M, von Itzstein M. DESIGN AND SYNTHESIS OF CARBOHYDRATES AND CARBOHYDRATE MIMETICS AS ANTI-INFLUENZA AGENTS. Glycochemical Synthesis 2016. [DOI: 10.1002/9781119006435.ch17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
532 Butler J, Stewart CR, Layton DS, Phommachanh P, Harper J, Payne J, Evans RM, Valdeter S, Walker S, Harvey G, Shan S, Bruce MP, Rootes CL, Gough TJ, Rohringer A, Peck GR, Fardy SJ, Karpala AJ, Johnson D, Wang J, Douangngeun B, Morrissy C, Wong FY, Bean AG, Bingham J, Williams DT. Novel Reassortant H5N6 Influenza A Virus from the Lao People's Democratic Republic Is Highly Pathogenic in Chickens. PLoS One 2016;11:e0162375. [PMID: 27631618 DOI: 10.1371/journal.pone.0162375] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
533 Hall OJ, Limjunyawong N, Vermillion MS, Robinson DP, Wohlgemuth N, Pekosz A, Mitzner W, Klein SL. Progesterone-Based Therapy Protects Against Influenza by Promoting Lung Repair and Recovery in Females. PLoS Pathog 2016;12:e1005840. [PMID: 27631986 DOI: 10.1371/journal.ppat.1005840] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 10.7] [Reference Citation Analysis]
534 Clark TW, Ewings S, Medina MJ, Batham S, Curran MD, Parmar S, Nicholson KG. Viral load is strongly associated with length of stay in adults hospitalised with viral acute respiratory illness. J Infect 2016;73:598-606. [PMID: 27615557 DOI: 10.1016/j.jinf.2016.09.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
535 Sarawar S, Hatta Y, Watanabe S, Dias P, Neumann G, Kawaoka Y, Bilsel P. M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice. Vaccine 2016;34:5090-8. [PMID: 27595896 DOI: 10.1016/j.vaccine.2016.08.061] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
536 Davidson S, McCabe TM, Crotta S, Gad HH, Hessel EM, Beinke S, Hartmann R, Wack A. IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment. EMBO Mol Med 2016;8:1099-112. [PMID: 27520969 DOI: 10.15252/emmm.201606413] [Cited by in Crossref: 153] [Cited by in F6Publishing: 160] [Article Influence: 21.9] [Reference Citation Analysis]
537 Cai W, Chen S, Li Y, Zhang A, Zhou H, Chen H, Jin M. 14-Deoxy-11,12-didehydroandrographolide attenuates excessive inflammatory responses and protects mice lethally challenged with highly pathogenic A(H5N1) influenza viruses. Antiviral Research 2016;133:95-105. [DOI: 10.1016/j.antiviral.2016.07.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
538 Chiu C. Seasonal influenza vaccines and hurdles to mutual protection. Clin Microbiol Infect 2016;22 Suppl 5:S113-9. [PMID: 27568914 DOI: 10.1016/j.cmi.2016.03.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
539 Kuriakose T, Man SM, Malireddi RK, Karki R, Kesavardhana S, Place DE, Neale G, Vogel P, Kanneganti TD. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol 2016;1:aag2045. [PMID: 27917412 DOI: 10.1126/sciimmunol.aag2045] [Cited by in Crossref: 304] [Cited by in F6Publishing: 311] [Article Influence: 43.4] [Reference Citation Analysis]
540 Kim SM, Kim YI, Pascua PN, Choi YK. Avian Influenza A Viruses: Evolution and Zoonotic Infection. Semin Respir Crit Care Med 2016;37:501-11. [PMID: 27486732 DOI: 10.1055/s-0036-1584953] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
541 Hagan M, Ranadheera C, Audet J, Morin J, Leung A, Kobasa D. Post-exposure treatment with whole inactivated H5N1 avian influenza virus protects against lethal homologous virus infection in mice. Sci Rep 2016;6:29433. [PMID: 27405487 DOI: 10.1038/srep29433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
542 van Riel D, Mittrücker HW, Engels G, Klingel K, Markert UR, Gabriel G. Influenza pathogenicity during pregnancy in women and animal models. Semin Immunopathol 2016;38:719-26. [PMID: 27387428 DOI: 10.1007/s00281-016-0580-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
543 Li J, Chen C, Wong G, Dong W, Zheng W, Li Y, Sun L, Zhang L, Gao GF, Bi Y, Liu W. Cyclophilin A protects mice against infection by influenza A virus. Sci Rep 2016;6:28978. [PMID: 27354005 DOI: 10.1038/srep28978] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
544 Li Y, Lai Y, Wang Y, Liu N, Zhang F, Xu P. 1, 8-Cineol Protect Against Influenza-Virus-Induced Pneumonia in Mice. Inflammation 2016;39:1582-93. [DOI: 10.1007/s10753-016-0394-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 7.3] [Reference Citation Analysis]
545 Hagenaars TJ, Fischer EA, Jansen CA, Rebel JM, Spekreijse D, Vervelde L, Backer JA, de Jong MC, Koets AP. Modelling the Innate Immune Response against Avian Influenza Virus in Chicken. PLoS One 2016;11:e0157816. [PMID: 27328069 DOI: 10.1371/journal.pone.0157816] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
546 Music N, Reber AJ, Kim JH, York IA. Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus. PLoS One 2016;11:e0157903. [PMID: 27315117 DOI: 10.1371/journal.pone.0157903] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
547 Xue J, Fan X, Yu J, Zhang S, Xiao J, Hu Y, Wang M. Short-Term Heat Shock Affects Host-Virus Interaction in Mice Infected with Highly Pathogenic Avian Influenza Virus H5N1. Front Microbiol 2016;7:924. [PMID: 27379054 DOI: 10.3389/fmicb.2016.00924] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
548 Qin Z, Yang Y, Wang H, Luo J, Huang X, You J, Wang B, Li M. Role of Autophagy and Apoptosis in the Postinfluenza Bacterial Pneumonia. Biomed Res Int 2016;2016:3801026. [PMID: 27376082 DOI: 10.1155/2016/3801026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
549 Li H, Cao B. Avian influenza: H7N9, H5N1 and other novel strains. SARS, MERS and other Viral Lung Infections. [DOI: 10.1183/2312508x.10010215] [Reference Citation Analysis]
550 Bi Y, Liu J, Xiong H, Zhang Y, Liu D, Liu Y, Gao GF, Wang B. A new reassortment of influenza A (H7N9) virus causing human infection in Beijing, 2014. Sci Rep 2016;6:26624. [PMID: 27230107 DOI: 10.1038/srep26624] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
551 Marathe BM, Wong SS, Vogel P, Garcia-Alcalde F, Webster RG, Webby RJ, Najera I, Govorkova EA. Combinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in Mice. Sci Rep 2016;6:26742. [PMID: 27221530 DOI: 10.1038/srep26742] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
552 Liu S, Sha J, Yu Z, Hu Y, Chan TC, Wang X, Pan H, Cheng W, Mao S, Zhang RJ, Chen E. Avian influenza virus in pregnancy. Rev Med Virol 2016;26:268-84. [PMID: 27187752 DOI: 10.1002/rmv.1884] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
553 Basile K, Dwyer DE, Kok J. Fat and flu: fact or fiction? Future Virology 2016;11:357-67. [DOI: 10.2217/fvl-2016-0014] [Reference Citation Analysis]
554 Santos PC, Teixeira MM, Souza DG. Opportunities for the development of novel therapies based on host-microbial interactions. Pharmacol Res 2016;112:68-83. [PMID: 27107789 DOI: 10.1016/j.phrs.2016.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
555 Hussein ITM, Ma EJ, Hill NJ, Meixell BW, Lindberg M, Albrecht RA, Bahl J, Runstadler JA. A point mutation in the polymerase protein PB2 allows a reassortant H9N2 influenza isolate of wild-bird origin to replicate in human cells. Infect Genet Evol 2016;41:279-88. [PMID: 27101787 DOI: 10.1016/j.meegid.2016.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
556 Ranaware PB, Mishra A, Vijayakumar P, Gandhale PN, Kumar H, Kulkarni DD, Raut AA. Genome Wide Host Gene Expression Analysis in Chicken Lungs Infected with Avian Influenza Viruses. PLoS One 2016;11:e0153671. [PMID: 27071061 DOI: 10.1371/journal.pone.0153671] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 7.4] [Reference Citation Analysis]
557 Tcherniuk S, Cenac N, Comte M, Frouard J, Errazuriz-Cerda E, Galabov A, Morange PE, Vergnolle N, Si-Tahar M, Alessi MC, Riteau B. Formyl Peptide Receptor 2 Plays a Deleterious Role During Influenza A Virus Infections. J Infect Dis 2016;214:237-47. [PMID: 27034344 DOI: 10.1093/infdis/jiw127] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
558 To KK, Lau CC, Woo PC, Lau SK, Chan JF, Chan KH, Zhang AJ, Chen H, Yuen KY. Human H7N9 virus induces a more pronounced pro-inflammatory cytokine but an attenuated interferon response in human bronchial epithelial cells when compared with an epidemiologically-linked chicken H7N9 virus. Virol J 2016;13:42. [PMID: 26975414 DOI: 10.1186/s12985-016-0498-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
559 González Álvarez DA, López Cortés LF, Cordero E. Impact of HIV on the severity of influenza. Expert Rev Respir Med 2016;10:463-72. [PMID: 26918376 DOI: 10.1586/17476348.2016.1157474] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
560 Peng M, Dai W, Liu S, Yu L, Wu Y, Liu R, Chen X, Lai X, Li X, Zhao Z, Li G. Bioactive glycosides from the roots of Ilex asprella. Pharmaceutical Biology 2016;54:2127-34. [DOI: 10.3109/13880209.2016.1146779] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
561 Chockalingam AK, Hamed S, Goodwin DG, Rosenzweig BA, Pang E, Boyne MT 2nd, Patel V. The Effect of Oseltamivir on the Disease Progression of Lethal Influenza A Virus Infection: Plasma Cytokine and miRNA Responses in a Mouse Model. Dis Markers 2016;2016:9296457. [PMID: 27110056 DOI: 10.1155/2016/9296457] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
562 Hayden FG, Palese P. Influenza Virus. Clinical Virology 2016. [DOI: 10.1128/9781555819439.ch43] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
563 Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev. 2016;3:CD010406. [PMID: 26950335 DOI: 10.1002/14651858.cd010406.pub2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 72] [Article Influence: 5.3] [Reference Citation Analysis]
564 Reyes-Silveyra J, Mikler AR. Modeling immune response and its effect on infectious disease outbreak dynamics. Theor Biol Med Model 2016;13:10. [PMID: 26944943 DOI: 10.1186/s12976-016-0033-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
565 Wang Z, Loh L, Kedzierski L, Kedzierska K. Avian Influenza Viruses, Inflammation, and CD8(+) T Cell Immunity. Front Immunol 2016;7:60. [PMID: 26973644 DOI: 10.3389/fimmu.2016.00060] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
566 Levin D, Forrest S, Banerjee S, Clay C, Cannon J, Moses M, Koster F. A spatial model of the efficiency of T cell search in the influenza-infected lung. J Theor Biol 2016;398:52-63. [PMID: 26920246 DOI: 10.1016/j.jtbi.2016.02.022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
567 Virlogeux V, Yang J, Fang VJ, Feng L, Tsang TK, Jiang H, Wu P, Zheng J, Lau EH, Qin Y, Peng Z, Peiris JS, Yu H, Cowling BJ. Association between the Severity of Influenza A(H7N9) Virus Infections and Length of the Incubation Period. PLoS One 2016;11:e0148506. [PMID: 26885816 DOI: 10.1371/journal.pone.0148506] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
568 Itoh Y. Translational research on influenza virus infection using a nonhuman primate model. Pathol Int 2016;66:132-41. [PMID: 26811109 DOI: 10.1111/pin.12385] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
569 Liu Q, Ma J, Wang XF, Xiao F, Li LJ, Zhang JE, Lin YZ, Du C, He XJ, Wang X, Zhou JH. Infection with equine infectious anemia virus vaccine strain EIAVDLV121 causes no visible histopathological lesions in target organs in association with restricted viral replication and unique cytokine response. Vet Immunol Immunopathol 2016;170:30-40. [PMID: 26832985 DOI: 10.1016/j.vetimm.2016.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
570 Wu W, Shi D, Fang D, Guo F, Guo J, Huang F, Chen Y, Lv L, Li L. A new perspective on C-reactive protein in H7N9 infections. Int J Infect Dis. 2016;44:31-36. [PMID: 26809124 DOI: 10.1016/j.ijid.2016.01.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
571 Dixit R, Herz J, Dalton R, Booy R. Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens. Vaccine 2016;34:1152-61. [PMID: 26802604 DOI: 10.1016/j.vaccine.2016.01.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
572 Lin X, Wang R, Zou W, Sun X, Liu X, Zhao L, Wang S, Jin M. The Influenza Virus H5N1 Infection Can Induce ROS Production for Viral Replication and Host Cell Death in A549 Cells Modulated by Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression. Viruses 2016;8:E13. [PMID: 26761025 DOI: 10.3390/v8010013] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
573 Lowen AC. Virology: Host protein clips bird flu's wings in mammals. Nature 2016;529:30-1. [PMID: 26738587 DOI: 10.1038/529030a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
574 Zhang Y, Liu J, Yu L, Zhou N, Ding W, Zheng S, Shi D, Li L. Prevalence and characteristics of hypoxic hepatitis in the largest single-centre cohort of avian influenza A(H7N9) virus-infected patients with severe liver impairment in the intensive care unit. Emerg Microbes Infect. 2016;5:e1. [PMID: 26733380 DOI: 10.1038/emi.2016.1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
575 Hu Y, Zhang Y, Ren X, Liu Y, Xiao Y, Li L, Yang F, Su H, Liu F, Liu H, Cao B, Jin Q. A case report demonstrating the utility of next generation sequencing in analyzing serial samples from the lung following an infection with influenza A (H7N9) virus. J Clin Virol 2016;76:45-50. [PMID: 26826577 DOI: 10.1016/j.jcv.2015.12.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
576 Ciancanelli MJ, Abel L, Zhang SY, Casanova JL. Host genetics of severe influenza: from mouse Mx1 to human IRF7. Curr Opin Immunol 2016;38:109-20. [PMID: 26761402 DOI: 10.1016/j.coi.2015.12.002] [Cited by in Crossref: 90] [Cited by in F6Publishing: 94] [Article Influence: 12.9] [Reference Citation Analysis]
577 Teijaro JR. Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses. Adv Immunol 2016;132:135-58. [PMID: 27769506 DOI: 10.1016/bs.ai.2016.08.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
578 Carolan LA, Rockman S, Borg K, Guarnaccia T, Reading P, Mosse J, Kelso A, Barr I, Laurie KL. Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B Viruses. J Virol 2015;90:2838-48. [PMID: 26719259 DOI: 10.1128/JVI.02797-15] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
579 Anfasa F, Nainggolan L, Martina BEE. Dengue Virus Infection in Humans: Epidemiology, Biology, Pathogenesis, and Clinical Aspects. Human Emerging and Re‐emerging Infections 2015. [DOI: 10.1002/9781118644843.ch7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
580 Briata P, Bordo D, Puppo M, Gorlero F, Rossi M, Perrone-Bizzozero N, Gherzi R. Diverse roles of the nucleic acid-binding protein KHSRP in cell differentiation and disease. Wiley Interdiscip Rev RNA 2016;7:227-40. [PMID: 26708421 DOI: 10.1002/wrna.1327] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
581 McClain MT, Henao R, Williams J, Nicholson B, Veldman T, Hudson L, Tsalik EL, Lambkin-Williams R, Gilbert A, Mann A, Ginsburg GS, Woods CW. Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge. Clin Exp Immunol 2016;183:441-51. [PMID: 26506932 DOI: 10.1111/cei.12736] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
582 Xia C, Vijayan M, Pritzl CJ, Fuchs SY, McDermott AB, Hahm B. Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1. J Virol 2015;90:2403-17. [PMID: 26676772 DOI: 10.1128/JVI.02749-15] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
583 Lee PH, Bird N, MacKenzie-Kludas C, Mansell A, Kedzierska K, Brown L, McAuley J. Induction of memory cytotoxic T cells to influenza A virus and subsequent viral clearance is not modulated by PB1-F2-dependent inflammasome activation. Immunol Cell Biol 2016;94:439-46. [PMID: 26667784 DOI: 10.1038/icb.2015.115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
584 Edenborough KM, Lowther S, Laurie K, Yamada M, Long F, Bingham J, Payne J, Harper J, Haining J, Arkinstall R, Gilbertson B, Middleton D, Brown LE. Predicting Disease Severity and Viral Spread of H5N1 Influenza Virus in Ferrets in the Context of Natural Exposure Routes. J Virol 2016;90:1888-97. [PMID: 26656692 DOI: 10.1128/JVI.01878-15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
585 Screaton G, Mongkolsapaya J, Yacoub S, Roberts C. New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol 2015;15:745-59. [DOI: 10.1038/nri3916] [Cited by in Crossref: 230] [Cited by in F6Publishing: 232] [Article Influence: 28.8] [Reference Citation Analysis]
586 Lim WS, Brittain C, Duley L, Edwards S, Gordon S, Montgomery A, Nguyen-Van-Tam J, Read R, Whitham D, Whynes D, Woodhead M, Wootton D. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation. Health Technol Assess 2015;19:1-78, vii-viii. [PMID: 25716702 DOI: 10.3310/hta19160] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
587 Dong T. CD8+ cytotoxic T lymphocytes in human influenza virus infection. Natl Sci Rev 2015;2:264-5. [PMID: 26543667 DOI: 10.1093/nsr/nwv033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
588 Cressler CE, Graham AL, Day T. Evolution of hosts paying manifold costs of defence. Proc Biol Sci 2015;282:20150065. [PMID: 25740895 DOI: 10.1098/rspb.2015.0065] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
589 Samy RP, Lim LH. DAMPs and influenza virus infection in ageing. Ageing Res Rev 2015;24:83-97. [PMID: 26200296 DOI: 10.1016/j.arr.2015.07.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
590 Rodriguez-frandsen A, Alfonso R, Nieto A. Influenza virus polymerase: Functions on host range, inhibition of cellular response to infection and pathogenicity. Virus Research 2015;209:23-38. [DOI: 10.1016/j.virusres.2015.03.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
591 Ng LF, Solomon T. Decade in review-CNS infections: major advances against a moving target of CNS infections. Nat Rev Neurol 2015;11:623-4. [PMID: 26503929 DOI: 10.1038/nrneurol.2015.202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
592 Luczo JM, Stambas J, Durr PA, Michalski WP, Bingham J. Molecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motif. Rev Med Virol 2015;25:406-30. [PMID: 26467906 DOI: 10.1002/rmv.1846] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
593 Furuya Y, Furuya AK, Roberts S, Sanfilippo AM, Salmon SL, Metzger DW. Prevention of Influenza Virus-Induced Immunopathology by TGF-β Produced during Allergic Asthma. PLoS Pathog 2015;11:e1005180. [PMID: 26407325 DOI: 10.1371/journal.ppat.1005180] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
594 Cho S, Youn HN, Hoang PM, Cho S, Kim KE, Kil EJ, Lee G, Cho MJ, Hong J, Byun SJ, Song CS, Lee S. Preventive Activity against Influenza (H1N1) Virus by Intranasally Delivered RNA-Hydrolyzing Antibody in Respiratory Epithelial Cells of Mice. Viruses 2015;7:5133-44. [PMID: 26402693 DOI: 10.3390/v7092863] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
595 Travanty E, Zhou B, Zhang H, Di YP, Alcorn JF, Wentworth DE, Mason R, Wang J. Differential Susceptibilities of Human Lung Primary Cells to H1N1 Influenza Viruses. J Virol 2015;89:11935-44. [PMID: 26378172 DOI: 10.1128/JVI.01792-15] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
596 Cheng QL, Ding H, Sun Z, Kao QJ, Yang XH, Huang RJ, Wen YY, Wang J, Xie L. Retrospective study of risk factors for mortality in human avian influenza A(H7N9) cases in Zhejiang Province, China, March 2013 to June 2014. Int J Infect Dis 2015;39:95-101. [PMID: 26376223 DOI: 10.1016/j.ijid.2015.09.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
597 Li J, Zhou B, Li C, Chen Q, Wang Y, Li Z, Chen T, Yang C, Jiang Z, Zhong N, Yang Z, Chen R. Lariciresinol-4-O-β-D-glucopyranoside from the root of Isatis indigotica inhibits influenza A virus-induced pro-inflammatory response. J Ethnopharmacol 2015;174:379-86. [PMID: 26320688 DOI: 10.1016/j.jep.2015.08.037] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
598 Ju X, Yan Y, Liu Q, Li N, Sheng M, Zhang L, Li X, Liang Z, Huang F, Liu K, Zhao Y, Zhang Y, Zou Z, Du J, Zhong Y, Zhou H, Yang P, Lu H, Tian M, Li D, Zhang J, Jin N, Jiang C. Neuraminidase of Influenza A Virus Binds Lysosome-Associated Membrane Proteins Directly and Induces Lysosome Rupture. J Virol 2015;89:10347-58. [PMID: 26246576 DOI: 10.1128/JVI.01411-15] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
599 Vissers M, Schreurs I, Jans J, Heldens J, de Groot R, de Jonge MI, Ferwerda G. Antibodies enhance CXCL10 production during RSV infection of infant and adult immune cells. Cytokine 2015;76:458-64. [PMID: 26253531 DOI: 10.1016/j.cyto.2015.07.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
600 Kuriakose T, Tripp RA, Watford WT. Tumor Progression Locus 2 Promotes Induction of IFNλ, Interferon Stimulated Genes and Antigen-Specific CD8+ T Cell Responses and Protects against Influenza Virus. PLoS Pathog 2015;11:e1005038. [PMID: 26241898 DOI: 10.1371/journal.ppat.1005038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
601 He J, Duan J. First human case of avian influenza A (H5N6) in Yunnan province, China. SAGE Open Med Case Rep 2015;3:2050313X15596484. [PMID: 27489694 DOI: 10.1177/2050313X15596484] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
602 Thanunchai M, Hongeng S, Thitithanyanont A. Mesenchymal Stromal Cells and Viral Infection. Stem Cells Int. 2015;2015:860950. [PMID: 26294919 DOI: 10.1155/2015/860950] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
603 Hartmann BM, Thakar J, Albrecht RA, Avey S, Zaslavsky E, Marjanovic N, Chikina M, Fribourg M, Hayot F, Schmolke M, Meng H, Wetmur J, García-Sastre A, Kleinstein SH, Sealfon SC. Human Dendritic Cell Response Signatures Distinguish 1918, Pandemic, and Seasonal H1N1 Influenza Viruses. J Virol 2015;89:10190-205. [PMID: 26223639 DOI: 10.1128/JVI.01523-15] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
604 Traboulsi H, Cloutier A, Boyapelly K, Bonin MA, Marsault É, Cantin AM, Richter MV. The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection. Antimicrob Agents Chemother 2015;59:6317-27. [PMID: 26248373 DOI: 10.1128/AAC.01098-15] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
605 Ramos I, Fernandez-Sesma A. Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs. Front Immunol 2015;6:361. [PMID: 26257731 DOI: 10.3389/fimmu.2015.00361] [Cited by in Crossref: 81] [Cited by in F6Publishing: 83] [Article Influence: 10.1] [Reference Citation Analysis]
606 Liu Q, Zhou YH, Yang ZQ. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol. 2016;13:3-10. [PMID: 26189369 DOI: 10.1038/cmi.2015.74] [Cited by in Crossref: 416] [Cited by in F6Publishing: 434] [Article Influence: 52.0] [Reference Citation Analysis]
607 Lersritwimanmaen P, Na-Ek P, Thanunchai M, Thewsoongnoen J, Sa-Ard-Iam N, Wiboon-ut S, Mahanonda R, Thitithanyanont A. The presence of monocytes enhances the susceptibility of B cells to highly pathogenic avian influenza (HPAI) H5N1 virus possibly through the increased expression of α2,3 SA receptor. Biochem Biophys Res Commun 2015;464:888-93. [PMID: 26187669 DOI: 10.1016/j.bbrc.2015.07.061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
608 Yamaya M, Shimotai Y, Hatachi Y, Lusamba Kalonji N, Tando Y, Kitajima Y, Matsuo K, Kubo H, Nagatomi R, Hongo S, Homma M, Nishimura H. The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells. Pulm Pharmacol Ther 2015;33:66-74. [PMID: 26166259 DOI: 10.1016/j.pupt.2015.07.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 7.5] [Reference Citation Analysis]
609 Pan M, Gao R, Lv Q, Huang S, Zhou Z, Yang L, Li X, Zhao X, Zou X, Tong W, Mao S, Zou S, Bo H, Zhu X, Liu L, Yuan H, Zhang M, Wang D, Li Z, Zhao W, Ma M, Li Y, Li T, Yang H, Xu J, Zhou L, Zhou X, Tang W, Song Y, Chen T, Bai T, Zhou J, Wang D, Wu G, Li D, Feng Z, Gao GF, Wang Y, He S, Shu Y. Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: Virological and clinical findings. J Infect 2016;72:52-9. [PMID: 26143617 DOI: 10.1016/j.jinf.2015.06.009] [Cited by in Crossref: 120] [Cited by in F6Publishing: 122] [Article Influence: 15.0] [Reference Citation Analysis]
610 Fan J, Huang H, Liu C, Yang C, Guo J, Chang C, Chang Y. Effects of landslide and other physiographic factors on the occurrence probability of debris flows in central Taiwan. Environ Earth Sci 2015;74:1785-1801. [DOI: 10.1007/s12665-015-4187-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
611 Koçer ZA, Krauss S, Zanin M, Danner A, Gulati S, Jones JC, Friedman K, Graham A, Forrest H, Seiler J, Air GM, Webster RG. Possible basis for the emergence of H1N1 viruses with pandemic potential from avian hosts. Emerg Microbes Infect 2015;4:e40. [PMID: 26251829 DOI: 10.1038/emi.2015.40] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
612 Shi X, Shi Z, Huang H, Zhu H, Zhou P, Zhu H, Ju D. Ability of recombinant human catalase to suppress inflammation of the murine lung induced by influenza A. Inflammation 2014;37:809-17. [PMID: 24385240 DOI: 10.1007/s10753-013-9800-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
613 Nosaka N, Yashiro M, Yamada M, Fujii Y, Tsukahara H, Liu K, Nishibori M, Matsukawa A, Morishima T. Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice. Crit Care 2015;19:249. [PMID: 26067826 DOI: 10.1186/s13054-015-0983-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
614 Camp JV, Bagci U, Chu YK, Squier B, Fraig M, Uriarte SM, Guo H, Mollura DJ, Jonsson CB. Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils. J Virol 2015;89:8733-48. [PMID: 26063430 DOI: 10.1128/JVI.00817-15] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
615 Lê VB, Schneider JG, Boergeling Y, Berri F, Ducatez M, Guerin JL, Adrian I, Errazuriz-Cerda E, Frasquilho S, Antunes L, Lina B, Bordet JC, Jandrot-Perrus M, Ludwig S, Riteau B. Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. Am J Respir Crit Care Med 2015;191:804-19. [PMID: 25664391 DOI: 10.1164/rccm.201406-1031OC] [Cited by in Crossref: 110] [Cited by in F6Publishing: 113] [Article Influence: 13.8] [Reference Citation Analysis]
616 Shoemaker JE, Fukuyama S, Eisfeld AJ, Zhao D, Kawakami E, Sakabe S, Maemura T, Gorai T, Katsura H, Muramoto Y, Watanabe S, Watanabe T, Fuji K, Matsuoka Y, Kitano H, Kawaoka Y. An Ultrasensitive Mechanism Regulates Influenza Virus-Induced Inflammation. PLoS Pathog 2015;11:e1004856. [PMID: 26046528 DOI: 10.1371/journal.ppat.1004856] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
617 Banerjee R, Roy A, Das S, Basak S. Similarity of currently circulating H1N1 virus with the 2009 pandemic clone: Viability of an imminent pandemic. Infection, Genetics and Evolution 2015;32:107-12. [DOI: 10.1016/j.meegid.2015.02.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
618 Guo J, Huang F, Liu J, Chen Y, Wang W, Cao B, Zou Z, Liu S, Pan J, Bao C, Zeng M, Xiao H, Gao H, Yang S, Zhao Y, Liu Q, Zhou H, Zhu J, Liu X, Liang W, Yang Y, Zheng S, Yang J, Diao H, Su K, Shao L, Cao H, Wu Y, Zhao M, Tan S, Li H, Xu X, Wang C, Zhang J, Wang L, Wang J, Xu J, Li D, Zhong N, Cao X, Gao GF, Li L, Jiang C. The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes. Sci Rep 2015;5:10942. [PMID: 26028236 DOI: 10.1038/srep10942] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 10.3] [Reference Citation Analysis]
619 Boergeling Y, Rozhdestvensky TS, Schmolke M, Resa-Infante P, Robeck T, Randau G, Wolff T, Gabriel G, Brosius J, Ludwig S. Evidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded Protein. PLoS Pathog. 2015;11:e1004924. [PMID: 26024522 DOI: 10.1371/journal.ppat.1004924] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
620 McMaster SR, Wilson JJ, Wang H, Kohlmeier JE. Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-γ Production. J Immunol 2015;195:203-9. [PMID: 26026054 DOI: 10.4049/jimmunol.1402975] [Cited by in Crossref: 159] [Cited by in F6Publishing: 168] [Article Influence: 19.9] [Reference Citation Analysis]
621 Liu R, An L, Liu G, Li X, Tang W, Chen X. Mouse lung slices: An ex vivo model for the evaluation of antiviral and anti-inflammatory agents against influenza viruses. Antiviral Res 2015;120:101-11. [PMID: 26022197 DOI: 10.1016/j.antiviral.2015.05.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
622 Lin X, Wang R, Zhang J, Sun X, Zou Z, Wang S, Jin M. Insights into Human Astrocyte Response to H5N1 Infection by Microarray Analysis. Viruses 2015;7:2618-40. [PMID: 26008703 DOI: 10.3390/v7052618] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
623 Rendón-Ramirez EJ, Ortiz-Stern A, Martinez-Mejia C, Salinas-Carmona MC, Rendon A, Mata-Tijerina VL, Rosas-Taraco AG. TGF-β Blood Levels Distinguish Between Influenza A (H1N1)pdm09 Virus Sepsis and Sepsis due to Other Forms of Community-Acquired Pneumonia. Viral Immunol 2015;28:248-54. [PMID: 25923384 DOI: 10.1089/vim.2014.0123] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
624 Li C, Jiao S, Wang G, Gao Y, Liu C, He X, Zhang C, Xiao J, Li W, Zhang G, Wei B, Chen H, Wang H. The Immune Adaptor ADAP Regulates Reciprocal TGF-β1-Integrin Crosstalk to Protect from Influenza Virus Infection. PLoS Pathog 2015;11:e1004824. [PMID: 25909459 DOI: 10.1371/journal.ppat.1004824] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
625 Hui KP, Kuok DI, Kang SS, Li HS, Ng MM, Bui CH, Peiris JS, Chan RW, Chan MC. Modulation of sterol biosynthesis regulates viral replication and cytokine production in influenza A virus infected human alveolar epithelial cells. Antiviral Res 2015;119:1-7. [PMID: 25882623 DOI: 10.1016/j.antiviral.2015.04.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
626 Lai CH, Tang N, Jan JT, Huang MH, Lu CY, Chiang BL, Huang LM, Wu SC. Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection. Vaccine 2015;33:4321-9. [PMID: 25858857 DOI: 10.1016/j.vaccine.2015.03.082] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
627 Price I, Mochan-Keef ED, Swigon D, Ermentrout GB, Lukens S, Toapanta FR, Ross TM, Clermont G. The inflammatory response to influenza A virus (H1N1): An experimental and mathematical study. J Theor Biol 2015;374:83-93. [PMID: 25843213 DOI: 10.1016/j.jtbi.2015.03.017] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
628 Woods PS, Tazi MF, Chesarino NM, Amer AO, Davis IC. TGF-β-induced IL-6 prevents development of acute lung injury in influenza A virus-infected F508del CFTR-heterozygous mice. Am J Physiol Lung Cell Mol Physiol 2015;308:L1136-44. [PMID: 25840995 DOI: 10.1152/ajplung.00078.2015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
629 Lee E, Kang H, Kim K, Choi J, To TL, Nguyen TD, Song B, Jeong J, Choi K, Kim J, Lee H, Lee Y, Kim J. Genetic evolution of H5 highly pathogenic avian influenza virus in domestic poultry in Vietnam between 2011 and 2013. Poultry Science 2015;94:650-61. [DOI: 10.3382/ps/pev036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
630 Tolosa JM, Parsons KS, Hansbro PM, Smith R, Wark PA. The placental protein syncytin-1 impairs antiviral responses and exaggerates inflammatory responses to influenza. PLoS One 2015;10:e0118629. [PMID: 25831059 DOI: 10.1371/journal.pone.0118629] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
631 Enkirch T, von Messling V. Ferret models of viral pathogenesis. Virology 2015;479-480:259-70. [PMID: 25816764 DOI: 10.1016/j.virol.2015.03.017] [Cited by in Crossref: 109] [Cited by in F6Publishing: 118] [Article Influence: 13.6] [Reference Citation Analysis]
632 Abdal Dayem A, Choi HY, Kim YB, Cho SG. Antiviral effect of methylated flavonol isorhamnetin against influenza. PLoS One 2015;10:e0121610. [PMID: 25806943 DOI: 10.1371/journal.pone.0121610] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 7.5] [Reference Citation Analysis]
633 Baharom F, Thomas S, Bieder A, Hellmér M, Volz J, Sandgren KJ, McInerney GM, Karlsson Hedestam GB, Mellman I, Smed-Sörensen A. Protection of human myeloid dendritic cell subsets against influenza A virus infection is differentially regulated upon TLR stimulation. J Immunol 2015;194:4422-30. [PMID: 25801434 DOI: 10.4049/jimmunol.1402671] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
634 Cai W, Li Y, Chen S, Wang M, Zhang A, Zhou H, Chen H, Jin M. 14-Deoxy-11,12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes. Antiviral Res 2015;118:82-92. [PMID: 25800824 DOI: 10.1016/j.antiviral.2015.03.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
635 Li Y, Jin S, Lei L, Pan Z, Zou X. Deciphering deterioration mechanisms of complex diseases based on the construction of dynamic networks and systems analysis. Sci Rep 2015;5:9283. [PMID: 25788156 DOI: 10.1038/srep09283] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
636 Chiu C, Openshaw PJ. Antiviral B cell and T cell immunity in the lungs. Nat Immunol 2015;16:18-26. [PMID: 25521681 DOI: 10.1038/ni.3056] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 11.1] [Reference Citation Analysis]
637 Kash JC, Taubenberger JK. The role of viral, host, and secondary bacterial factors in influenza pathogenesis. Am J Pathol 2015;185:1528-36. [PMID: 25747532 DOI: 10.1016/j.ajpath.2014.08.030] [Cited by in Crossref: 111] [Cited by in F6Publishing: 97] [Article Influence: 13.9] [Reference Citation Analysis]
638 Lowen AC, Bouvier NM, Steel J. Transmission in the guinea pig model. Curr Top Microbiol Immunol 2014;385:157-83. [PMID: 25001209 DOI: 10.1007/82_2014_390] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
639 Dutta A, Huang C, Chen T, Lin C, Chiu C, Lin Y, Chang C, He Y. IL-10 inhibits neuraminidase-activated TGF-β and facilitates Th1 phenotype during early phase of infection. Nat Commun 2015;6. [DOI: 10.1038/ncomms7374] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
640 Yang ZF, Mok CK, Liu XQ, Li XB, He JF, Guan WD, Xu YH, Pan WQ, Chen LY, Lin YP, Wu SG, Pan SH, Huang JC, Ding GY, Zheng K, Ke CW, Lin JY, Zhang YH, Lee HH, Liu WK, Yang CG, Zhou R, Peiris JS, Li YM, Chen RC, Chen L, Zhong NS. Clinical, virological and immunological features from patients infected with re-emergent avian-origin human H7N9 influenza disease of varying severity in Guangdong province. PLoS One 2015;10:e0117846. [PMID: 25723593 DOI: 10.1371/journal.pone.0117846] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
641 Davidson S, Maini MK, Wack A. Disease-promoting effects of type I interferons in viral, bacterial, and coinfections. J Interferon Cytokine Res. 2015;35:252-264. [PMID: 25714109 DOI: 10.1089/jir.2014.0227] [Cited by in Crossref: 125] [Cited by in F6Publishing: 118] [Article Influence: 15.6] [Reference Citation Analysis]
642 Voellmy R, Bloom DC, Vilaboa N. A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virus. Expert Rev Vaccines 2015;14:637-51. [PMID: 25676927 DOI: 10.1586/14760584.2015.1013941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
643 Zeng H, Belser JA, Goldsmith CS, Gustin KM, Veguilla V, Katz JM, Tumpey TM. A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 virus. J Virol 2015;89:4655-67. [PMID: 25673714 DOI: 10.1128/JVI.03095-14] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
644 Lee Y, Kim YJ, Jung YJ, Kim KH, Kwon YM, Kim SI, Kang SM. Systems biology from virus to humans. J Anal Sci Technol 2015;6:3. [PMID: 26269748 DOI: 10.1186/s40543-015-0047-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
645 Lazarus R, Lim PL. Avian influenza: recent epidemiology, travel-related risk, and management. Curr Infect Dis Rep 2015;17:456. [PMID: 25475382 DOI: 10.1007/s11908-014-0456-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
646 Yang ZF, He JF, Li XB, Guan WD, Ke CW, Wu SG, Pan SH, Li RF, Kang M, Wu J, Lin JY, Ding GY, Huang JC, Pan WQ, Zhou R, Lin YP, Chen RC, Li YM, Chen L, Xiao WL, Zhang YH, Zhong NS. Epidemiological and viral genome characteristics of the first human H7N9 influenza infection in Guangdong Province, China. J Thorac Dis 2014;6:1785-93. [PMID: 25589974 DOI: 10.3978/j.issn.2072-1439.2014.12.09] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
647 Liu M, Li X, Yuan H, Zhou J, Wu J, Bo H, Xia W, Xiong Y, Yang L, Gao R, Guo J, Huang W, Zhang Y, Zhao X, Zou X, Chen T, Wang D, Li Q, Wang S, Chen S, Hu M, Ni X, Gong T, Shi Y, Li J, Zhou J, Cai J, Xiao Z, Zhang W, Sun J, Li D, Wu G, Feng Z, Wang Y, Chen H, Shu Y. Genetic diversity of avian influenza A (H10N8) virus in live poultry markets and its association with human infections in China. Sci Rep 2015;5:7632. [PMID: 25591167 DOI: 10.1038/srep07632] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
648 To KK, Chan JF, Yuen KY. Viral lung infections: epidemiology, virology, clinical features, and management of avian influenza A(H7N9). Curr Opin Pulm Med 2014;20:225-32. [PMID: 24637225 DOI: 10.1097/MCP.0000000000000047] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
649 Long GH, Graham AL. Consequences of immunopathology for pathogen virulence evolution and public health: malaria as a case study. Evol Appl 2011;4:278-91. [PMID: 25567973 DOI: 10.1111/j.1752-4571.2010.00178.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
650 Liu AL, Li YF, Qi W, Ma XL, Yu KX, Huang B, Liao M, Li F, Pan J, Song MX. Comparative analysis of selected innate immune-related genes following infection of immortal DF-1 cells with highly pathogenic (H5N1) and low pathogenic (H9N2) avian influenza viruses. Virus Genes 2015;50:189-99. [PMID: 25557928 DOI: 10.1007/s11262-014-1151-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
651 Peretz J, Hall OJ, Klein SL. Sex Differences in Influenza Virus Infection, Vaccination, and Therapies. Sex and Gender Differences in Infection and Treatments for Infectious Diseases 2015. [DOI: 10.1007/978-3-319-16438-0_6] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
652 Lu P, Zhao Q. Highly Pathogenic Avian Influenza. Radiology of Infectious Diseases: Volume 1 2015. [DOI: 10.1007/978-94-017-9882-2_18] [Reference Citation Analysis]
653 Norval M, Björn LO. Vitamin D: Photobiological and Ecological Aspects. Photobiology 2015. [DOI: 10.1007/978-1-4939-1468-5_23] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
654 Broadbent AJ, Boonnak K, Subbarao K. Respiratory Virus Vaccines. Mucosal Immunology 2015. [DOI: 10.1016/b978-0-12-415847-4.00059-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
655 Treanor JJ. Influenza (Including Avian Influenza and Swine Influenza). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2015. [DOI: 10.1016/b978-1-4557-4801-3.00167-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
656 Skidmore MA, Kajaste-rudnitski A, Wells NM, Guimond SE, Rudd TR, Yates EA, Vicenzi E. Inhibition of influenza H5N1 invasion by modified heparin derivatives. Med Chem Commun 2015;6:640-6. [DOI: 10.1039/c4md00516c] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
657 Long JS, Benfield CT, Barclay WS. One-way trip: Influenza virus' adaptation to gallinaceous poultry may limit its pandemic potential: Prospects & Overviews. BioEssays 2015;37:204-12. [DOI: 10.1002/bies.201400133] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
658 Ye S, Lowther S, Stambas J. Inhibition of reactive oxygen species production ameliorates inflammation induced by influenza A viruses via upregulation of SOCS1 and SOCS3. J Virol 2015;89:2672-83. [PMID: 25520513 DOI: 10.1128/JVI.03529-14] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
659 Oshansky CM, Wong SS, Jeevan T, Smallwood HS, Webby RJ, Shafir SC, Thomas PG. Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers. mBio 2014;5:e02107. [PMID: 25491354 DOI: 10.1128/mBio.02107-14] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
660 Nolte MA, van der Meer JW. Inflammatory responses to infection: the Dutch contribution. Immunol Lett 2014;162:113-20. [PMID: 25455597 DOI: 10.1016/j.imlet.2014.10.007] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
661 Qian G, Wang S, Chi X, Li H, Wei H, Zhu X, Chen Y, Chen JL. The amino-terminal region of the neuraminidase protein from avian H5N1 influenza virus is important for its biosynthetic transport to the host cell surface. Vet J 2014;202:612-7. [PMID: 25458889 DOI: 10.1016/j.tvjl.2014.10.015] [Reference Citation Analysis]
662 Xie J, Zhang S, Hu Y, Li D, Cui J, Xue J, Zhang G, Khachigian LM, Wong J, Sun L, Wang M. Regulatory roles of c-jun in H5N1 influenza virus replication and host inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014;1842:2479-88. [DOI: 10.1016/j.bbadis.2014.04.017] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
663 Tang L, Mao Z, Li X, Chen M, Li S, Tsoi B, Cao L, Li L, Zeng J, Wang Z, Yu G, Xiao W, Li Y, Kurihara H, He R. ReDuNing, a patented Chinese medicine, reduces the susceptibility to H1N1 influenza of mice loaded with restraint stress. European Journal of Integrative Medicine 2014;6:637-45. [DOI: 10.1016/j.eujim.2014.07.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
664 Westenius V, Mäkelä SM, Ziegler T, Julkunen I, Österlund P. Efficient replication and strong induction of innate immune responses by H9N2 avian influenza virus in human dendritic cells. Virology 2014;471-473:38-48. [DOI: 10.1016/j.virol.2014.10.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
665 de Chassey B, Meyniel-Schicklin L, Vonderscher J, André P, Lotteau V. Virus-host interactomics: new insights and opportunities for antiviral drug discovery. Genome Med 2014;6:115. [PMID: 25593595 DOI: 10.1186/s13073-014-0115-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 8.1] [Reference Citation Analysis]
666 Kuchipudi SV, Tellabati M, Sebastian S, Londt BZ, Jansen C, Vervelde L, Brookes SM, Brown IH, Dunham SP, Chang KC. Highly pathogenic avian influenza virus infection in chickens but not ducks is associated with elevated host immune and pro-inflammatory responses. Vet Res 2014;45:118. [PMID: 25431115 DOI: 10.1186/s13567-014-0118-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 7.2] [Reference Citation Analysis]
667 Edenborough K, Marsh GA. Reverse genetics: Unlocking the secrets of negative sense RNA viral pathogens. World J Clin Infect Dis 2014; 4(4): 16-26 [DOI: 10.5495/wjcid.v4.i4.16] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
668 Boon AC, Williams RW, Sinasac DS, Webby RJ. A novel genetic locus linked to pro-inflammatory cytokines after virulent H5N1 virus infection in mice. BMC Genomics 2014;15:1017. [PMID: 25418976 DOI: 10.1186/1471-2164-15-1017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
669 Marois I, Cloutier A, Garneau É, Lesur O, Richter MV. The administration of oseltamivir results in reduced effector and memory CD8+ T cell responses to influenza and affects protective immunity. FASEB J 2015;29:973-87. [PMID: 25414485 DOI: 10.1096/fj.14-260687] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
670 Rodrigo C, Leonardi-bee J, Nguyen-van-tam JS, Lim WS. Effect of Corticosteroid Therapy on Influenza-Related Mortality: A Systematic Review and Meta-analysis. J Infect Dis 2015;212:183-94. [DOI: 10.1093/infdis/jiu645] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
671 Mehrbod P, Omar AR, Hair-Bejo M, Haghani A, Ideris A. Mechanisms of action and efficacy of statins against influenza. Biomed Res Int 2014;2014:872370. [PMID: 25478576 DOI: 10.1155/2014/872370] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 6.4] [Reference Citation Analysis]
672 Feng Y, Hu L, Lu S, Chen Q, Zheng Y, Zeng D, Zhang J, Zhang A, Chen L, Hu Y, Zhang Z. Molecular pathology analyses of two fatal human infections of avian influenza A(H7N9) virus. J Clin Pathol 2015;68:57-63. [PMID: 25378539 DOI: 10.1136/jclinpath-2014-202441] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
673 Liu X, Zhang Y, Xu X, Du W, Su K, Zhu C, Chen Y, Lei S, Zheng S, Jiang J, Yang S, Guo J, Shao L, Yang Q, Chen J, Li L. Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A (H7N9): a cohort study. Ther Apher Dial 2015;19:178-84. [PMID: 25363618 DOI: 10.1111/1744-9987.12240] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
674 Hoang LT, Tolfvenstam T, Ooi EE, Khor CC, Naim AN, Ho EX, Ong SH, Wertheim HF, Fox A, Van Vinh Nguyen C, Nghiem NM, Ha TM, Thi Ngoc Tran A, Tambayah P, Lin R, Sangsajja C, Manosuthi W, Chuchottaworn C, Sansayunh P, Chotpitayasunondh T, Suntarattiwong P, Chokephaibulkit K, Puthavathana P, de Jong MD, Farrar J, van Doorn HR, Hibberd ML. Patient-based transcriptome-wide analysis identify interferon and ubiquination pathways as potential predictors of influenza A disease severity. PLoS One 2014;9:e111640. [PMID: 25365328 DOI: 10.1371/journal.pone.0111640] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
675 Bi Y, Xie Q, Zhang S, Li Y, Xiao H, Jin T, Zheng W, Li J, Jia X, Sun L, Liu J, Qin C, Gao GF, Liu W. Assessment of the internal genes of influenza A (H7N9) virus contributing to high pathogenicity in mice. J Virol 2015;89:2-13. [PMID: 25320305 DOI: 10.1128/JVI.02390-14] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 7.0] [Reference Citation Analysis]
676 Furman D. Sexual dimorphism in immunity: improving our understanding of vaccine immune responses in men. Expert Rev Vaccines 2015;14:461-71. [PMID: 25278153 DOI: 10.1586/14760584.2015.966694] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
677 Choi EJ, Kim HB, Baek YH, Kim EH, Pascua PN, Park SJ, Kwon HI, Lim GJ, Kim S, Kim YI, Choi YK. Differential microRNA expression following infection with a mouse-adapted, highly virulent avian H5N2 virus. BMC Microbiol 2014;14:252. [PMID: 25266911 DOI: 10.1186/s12866-014-0252-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
678 Kay AW, Fukuyama J, Aziz N, Dekker CL, Mackey S, Swan GE, Davis MM, Holmes S, Blish CA. Enhanced natural killer-cell and T-cell responses to influenza A virus during pregnancy. Proc Natl Acad Sci U S A 2014;111:14506-11. [PMID: 25246558 DOI: 10.1073/pnas.1416569111] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]
679 Fereidouni S, Munoz O, Von Dobschuetz S, De Nardi M. Influenza Virus Infection of Marine Mammals. Ecohealth 2016;13:161-70. [PMID: 25231137 DOI: 10.1007/s10393-014-0968-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
680 Li C, Li C, Zhang AJ, To KK, Lee AC, Zhu H, Wu HW, Chan JF, Chen H, Hung IF, Li L, Yuen KY. Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor. PLoS One 2014;9:e107966. [PMID: 25232731 DOI: 10.1371/journal.pone.0107966] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
681 Danzy S, Studdard LR, Manicassamy B, Solorzano A, Marshall N, García-Sastre A, Steel J, Lowen AC. Mutations to PB2 and NP proteins of an avian influenza virus combine to confer efficient growth in primary human respiratory cells. J Virol 2014;88:13436-46. [PMID: 25210184 DOI: 10.1128/JVI.01093-14] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
682 Bryson KJ, Nash AA, Norval M. Does vitamin D protect against respiratory viral infections? Epidemiol Infect 2014;142:1789-801. [PMID: 25030183 DOI: 10.1017/S0950268814000193] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
683 Heaton NS, Langlois RA, Sachs D, Lim JK, Palese P, tenOever BR. Long-term survival of influenza virus infected club cells drives immunopathology. J Exp Med 2014;211:1707-14. [PMID: 25135297 DOI: 10.1084/jem.20140488] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 7.3] [Reference Citation Analysis]
684 Guihot A, Luyt CE, Parrot A, Rousset D, Cavaillon JM, Boutolleau D, Fitting C, Pajanirassa P, Mallet A, Fartoukh M, Agut H, Musset L, Zoorob R, Kirilovksy A, Combadière B, van der Werf S, Autran B, Carcelain G; FluBAL Study Group. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. Am J Respir Crit Care Med 2014;189:1240-9. [PMID: 24646009 DOI: 10.1164/rccm.201311-2071OC] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
685 Strayer DR, Carter WA, Stouch BC, Stittelaar KJ, Thoolen RJ, Osterhaus AD, Mitchell WM. Protection from pulmonary tissue damage associated with infection of cynomolgus macaques by highly pathogenic avian influenza virus (H5N1) by low dose natural human IFN-α administered to the buccal mucosa. Antiviral Res 2014;110:175-80. [PMID: 25111905 DOI: 10.1016/j.antiviral.2014.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
686 Bolton KJ, McCaw JM, McVernon J, Mathews JD. The influence of changing host immunity on 1918-19 pandemic dynamics. Epidemics 2014;8:18-27. [PMID: 25240900 DOI: 10.1016/j.epidem.2014.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
687 Okino CH, dos Santos IL, Fernando FS, Alessi AC, Wang X, Montassier HJ. Inflammatory and cell-mediated immune responses in the respiratory tract of chickens to infection with avian infectious bronchitis virus. Viral Immunol 2014;27:383-91. [PMID: 25105981 DOI: 10.1089/vim.2014.0054] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
688 Halbroth BR, Heil A, Distler E, Dass M, Wagner EM, Plachter B, Probst HC, Strand D, Hartwig UF, Karner A, Aichinger G, Kistner O, Landfester K, Herr W. Superior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines. PLoS One 2014;9:e103392. [PMID: 25072749 DOI: 10.1371/journal.pone.0103392] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
689 Yamaya M, Nadine LK, Ota C, Kubo H, Makiguchi T, Nagatomi R, Nishimura H. Magnitude of influenza virus replication and cell damage is associated with interleukin-6 production in primary cultures of human tracheal epithelium. Respir Physiol Neurobiol 2014;202:16-23. [PMID: 25064661 DOI: 10.1016/j.resp.2014.07.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
690 Palermo RE, Tisoncik-Go J, Korth MJ, Katze MG. Old world monkeys and new age science: the evolution of nonhuman primate systems virology. ILAR J 2013;54:166-80. [PMID: 24174440 DOI: 10.1093/ilar/ilt039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
691 Gotts JE, Abbott J, Matthay MA. Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy. Am J Physiol Lung Cell Mol Physiol 2014;307:L395-406. [PMID: 25038188 DOI: 10.1152/ajplung.00110.2014] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 6.9] [Reference Citation Analysis]
692 Tsunetsugu-Yokota Y, Nishimura K, Misawa S, Kobayashi-Ishihara M, Takahashi H, Takayama I, Ohnishi K, Itamura S, Nguyen HL, Le MT, Dang GT, Nguyen LT, Tashiro M, Kageyama T. Development of a sensitive novel diagnostic kit for the highly pathogenic avian influenza A (H5N1) virus. BMC Infect Dis 2014;14:362. [PMID: 24992826 DOI: 10.1186/1471-2334-14-362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
693 Morrison J, Josset L, Tchitchek N, Chang J, Belser JA, Swayne DE, Pantin-Jackwood MJ, Tumpey TM, Katze MG. H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice. J Virol 2014;88:10556-68. [PMID: 24991006 DOI: 10.1128/JVI.00570-14] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
694 Pedersen GK, Höschler K, Øie Solbak SM, Bredholt G, Pathirana RD, Afsar A, Breakwell L, Nøstbakken JK, Raae AJ, Brokstad KA, Sjursen H, Zambon M, Cox RJ. Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination. Vaccine 2014;32:4550-7. [DOI: 10.1016/j.vaccine.2014.06.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
695 Negri P, Choi JY, Jones C, Tompkins SM, Tripp RA, Dluhy RA. Identification of virulence determinants in influenza viruses. Anal Chem 2014;86:6911-7. [PMID: 24937567 DOI: 10.1021/ac500659f] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
696 Aeffner F, Woods PS, Davis IC. Activation of A1-adenosine receptors promotes leukocyte recruitment to the lung and attenuates acute lung injury in mice infected with influenza A/WSN/33 (H1N1) virus. J Virol 2014;88:10214-27. [PMID: 24965449 DOI: 10.1128/JVI.01068-14] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
697 Pan H, Zhang P, Gao D, Zhang Y, Li P, Liu L, Wang C, Wang H, Ma Y, Cai L. Noninvasive visualization of respiratory viral infection using bioorthogonal conjugated near-infrared-emitting quantum dots. ACS Nano 2014;8:5468-77. [PMID: 24797178 DOI: 10.1021/nn501028b] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 6.1] [Reference Citation Analysis]
698 Klamp T, Camps M, Nieto B, Guasch F, Ranasinghe RT, Wiedemann J, Petrášek Z, Schwille P, Klenerman D, Sauer M. Highly rapid amplification-free and quantitative DNA imaging assay. Sci Rep 2013;3:1852. [PMID: 23677392 DOI: 10.1038/srep01852] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
699 Wang J, Li F, Sun R, Gao X, Wei H, Tian Z. Klebsiella pneumoniae alleviates influenza-induced acute lung injury via limiting NK cell expansion. J Immunol 2014;193:1133-41. [PMID: 24951819 DOI: 10.4049/jimmunol.1303303] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
700 Pascua PN, Choi YK. Zoonotic infections with avian influenza A viruses and vaccine preparedness: a game of "mix and match". Clin Exp Vaccine Res 2014;3:140-8. [PMID: 25003087 DOI: 10.7774/cevr.2014.3.2.140] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
701 Barbosa RP, Salgado AP, Garcia CC, Filho BG, Gonçalves AP, Lima BH, Lopes GA, Rachid MA, Peixoto AC, de Oliveira DB, Ataíde MA, Zirke CA, Cotrim TM, Costa ÉA, Almeida GM, Russo RC, Gazzinelli RT, Machado Ade M. Protective immunity and safety of a genetically modified influenza virus vaccine. PLoS One 2014;9:e98685. [PMID: 24927156 DOI: 10.1371/journal.pone.0098685] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
702 Han Y, Bo ZJ, Xu MY, Sun N, Liu DH. The Protective Role of TLR3 and TLR9 Ligands in Human Pharyngeal Epithelial Cells Infected with Influenza A Virus. Korean J Physiol Pharmacol 2014;18:225-31. [PMID: 24976762 DOI: 10.4196/kjpp.2014.18.3.225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
703 Liu B, Meng D, Wei T, Zhang S, Hu Y, Wang M. Apoptosis and pro-inflammatory cytokine response of mast cells induced by influenza A viruses. PLoS One 2014;9:e100109. [PMID: 24923273 DOI: 10.1371/journal.pone.0100109] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
704 Kitano M, Itoh Y, Ishigaki H, Nakayama M, Ishida H, Pham VL, Arikata M, Shichinohe S, Tsuchiya H, Kitagawa N, Kobayashi M, Yoshida R, Sato A, Le QM, Kawaoka Y, Ogasawara K. Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques. Antimicrob Agents Chemother 2014;58:4795-803. [PMID: 24913156 DOI: 10.1128/AAC.02817-14] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
705 Yum J, Park EH, Ku KB, Kim JA, Oh SK, Kim HS, Seo SH. Low infectivity of a novel avian-origin H7N9 influenza virus in pigs. Arch Virol 2014;159:2745-9. [PMID: 24906526 DOI: 10.1007/s00705-014-2143-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
706 Czudai-Matwich V, Otte A, Matrosovich M, Gabriel G, Klenk HD. PB2 mutations D701N and S714R promote adaptation of an influenza H5N1 virus to a mammalian host. J Virol 2014;88:8735-42. [PMID: 24899203 DOI: 10.1128/JVI.00422-14] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 7.3] [Reference Citation Analysis]
707 Muramoto Y, Shoemaker JE, Le MQ, Itoh Y, Tamura D, Sakai-Tagawa Y, Imai H, Uraki R, Takano R, Kawakami E, Ito M, Okamoto K, Ishigaki H, Mimuro H, Sasakawa C, Matsuoka Y, Noda T, Fukuyama S, Ogasawara K, Kitano H, Kawaoka Y. Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses. J Virol 2014;88:8981-97. [PMID: 24899188 DOI: 10.1128/JVI.00907-14] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
708 Hicks DJ, Kelly M, Brookes SM, Londt BZ, Ortiz Pelaez A, Orlowska A, Brown IH, Spencer YI, Núñez A. Cytokine Expression at Different Stages of Influenza A(H1N1)pdm09 Virus Infection in the Porcine Lung, Using Laser Capture Microdissection. Transbound Emerg Dis 2016;63:e71-9. [PMID: 24889764 DOI: 10.1111/tbed.12232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
709 Cauldwell AV, Long JS, Moncorgé O, Barclay WS. Viral determinants of influenza A virus host range. Journal of General Virology 2014;95:1193-210. [DOI: 10.1099/vir.0.062836-0] [Cited by in Crossref: 109] [Cited by in F6Publishing: 112] [Article Influence: 12.1] [Reference Citation Analysis]
710 Webster RG, Govorkova EA. Continuing challenges in influenza. Ann N Y Acad Sci 2014;1323:115-39. [PMID: 24891213 DOI: 10.1111/nyas.12462] [Cited by in Crossref: 221] [Cited by in F6Publishing: 234] [Article Influence: 24.6] [Reference Citation Analysis]
711 Davidson S, Crotta S, McCabe TM, Wack A. Pathogenic potential of interferon αβ in acute influenza infection. Nat Commun 2014;5:3864. [PMID: 24844667 DOI: 10.1038/ncomms4864] [Cited by in Crossref: 244] [Cited by in F6Publishing: 255] [Article Influence: 27.1] [Reference Citation Analysis]
712 Mann AJ, Noulin N, Catchpole A, Stittelaar KJ, de Waal L, Veldhuis Kroeze EJ, Hinchcliffe M, Smith A, Montomoli E, Piccirella S, Osterhaus AD, Knight A, Oxford JS, Lapini G, Cox R, Lambkin-Williams R. Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge. PLoS One 2014;9:e93761. [PMID: 24850536 DOI: 10.1371/journal.pone.0093761] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
713 Chen Y, Li X, Tian L, Zheng S, Yang S, Dong Y, Wang Y, Cui D, Liu X, Liang W, Chen H, Li L. Dynamic behavior of lymphocyte subgroups correlates with clinical outcomes in human H7N9 infection. J Infect 2014;69:358-65. [PMID: 24841136 DOI: 10.1016/j.jinf.2014.05.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
714 Yamaya M, Nadine L, Kubo H, Saito K, Saito R, Nishimura H. The effects of neuraminidase inhibitors on the release of oseltamivir-sensitive and oseltamivir-resistant influenza viruses from primary cultures of human tracheal epithelium. J Med Virol 2015;87:25-34. [PMID: 24838828 DOI: 10.1002/jmv.23974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
715 Cardoso FM, Ibañez LI, Van den Hoecke S, De Baets S, Smet A, Roose K, Schepens B, Descamps FJ, Fiers W, Muyldermans S, Depicker A, Saelens X. Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge. J Virol 2014;88:8278-96. [PMID: 24829341 DOI: 10.1128/JVI.03178-13] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
716 Boonnak K, Vogel L, Feldmann F, Feldmann H, Legge KL, Subbarao K. Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cells. J Immunol 2014;192:5906-12. [PMID: 24829418 DOI: 10.4049/jimmunol.1302992] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
717 Arilahti V, Mäkelä SM, Tynell J, Julkunen I, Österlund P. Novel avian influenza A (H7N9) virus induces impaired interferon responses in human dendritic cells. PLoS One 2014;9:e96350. [PMID: 24804732 DOI: 10.1371/journal.pone.0096350] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
718 Hui DS, Lee N. Adjunctive therapies and immunomodulating agents for severe influenza. Influenza Other Respir Viruses 2013;7 Suppl 3:52-9. [PMID: 24215382 DOI: 10.1111/irv.12171] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
719 Deng JC. Viral-bacterial interactions-therapeutic implications. Influenza Other Respir Viruses 2013;7 Suppl 3:24-35. [PMID: 24215379 DOI: 10.1111/irv.12174] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
720 Anikina AG, Shkurupii VA, Potapova OV, Kovner AV, Shestopalov AM. Expression of profibrotic growth factors and their receptors by mouse lung macrophages and fibroblasts under conditions of acute viral inflammation in influenza A/H5N1 virus. Bull Exp Biol Med 2014;156:833-7. [PMID: 24824710 DOI: 10.1007/s10517-014-2463-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
721